<SEC-DOCUMENT>0001213900-22-054910.txt : 20220909
<SEC-HEADER>0001213900-22-054910.hdr.sgml : 20220909
<ACCEPTANCE-DATETIME>20220909084740
ACCESSION NUMBER:		0001213900-22-054910
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		43
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220909
DATE AS OF CHANGE:		20220909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SaverOne 2014 Ltd.
		CENTRAL INDEX KEY:			0001894693
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41387
		FILM NUMBER:		221235114

	BUSINESS ADDRESS:	
		STREET 1:		EM HAMOSHAVOT RD.
		STREET 2:		94
		CITY:			PETAH TIKVAH
		STATE:			L3
		ZIP:			49130
		BUSINESS PHONE:		972-3-9094177

	MAIL ADDRESS:	
		STREET 1:		EM HAMOSHAVOT RD.
		STREET 2:		94
		CITY:			PETAH TIKVAH
		STATE:			L3
		ZIP:			49130
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea165490-6k_saverone.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<html xmlns:svre="http://www.saver.com/20220630" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Form <ix:nonNumeric contextRef="c0" name="dei:DocumentType">6-K</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Report of Foreign Private Issuer</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Rule 13a-16 or 15d-16</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">under the Securities Exchange Act of 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of <span style="-sec-ix-hidden: hidden-fact-0">September <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-41334</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="text-decoration:underline">SaverOne 2014 Ltd.</span></b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&#8217;s name into English)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Em Hamoshavot Rd. 94</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Petah Tikvah, Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form
40-F&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONTENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 9, 2022, SaverOne
2014 Ltd. issued unaudited interim condensed financial statements as of June 30, 2022, as well as its operating and financial review as
of June 30, 2022. Attached hereto and incorporated by reference herein are the following exhibits:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 9%"><span style="font-size: 10pt">99.1</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%"><span style="font-size: 10pt"><a href="ea165490ex99-1_saverone.htm">Operating and Financial Review as of June 30, 2022</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea165490ex99-2_saverone.htm">Unaudited Interim Condensed Financial Statements as of June 30, 2022</a></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">EXHIBIT INDEX</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 90%; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">99.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea165490ex99-1_saverone.htm">Operating and Financial Review as of June 30, 2022</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">99.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea165490ex99-2_saverone.htm">Unaudited Interim Condensed Financial Statements as of June 30, 2022</a></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">SIGNATURES</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-size: 10pt"><b>SaverOne 2014 Ltd.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: September 9, 2022</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ Tony Klein</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">Name:&#160;</span></td>
    <td style="width: 31%"><span style="font-size: 10pt">Tony Klein</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><div style="display: none"><ix:header>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ4Xc5jM3JYLIIgA3A4lxf70g==] CSR-->
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentPeriodEndDate">2022-06-30</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="svre-20220630.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea165490ex99-1_saverone.htm
<DESCRIPTION>OPERATING AND FINANCIAL REVIEW AS OF JUNE 30, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OPERATING AND FINANCIAL REVIEW AND PROSPECTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>You should read the following
discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes
included elsewhere in this Report on Form 6-K. The following discussion is based on our financial information prepared in accordance with
the IFRS, as issued by the IASB, which may differ in material respects from generally accepted accounting principles in other jurisdictions,
including U.S.&nbsp;generally accepted accounting principles, or GAAP. We maintain our accounting books and records in New Israeli Shekels
and our functional currency is the New Israeli Shekel. Certain amounts presented herein may not sum due to rounding. Unless the context
requires otherwise, references in this report to &ldquo;Company&rdquo;, &ldquo;SaverOne&rdquo;, &ldquo;we&rdquo; or &ldquo;our&rdquo;
refers to SaverOne 2014 Ltd. thereafter unless otherwise required by the context.. &ldquo;NIS&rdquo; means New Israeli Shekel, and &ldquo;$,&rdquo;
&ldquo;US$,&ldquo;U.S. dollars&rdquo; and &ldquo;USD&rdquo; mean United States dollars.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>The following discussion
and analysis of our financial condition and results of operations contains conversions of NIS amounts into U.S. dollars at specific rates
solely for the convenience of the reader. Unless otherwise noted, for the purposes of the presentation of financial data, all conversions
from NIS to U.S. dollars and from U.S. dollars to NIS were made at the rate of NIS 3.5 to $1.00, based on the representative exchange
rate reported by the Bank of Israel on June 30, 2022.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion contains
&ldquo;forward-looking statements,&rdquo; including statements regarding expectations, beliefs, intentions or strategies for the future.
These statements may identify important factors which could cause our actual results to differ materially from those indicated by the
forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include,
but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the ability of our technology to substantially improve the
safety of drivers;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our planned level of revenues and capital expenditures and
our belief that our existing cash will be sufficient to fund our operations for at least the next 12 months;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to market and sell our products;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our plans to continue to invest in research and development
to develop technology for both existing and new products;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our intention to advance our technologies and commercialization
efforts;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our intention to use local distributors in each country or
region that we will conduct business to distribute our products or technology;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our plan to seek patent, trademark and other intellectual
property rights for our products and technologies in the United States and internationally, as well as our ability to maintain and protect
the validity of our currently held intellectual property rights;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our expectations regarding future changes in our cost of revenues
and our operating expenses;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our expectations regarding our tax classifications;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">interpretations of current laws and the passage of future
laws;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">acceptance of our business model by investors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the ability to correctly identify and enter new markets;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the impact of competition and new technologies;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">general market, political and economic conditions in the countries
in which we operate;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">projected capital expenditures and liquidity</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our intention to retain key employees, and our belief that
we maintain good relations with all of our employees;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the impact of the COVID-19 pandemic, and resulting government
actions on us; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">other risks and uncertainties, including those listed in the
section titled &ldquo;Risk Factors&rdquo; in the final prospectus on Form 424B4 filed with the SEC on June 6, 2022.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preceding list is not
intended to be an exhaustive list of any forward-looking statements are based on our beliefs, assumptions and expectations of future performance,
taking into account the information available to us. These statements are only predictions based upon our current expectations and projections
about future events. There are important factors that could cause our actual results to differ materially from the results expressed or
implied by the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">    The
forward-looking statements contained in this Report on Form 6-K are based upon information available to our management as of the date
hereof and, while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete,
and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available
relevant information. The forward-looking statements contained in this Report on Form 6-K are expressly qualified in their entirety by
this cautionary statement. Except as required by law, we undertake no obligation to update publicly any forward-looking statements after
the date of this Report on Form 6-K to conform these statements to actual results or to changes in our expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a development stage
technology company engaged in the design, development and commercialization of transportation and safety applications designed to save
lives by preventing car accidents resulting from the use of cellular phones while driving. Our SaverOne system provides an advanced driver
safety solution that can identify and monitor mobile phones located in the driver&rsquo;s vicinity and selectively block use of life-threatening
applications. Our technology is based on our proprietary hardware, software and algorithms, and we believe it has significant advantages
over our competitors&rsquo; because our solution meets the National Highway Traffic Safety Administration&rsquo;s, or NHTSA&rsquo;s guidelines
for a complete solution for distracted driving.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our roadmap consists of two
product lines, the first line target the aftermarket vehicle market (i.e. vehicles already supplied to customers) and the second product
line targets vehicle manufacturers (a.k.a. the OEM market). Our first-generation product is for the aftermarket vehicle market and is
intended for private vehicles, trucks and buses. This Generation 1.0 was launched in late 2019, initially for private cars, and thereafter
was made commercially available to trucks and buses. It is currently marketed in Israel as part of our pre-commercialization/early user
campaign. We are working on pilot programs with various fleet and system integrators in the United States, Europe, Asia and APAC. To date,
over 1,600 systems have been ordered (which includes over 450 systems ordered as part of our ongoing Generation 1.0 pilot program and
over 1,150 systems purchased in commercial orders by our Generation 1.0 customers) and over 1,000 of these systems have been installed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our second-generation product
will replace the fist-generation in the aftermarket product line. This Generation 2.0 is intended for the global automobile market. It
includes significant improvements to our Generation 1.0 solution for maximal performance, compatibility with automobiles and cellular
networks, market penetration and profitability. We expect to launch the Generation 2.0 solution for sale in the third quarter of 2022.
We expect to target the global aftermarket automobile market starting with the U.S. and Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our second product line, for
the vehicle manufacturers, consists of our OEM solution. We plan to integrate it into the vehicle manufacturing process, to be offered
directly to customers by the vehicle manufacturer as part of the vehicle. We are currently working with one of the leading global OEMs
in order to have the SaverOne technology integrated into vehicles during the manufacturing process. The OEM solution is in the early stage
of development, and we expect to launch it during 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have experienced net losses
in every period since the inception of SaverOne. We incurred net losses of NIS 26.5 million (approximately $7.6 million), NIS 13.3 million
(approximately $3.8 million) and NIS 11.9 million (approximately $3.4 million) for the year ended December&nbsp;31, 2021, the six months
ended June 20, 2021, and the six months ended June 20, 2022, respectively. As of June 30, 2022, we had an accumulated deficit of NIS 88.7
million (approximately $25.3 million). We anticipate that we will continue to incur significant losses for the foreseeable future as our
operating expenses and capital expenditures increase substantially due to our continued investment in our research and development activities
and as we hire additional employees over the coming years. Furthermore, we are incurring additional expenses associated with operating
as a U.S.&nbsp;public company, including significant legal, accounting, investor relations and other expenses, the extent to which we
did not incur as a TASE-listed company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Components of Operating Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Revenues and Cost of Revenues</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our total revenue consists
of selling our Generation 1.0 SaverOne system and our cost of revenues consists of the direct cost of producing and installing the system.
Currently, our business activity is only in Israel. Since we are still in the initial phase in rolling out our Generation 1.0 SaverOne
system and our Generation 2.0 system is still in development, we cannot forecast our revenue in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Research and Development Expenses, Net</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have invested almost all
of our efforts and financial resources in the research and development of our SaverOne system which is still in development. Research
and development related activities are currently our primary expenditure. Development timelines, the probability of success and development
costs can differ materially from expectations. In addition, we cannot forecast whether and when we will enter into collaboration arrangements,
if at all, and to what degree such arrangements would affect our development plans and capital requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our research and
development expenses to increase over the next several years as our development programs progress and we expect that our research and
development expenses will continue to be significant in absolute dollars in future periods as we continue to invest in research and development
activities related to the development of our solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses
include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">employee-related expenses, such
as salaries and share-based compensation;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">expenses relating to outsourced
and contracted services, such as consulting, research and advisory services;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">supply and development costs;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">costs associated with regulatory
compliance.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize research and
development expenses as we incur them deducted by government grants in respect of a research and development project received from the
Israel Innovation Authority, or IIA, which are not reasonably assured that the amount received will not be refunded</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Selling and Marketing Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing expenses
until December 31, 2021 consisted primarily of share-based compensation recorded with respect of unregistered rights to shares issued
to Keshet Holdings Limited Partnership, which is managed by Keshet Broadcasting, or Keshet, who provided media and advertisement services
to the Company in 2020 and 2021. During 2022 onwards, selling and marketing expenses mainly consist of our sales department costs. As
we penetrate new markets, we anticipate that our selling and marketing expenses will increase in the future as we expand our sales department
and invest in the marketing of our solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses consist primarily of personnel costs, including share-based compensation related to directors and employees, facility costs,
patent application and maintenance expenses, and external professional service costs, including legal, accounting, audit, finance, business
development, investor relations and human resource services, and other consulting fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate that our general
and administrative expenses will increase in the future as we increase our administrative headcount and infrastructure to support our
continued research and development programs and the potential commercialization of our products. We also anticipate that we will continue
to incur increased expenses related to audit, legal, regulatory and tax-related&nbsp;services associated with maintaining compliance with
Nasdaq and SEC requirements, director and officer insurance premiums, director compensation, and other costs associated with being a public
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Finance Income (Expenses), Net</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Finance income (expenses),
net, consisted primarily of bank fees, exchange differences, direct and incremental issuance costs incurred through initial public offering
in Unites states that were allocated <FONT STYLE="font-family: Times New Roman, Times, Serif">to derivative warrant liability</FONT> and
changes in the fair value of warrants recorded as a derivative financial liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have yet to generate taxable
income in Israel. As of December 31, 2021, our operating tax loss carryforwards were approximately NIS 55.8 million (approximately $15.9
million). We anticipate that we will continue to generate tax losses for the foreseeable future and that we will be able to carry forward
these tax losses indefinitely to future taxable years. Accordingly, we do not expect to pay taxes in Israel until we have taxable income
after the full utilization of our carry forward tax losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Results of Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our results of operations
have varied in the past and can be expected to vary in the future due to numerous factors. We believe that period-to-period comparisons
of our operating results should not be relied upon as indications of future performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is a summary of our
unaudited results of operations for the periods indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Six Months Ended<BR> June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Six Months Ended<BR> June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;<B>NIS thousands</B></FONT></TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">NIS thousands</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; padding-bottom: 1.5pt">Revenues</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">382</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">201</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(267</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(165</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross Profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: left">Research and development expenses, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,184</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,854</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: left">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(481</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,677</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">General and administrative expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,511</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss from operations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(13,061</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(13,185</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: left">Finance expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(869</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(117</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Finance income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,030</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Finance income (expense), net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,161</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(116</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 4pt">Net loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(11,900</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(13,301</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Six Months Ended June 30, 2022 Compared
to Six Months Ended June 20, 2021&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Revenues</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues increased by approximately
NIS 181,000 (approximately $52,000), or 90%, to NIS 382,000 (approximately $109,000) for the six months ended June 30, 2022, compared
to NIS 201,000 (approximately $57,000) for the six months ended June 30, 2021. This increase was mainly the result of new agreements we
entered into in 2022 related to our Generation 1.0 solution which was launched in late 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Research and development expenses, net</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expenses,
net increased by approximately NIS 1,330,000 (approximately $380,000), or 15%, to approximately NIS 10,184,000 (approximately $2,910,000)
for the six months ended June 30, 2022, compared to NIS 8,854,000 (approximately $2,530,000) for the six months ended June 30, 2021. This
increase resulted mainly from salaries and related expenses and subcontractors, due to an increase in the number of employees, and an
increase in research and development activity, mainly related to the development of our Generation 2.0 solution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Selling and marketing expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing expenses
decreased by approximately NIS 1,196,000 (approximately $342,000), or 71%, to approximately NIS 481,000 (approximately $137,000) for the
six months ended June 30, 2022, compared to NIS 1,677,000 (approximately $479,000) for the six months ended June 30, 2021. Selling and
marketing expenses for the six months ended June 30, 2022 included mainly our sales department costs. Selling and marketing expenses for
the six months ended June 30, 2021 included share-based compensation in the amount of NIS 1,456,000 recorded with respect of unregistered
rights issued to Keshet, pursuant to our arrangement with Keshet for media advertisement for us on Keshet&rsquo;s various media channels.
The agreement with Keshet ended during 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>General and administrative expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses decreased by approximately NIS 179,000 (approximately $51,000), or 7%, to approximately NIS 2,511,000 (approximately $717,000)
for the six months ended June 30, 2022, compared to approximately NIS 2,690,000 (approximately $769,000) for the six months ended June
30, 2021. The decrease resulted mainly from lower share-based compensation expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Financing income (expenses), net</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financing income, net for
the six months ended June 30, 2022 were NIS 1,161,000 (approximately $332,000) and resulted mainly from exchange differences due to an
increase in the USD/NIS exchange rate less direct and incremental issuance costs incurred through the initial public offering in the Unites
States <FONT STYLE="font-family: Times New Roman, Times, Serif">allocated to derivative warrant liability</FONT>. Financing expenses,
net for the six months ended June 30, 2021 were NIS 116,000 (approximately $33,000) mainly from bank fees and exchange rate differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Net loss</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net loss decreased by approximately
NIS 1,401,000 (approximately $400,000), or 11%, to approximately NIS 11,900,000 (approximately $3,400,000) for the six months ended June
30, 2022, compared to NIS 13,301,000 (approximately $3,800,000) for the six months ended June 30, 2021. The decrease resulted mainly from
share-based compensation expenses and financing income from exchange rate differences due to an increase in the USD/NIS exchange rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not entered into any
off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes
in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material
to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We describe our significant
accounting policies and estimates in Note&nbsp;3 to our financial statements for the six months ended June 30, 2022. We believe that these
accounting policies and estimates are critical in order to fully understand and evaluate our financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We prepare our financial statements
in accordance with IFRS as issued by the IASB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment and that
affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates. Pursuant to International Accounting Standard No. 1, it is required
inter alia to give disclosure to the accounting principles whose implementation involves estimates and considerations having significant
sensitivity to future events, the occurrence of which may impact the reported amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recently-Issued Accounting Pronouncements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain recently-issued accounting
pronouncements are discussed in Note&nbsp;2, Summary of Significant Accounting Policies, to the financial statements included in elsewhere
in this registration statement, regarding the impact of the IFRS standards as issued by the IASB that we will adopt in future periods
in our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have financed our operations
since our inception primarily from private and public offerings, equity bridge investment transactions and government grants for research
and development project received from the IIA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From our inception date through
June 30, 2022, we raised an aggregate of NIS 119&nbsp;million (approximately $34 million) in private and public offerings and equity bridge
investments. As of June 30, 2022, we had NIS 41 million (approximately $11.7 million) in cash and cash equivalents and short-term bank
deposits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently in the research
and development stage and have not yet generated significant revenues from our operations. From inception date and through June 30, 2022,
we reported losses and a negative cash flow from current operating activity. As of June 30, 2022, we had an accumulated deficit of NIS
88.7 million (approximately $25 million) and we had a comprehensive loss and a negative cash flow from current operations in amounts of
NIS 11.9 million (approximately $3.4 million) and NIS 11.9 million (approximately $3.4 million) for the six months ended June 30, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate that we will
continue to incur net losses for the foreseeable future as we continue the development and potential commercialization of our products
and incur additional costs associated with being a public company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below shows a summary
of our cashflows for the periods indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended<BR>
 June 30,<BR>
 2022</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended<BR>
 June 30,<BR>
2021</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">NIS thousands</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Net cash used in operating activities</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(11,912</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(10,659</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net cash provided by (used in) investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,002</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,155</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net cash provided by financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">37,344</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">45</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net increase (decrease) in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">30,434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(22,769</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Six Months Ended June 30, 2022 Compared
to Six Months Ended June 30, 2021</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Net cash used in operating activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in operating
activities increased by NIS 1,253,000 (approximately $358,000), or 12%, to approximately NIS 11,912,000 (approximately $3,403,000) for
the six months ended June 30, 2022 compared to approximately NIS 10,659,000 (approximately $3,045,000) for the six months ended June 30,
2021. This increase was mainly the result of an increase in research and development expenses related to the development of the second
generation of our product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Net cash used in investing activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided by investing
activities for the six months ended June 30, 2022 was NIS 5,002,000 (approximately $1,429,000), compared to net cash used in investing
activities for the six months ended June 30, 2021 totalled NIS 12,155,000 (approximately $3,473,000). This change was mainly due to changes
in bank deposits during the periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Net cash provided by financing activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided by financing
activities increased by NIS 37,299,000 (approximately $10,657,000), or 829%, to approximately NIS 37,344,000 (approximately $10,670,000)
for the six months ended June 30, 2022 compared to approximately NIS 45,000 (approximately $13,000) for the six months ended June 30,
2021. This increase was mainly due to aggregate net proceeds of NIS 37.6 million (approximately $10.7 million) from our initial public
offering in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future Funding Requirements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have incurred losses and
cash flow deficits from operations since the inception date, resulting in an accumulated deficit as of June 30, 2022 of approximately
NIS 88.7 million (approximately $25.3 million). We anticipate that we will continue to incur net losses for the foreseeable future. We
believe that our existing cash and cash equivalents are sufficient to fund our projected cash needs for at least twelve months from the
date of this Report on Form 6-K. However, to meet future capital needs, we would need to raise additional capital through equity or debt
financing or other strategic transactions. However, any such financing may not be on favorable terms or even available to us. Our failure
to obtain sufficient funds on commercially acceptable terms when needed would have a material adverse effect on our business, results
of operations and financial condition. Our forecast of the period of time through which our financial resources will be adequate to support
our operations is a forward-looking statement that involves risks and uncertainties, and the actual amount of our expenses could vary
materially and adversely as a result of a number of factors. We have based our estimates on assumptions that may prove to be wrong, and
our expenses could prove to be significantly higher than we currently anticipate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future capital requirements
will depend on many factors, including, but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the progress and costs of our
research and development activities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the costs of development and
expansion of our operational infrastructure;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our ability, or that of our
collaborators, to achieve development milestones and other events or developments under potential future licensing agreements;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the amount of revenues and contributions
we receive under future licensing, collaboration, development and commercialization arrangements with respect to our technologies;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the costs of filing, prosecuting,
enforcing and defending patent claims and other intellectual property rights;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the costs of contracting with
third parties to provide sales and marketing capabilities for us or establishing such capabilities ourselves, once our technologies are
developed and ready for commercialization;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the costs of acquiring or undertaking
development and commercialization efforts for any future products or technology;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the magnitude of our general
and administrative expenses; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any additional costs that we
may incur under future in- and out-licensing arrangements relating to our technologies and futures products.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until we can generate significant
recurring revenues, we expect to satisfy our future cash needs through capital raising or by out-licensing and/or co-developing applications
of one or more of our products. We cannot be certain that additional funding will be available to us on acceptable terms, if at all. If
funds are not available on favorable terms, or at all, we may be required to delay, reduce the scope of or eliminate research or development
efforts or plans for commercialization with respect to our technologies and make necessary change to our operations to reduce the level
of our expenditures in line with available resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a development-stage
technology company and it is not possible for us to predict with any degree of accuracy the outcome of our research and development efforts.
As such, it is not possible for us to predict with any degree of accuracy any significant trends, uncertainties, demands, commitments
or events that are reasonably likely to have a material effect on our net loss, liquidity or capital resources, or that would cause financial
information to not necessarily be indicative of future operating results or financial condition. However, to the extent possible, certain
trends, uncertainties, demands, commitments and events are described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea165490ex99-2_saverone.htm
<DESCRIPTION>UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS AS OF JUNE 30, 2022
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<html xmlns:svre="http://www.saver.com/20220630" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml"><head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Exhibit 99.2</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONDENSED INTERIM FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>AS OF JUNE 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONDENSED INTERIM FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AS OF JUNE 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEX TO CONDENSED INTERIM FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1.5pt; width: 90%; text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial statements in NIS Thousands</b></span></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify; unicode-bidi: embed"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed statements of financial position </span></a></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify; unicode-bidi: embed"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed statements of comprehensive loss</span></a></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify; unicode-bidi: embed"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed statements of changes in shareholders&#8217; equity</span></a></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify; unicode-bidi: embed"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed statements of cash flows</span></a></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-6</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; direction: rtl; unicode-bidi: embed">&#160;</td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify; unicode-bidi: embed"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the condensed financial statements</span></a></td>
    <td style="text-align: center; direction: rtl; unicode-bidi: embed"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-13</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 30%"><span style="font-size: 8pt">&#160;</span></td>
  <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; width: 40%"><span style="font-size: 8pt">&#160;</span></td>
  <td style="width: 30%"><span style="font-size: 8pt">&#160;</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 40%"><span style="font-size: 8pt">&#160;</span></td>
  <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; width: 20%"><span style="font-size: 8pt">&#160;</span></td>
  <td style="width: 40%"><span style="font-size: 8pt">&#160;</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONDENSED STATEMENTS OF FINANCIAL POSITION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands)</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As of<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">41,075</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">14,855</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">8,683</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term bank deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentInvestments" scale="3" unitRef="ils">12,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentInvestments" scale="3" unitRef="ils">5,012</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Restricted deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentRestrictedCashAndCashEquivalents" scale="3" unitRef="ils">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="ils">374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="ils">347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="3" unitRef="ils">501</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="ils">958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="ils">888</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" scale="3" unitRef="ils">1,159</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="ils">855</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="ils">372</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="3" unitRef="ils">825</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="ils">43,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="ils">28,508</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="3" unitRef="ils">16,180</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="ils">211</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="ils">199</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" unitRef="ils">238</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="3" unitRef="ils">1,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Restricted deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="svre:RestrictedDeposits" scale="3" unitRef="ils">197</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="svre:RestrictedDeposits" scale="3" unitRef="ils">187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="svre:RestrictedDeposits" scale="3" unitRef="ils">191</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="ils">780</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="ils">1,205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="3" unitRef="ils">992</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total non-current assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="ils">1,188</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="ils">1,591</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="3" unitRef="ils">2,576</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="3" unitRef="ils">44,450</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="3" unitRef="ils">30,099</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="3" unitRef="ils">18,756</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current maturities of leasing liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="ils">467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="ils">467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" unitRef="ils">467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="ils">778</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="ils">825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" unitRef="ils">942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="3" unitRef="ils">3,642</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="3" unitRef="ils">2,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" scale="3" unitRef="ils">3,522</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Derivative warrants liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="3" unitRef="ils">4,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Liability in respect of government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentNonfinancialLiabilities" scale="3" unitRef="ils">109</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentNonfinancialLiabilities" scale="3" unitRef="ils">205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentNonfinancialLiabilities" scale="3" unitRef="ils">109</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="ils">9,019</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="ils">3,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="3" unitRef="ils">5,040</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Non-current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Liability in respect of government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentNonfinancialLiabilities" scale="3" unitRef="ils">1,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentNonfinancialLiabilities" scale="3" unitRef="ils">848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentNonfinancialLiabilities" scale="3" unitRef="ils">1,059</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Leasing liability, net current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="ils">395</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="ils">808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" unitRef="ils">605</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="ils">1,568</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="ils">1,656</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="3" unitRef="ils">1,664</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share capital and premium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="ils">112,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capital reserve in respect of share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="ils">9,868</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="ils">7,649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CapitalReserve" scale="3" unitRef="ils">8,425</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="ils">88,713</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="ils">63,624</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="3" sign="-" unitRef="ils">76,813</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total shareholders&#8217; equity</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">33,863</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">24,465</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">12,052</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total liabilities and shareholders&#8217; equity</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="3" unitRef="ils">44,450</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="3" unitRef="ils">30,099</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="3" unitRef="ils">18,756</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral of to these financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONDENSED STATEMENTS OF COMPREHENSIVE LOSS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="ils">382</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="ils">201</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="3" unitRef="ils">450</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="ils">267</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="ils">165</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="3" unitRef="ils">288</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="ils">115</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="ils">36</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="3" unitRef="ils">162</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Research and development expenses, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="ils">10,184</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="ils">8,854</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" unitRef="ils">18,847</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Selling and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="3" unitRef="ils">481</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="3" unitRef="ils">1,677</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="3" unitRef="ils">2,431</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">General and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="ils">2,511</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="ils">2,690</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="ils">5,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Operating loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="3" sign="-" unitRef="ils">13,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="3" sign="-" unitRef="ils">13,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="3" sign="-" unitRef="ils">26,265</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Financing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="svre:FinancingExpense" scale="3" unitRef="ils">869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="svre:FinancingExpense" scale="3" unitRef="ils">117</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="svre:FinancingExpense" scale="3" unitRef="ils">228</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Financing income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncome" scale="3" unitRef="ils">2,030</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncome" scale="3" unitRef="ils">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncome" scale="3" unitRef="ils">3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Financing income (expenses), net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" scale="3" unitRef="ils">1,161</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" scale="3" sign="-" unitRef="ils">116</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" scale="3" sign="-" unitRef="ils">225</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Loss for the period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Comprehensive loss for the period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"><div style="-sec-ix-hidden: hidden-fact-3; -sec-ix-hidden: hidden-fact-2; -sec-ix-hidden: hidden-fact-1">Basic and diluted loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="ilsPershares">1.15</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="ilsPershares">1.68</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="ilsPershares">3.33</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-6; -sec-ix-hidden: hidden-fact-5; -sec-ix-hidden: hidden-fact-4">Weighted average of number of shares used to calculate the basic and diluted loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">10,334,303</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">7,935,366</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">7,960,239</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral of to these financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>For the six-month period ended June 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Share<br/>
 capital and<br/>
 premium</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital<br/>
 reserve in<br/>
 respect of<br/>
 share-based<br/>
 payment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/>
 deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/>
 shareholders&#8217;<br/>
 equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; font-weight: bold; text-align: left">Balance as of January 1, 2022 (audited)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">8,425</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">76,813</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">12,052</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based payment to employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">545</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">545</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based payment to service provider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,056</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Partial exercise of over-allotment option into warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="3" unitRef="ils">158</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="3" unitRef="ils">158</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net proceed allocated to ADS and ADS to be issued through initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="ils">32,268</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="3" unitRef="ils">32,268</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Comprehensive loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Balance as of June 30, 2022 (unaudited)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">112,708</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">9,868</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">88,713</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">33,863</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -18.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the six-month period ended June 30, 2021</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Share<br/>
 capital and<br/>
 premium</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital<br/>
 reserve in<br/>
 respect of<br/>
 share-based<br/>
 payment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/>
 deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/>
 shareholders&#8217;<br/>
 equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left">Balance as of January 1, 2021 (audited)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">5,077</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">50,323</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">35,194</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share-based payment to employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">1,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">1,116</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based payment to service provider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercise of non-registered rights into ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">(*)-</div></td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">(*)-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Comprehensive loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Balance as of June 30, 2021 (unaudited)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">7,649</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">63,624</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">24,465</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -18.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the year ended December 31, 2021</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Share<br/>
 capital and<br/>
 premium</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital<br/>
 reserve in<br/>
 respect of<br/>
 share-based<br/>
 payment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/>
 deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/>
 shareholders&#8217;<br/>
 equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left">Balance as of January 1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">5,077</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">50,323</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">35,194</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share-based payment to employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">1,892</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" unitRef="ils">1,892</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based payment to service provider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="svre:SharebasedPaymentToServiceProvider" scale="3" unitRef="ils">1,456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercise of non-registered rights into ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">(*)-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">(*)-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Comprehensive loss for year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Balance as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">80,440</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">8,425</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" sign="-" unitRef="ils">76,813</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="3" unitRef="ils">12,052</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -18.75pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">Represents an amount lower than NIS 1.</ix:footnote></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes are an integral of to
these financial statements.</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONDENSED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/>
 December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flow from operating activity</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Comprehensive loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Adjustments required to present cash flows from operating activities (Appendix A)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="3" sign="-" unitRef="ils">12</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="3" unitRef="ils">2,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="3" unitRef="ils">3,357</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="ils">11,912</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="ils">10,659</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="3" sign="-" unitRef="ils">23,133</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from investment activity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in restricted deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangeInRestrictedDeposits" scale="3" unitRef="ils">6</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangeInRestrictedDeposits" scale="3" unitRef="ils">77</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangeInRestrictedDeposits" scale="3" unitRef="ils">41</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Changes in short-term deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" scale="3" unitRef="ils">5,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" scale="3" sign="-" unitRef="ils">12,006</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" scale="3" sign="-" unitRef="ils">5,012</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Purchase of property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="ils">4</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="ils">72</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" unitRef="ils">144</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash provided by (used in) investment activity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" unitRef="ils">5,002</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="ils">12,155</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" sign="-" unitRef="ils">5,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from financing activity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Deferred offering expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfOtherEquityInstruments" scale="3" unitRef="ils">750</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Receipt of government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" scale="3" unitRef="ils">251</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" scale="3" unitRef="ils">579</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net proceeds from issuance of ADS, pre-funded warrants and warrants through initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfWarrants" scale="3" unitRef="ils">37,578</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Repayment of principal in respect of lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="ils">234</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="ils">206</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" unitRef="ils">440</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Exercise of non-registered rights into ordinary shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">(*)-</div></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">(*)-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Net cash provided by (used in) financing activity</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="ils">37,344</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" unitRef="ils">45</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" sign="-" unitRef="ils">611</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Change in balance of cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" unitRef="ils">30,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="ils">22,769</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="3" sign="-" unitRef="ils">28,941</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Exchange differences on cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" unitRef="ils">1,958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance of cash and cash equivalents, beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">8,683</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">37,624</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">37,624</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Balance of cash and cash equivalents, end of period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">41,075</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">14,855</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="3" unitRef="ils">8,683</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Represents an amount lower than NIS 1.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>The accompanying notes are an integral of to these financial statements.</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONDENSED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Appendix A - Adjustments required to present cash flows from operating activities</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Income and expenses not involving cash flows</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="ils">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="ils">28</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" unitRef="ils">61</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Amortization of right for use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="ils">212</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="ils">185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="3" unitRef="ils">398</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Interest expense in respect of leasing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfInterestsInAssociates" scale="3" unitRef="ils">24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfInterestsInAssociates" scale="3" unitRef="ils">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfInterestsInAssociates" scale="3" unitRef="ils">61</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share-based payment to employees and service providers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAndOnBehalfOfEmployees" scale="3" unitRef="ils">545</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAndOnBehalfOfEmployees" scale="3" unitRef="ils">2,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsToAndOnBehalfOfEmployees" scale="3" unitRef="ils">3,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Direct and incremental issuance cost allocated to derivative warrant liability through U.S IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="3" unitRef="ils">723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Revaluation of derivative warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" scale="3" unitRef="ils">82</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exchange differences on cash and cash equivalent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:ExchangeDifferencesOnCashAndCashEquivalent" scale="3" unitRef="ils">1,958</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Changes in liability in respect of government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangesInLiabilityInRespectOfGovernmentGrants" scale="3" unitRef="ils">114</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangesInLiabilityInRespectOfGovernmentGrants" scale="3" sign="-" unitRef="ils">213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:IncomeAndExpensesNotInvolvingCashFlows" scale="3" sign="-" unitRef="ils">391</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="svre:IncomeAndExpensesNotInvolvingCashFlows" scale="3" unitRef="ils">2,815</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="svre:IncomeAndExpensesNotInvolvingCashFlows" scale="3" unitRef="ils">3,655</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Changes in asset and liability items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Decrease (increase) in other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" unitRef="ils">201</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" sign="-" unitRef="ils">376</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="3" sign="-" unitRef="ils">647</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Decrease (increase) in trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" unitRef="ils">127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" unitRef="ils">12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="3" sign="-" unitRef="ils">142</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Increase in inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" unitRef="ils">30</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" unitRef="ils">262</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" unitRef="ils">715</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Increase (decrease) in trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" unitRef="ils">164</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" unitRef="ils">63</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" sign="-" unitRef="ils">54</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Increase in other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" scale="3" unitRef="ils">245</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" scale="3" unitRef="ils">516</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" scale="3" unitRef="ils">1,152</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangesinAssetAndLiability" scale="3" unitRef="ils">379</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangesinAssetAndLiability" scale="3" sign="-" unitRef="ils">173</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="svre:ChangesinAssetAndLiability" scale="3" sign="-" unitRef="ils">298</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="3" sign="-" unitRef="ils">12</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="3" unitRef="ils">2,642</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="3" unitRef="ils">3,357</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Appendix B - Non-cash investment and financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Recognition of right for use asset against a leasing liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="svre:RecognitionOfRightForUseAssetAgainstALeasingLiability" scale="3" unitRef="ils">532</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="svre:RecognitionOfRightForUseAssetAgainstALeasingLiability" scale="3" unitRef="ils">532</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Deferred offering expenses not yet paid</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="svre:DeferredOfferingExpensesNotYetPaid" scale="3" unitRef="ils">405</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Direct and incremental stock-based payment expenses allocated to ADS and pre-fund warrants through U.S. IPO</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" scale="3" unitRef="ils">960</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Offering costs not yet paid</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:OfferingCostsNotYetPaid" scale="3" unitRef="ils">280</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Partial exercise of over-allotment option into warrants</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="svre:PartialExerciseOfOverallotmentOptionIntoWarrants" scale="3" unitRef="ils">158</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral of to these financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE CONDENSED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 1 - General</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_2" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.6pt"></td><td style="width: 28.3pt"><b>A.</b></td><td style="text-align: justify"><b>Incorporation and operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 82.15pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_3" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">Saverone 2014 Ltd.
(the &#8220;Company&#8221;) was founded in Israel on November 16, 2014 and commenced its business activity on that date (the &#8220;Inception
Date&#8221;). From the Inception Date, the Company has been active in <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="svre:NumberOfOperatingSegment" scale="0" unitRef="pure">one</ix:nonFraction> operating segment, i.e., development of the technology necessary
to create a life-saving system that prevents certain uses of cell phones while driving (the &#8220;Saverone System&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_4" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.6pt"></td><td style="width: 28.3pt"><b>B.</b></td><td style="text-align: justify"><b>The Company&#8217;s business position</b></td></tr></table></ix:continuation><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_5" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"><br/>
The Company&#8217;s main activity is research and development and it has not yet shown any operating profits. From the Inception Date and through
June 30, 2022, the Company reported losses and a negative cash flow from current operating activity. As of June 30, 2022, the Company
has an accumulated deficit of NIS <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" scale="0" unitRef="ils">88,713</ix:nonFraction> and it had a comprehensive loss of NIS <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="0" unitRef="ils">11,900</ix:nonFraction> for the period of six months ended June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_6" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The Company&#8217;s management
has been maintaining forecasts, monitoring its cash flows and has been actively involved in obtaining the financing it needs to continue
its operations and to realize its plans which include the implementation of a business plan formulated by the Company&#8217;s management to
complete the development and sale of products based on technologies that are still in their development stage. The ability of the Company
to meet its development targets and to realize its business plans, as above, are contingent upon the recruitment of sources of finance
which are not guaranteed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_7" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">	In June 2020,
the Company completed an initial public offering (&#8220;IPO&#8221;) on the Tel Aviv Stock Exchange, with a net consideration of NIS&#160;<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="svre:StockExchangeConsiderationAmount" scale="0" unitRef="ils">23,720</ix:nonFraction>.	In
addition, as part of the preparations of the Company for the above issuance, the entire balance of the bridging investments used to finance
Company activity were converted into shares by the date of the aforementioned issuance. Also, in November 2020, the Company completed
financing through a shelf offering, as part of which it raised an addition net amount of NIS <ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="svre:AdditionalNetAmount" scale="0" unitRef="ils">20,887</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -17.1pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_8" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"><span style="font-size: 10pt">In
June 2022, the Company completed an </span>underwritten <span style="font-size: 10pt">U.S. IPO (&#8220;U.S. IPO&#8221;) on the Nasdaq
under which the Company issued and sold&#160;(i) number of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:NumberOfUnit" scale="0" unitRef="shares">2,941,918</ix:nonFraction> units, each unit consisting of one American Depositary Share (&#8220;ADS&#8221;)
and one warrant to purchase one ADS (&#8220;Warrant&#8221;) at an offering price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="0" unitRef="usdPershares">4.13</ix:nonFraction>&#160;per unit and (ii) number of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:NumberOfPreFundUnits" scale="0" unitRef="shares">208,802</ix:nonFraction> pre-funded
units, each unit consisting of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS at an offering price of
$<ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" scale="0" unitRef="usd">4.129</ix:nonFraction> per pre-funded unit. The Company received gross proceeds of approximately $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="svre:GrossProceeds" scale="6" unitRef="usd">13</ix:nonFraction> million (approximately NIS <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:GrossProceeds" scale="0" unitRef="ils">43,441</ix:nonFraction>)&#160;before direct
and incremental costs incurred. In addition, the Company allotted to the underwriter as share-based payment by issuance of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:IssuanceOfWarrants" scale="0" unitRef="shares">157,510</ix:nonFraction> warrants
</span>(<span style="font-size: 10pt">&#8220;</span>Representative&#8217;s Warrant<span style="font-size: 10pt">&#8221;</span>) <span style="font-size: 10pt">and
<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:OverAllomentOptionShares" scale="0" unitRef="shares">469,654</ix:nonFraction> over-allotment option </span>(<span style="font-size: 10pt">&#8220;Over-Allotment Option&#8221;</span>) <span style="font-size: 10pt">which
was partially exercised. See also Note 3 below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_9" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The ADSs and warrants
are traded on the Nasdaq under the symbols &#8220;SVRE&#8221; and &#8220;SVREW&#8221;, respectively. Upon satisfaction of customary closing
conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#8220;Closing Date&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">As of June 30, 2022,
management has determined that the balance of cash and cash equivalents are sufficient for the Company to continue its business plans
and operation at least for the 12-months period subsequent to the reporting period.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -14.2pt"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -14.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE CONDENSED FINANCIAL STATEMENTS
(CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -14.2pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 2 - Significant accounting policies</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_2" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>A.</b></td><td style="text-align: justify"><b>Basis of presentation</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_3" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_2"><ix:continuation continuedAt="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_2" id="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The accompanying unaudited condensed
financial statements and related notes should be read in conjunction with the Company&#8217;s financial statements and related notes included
elsewhere in the Company&#8217;s Registration Statement on Form F-1 for the fiscal year ended December 31, 2021, which was filed with
the Securities and Exchange Commission (&#8220;SEC&#8221;) and became effective on June 2, 2022. The unaudited condensed interim financial
statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. The interim
condensed financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial
statements for interim periods, as prescribed in IAS 34 &#8220;Interim Financial Reporting&#8221;. The financial information contained
herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results
of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring
nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_4" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_3"><ix:continuation id="_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The results for the six months ended
June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other interim
period or for any future period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_5" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_6" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_5"><ix:continuation id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The preparation of
financial statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment
and that affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_7" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>C.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_8" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_7"><ix:continuation id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_9" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>D.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_10" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_9"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Basic net loss per ordinary share is
computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of ordinary shares
outstanding during the period (including shares that were fully paid under the pre-funded amount). Diluted loss per share gives effect
to all potentially dilutive common shares outstanding during the period using the treasury stock method with respect to options and certain
warrants and using the if-converted method with respect to certain warrants accounted for as derivative financial liability. In computing
diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from
the exercise of options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_11" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_10"><ix:continuation id="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">During the period of six months ended
June 30, 2022 and 2021, the total weighted average number of ordinary shares, par value NIS <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" unitRef="ilsPershares">0.01</ix:nonFraction></ix:nonFraction> per share, of the Company related to
outstanding options and warrants excluded from the calculation of the diluted loss per share was <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" scale="0" unitRef="shares">4,352,144</ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding" scale="0" unitRef="shares">1,098,938</ix:nonFraction>, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE CONDENSED FINANCIAL STATEMENTS
(CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2 - Significant accounting policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_12" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>E.</b></td><td style="text-align: justify"><b>Derivative Warrants Liability</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_13" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_12"><ix:continuation id="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Certain warrants that were issued by
the Company to investors through an U.S. IPO transaction (see also Note 3) are exercisable into a number of ADS with a fixed exercise
price which is denominated in U.S. dollar currency which is different from the functional currency of the Company (New Israeli Shekels)
and are also might be exercisable to a variable number of shares due to the existence of cashless exercise mechanism under certain circumstances.
Accordingly, such warrants are considered as a current financial liability classified under &#8216;Fair value through profit or loss&#8217; category
(FVTPL). The fair value of the liability was determined at level 1 in the fair value hierarchy based on the quoted market price of the
warrants. Changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the financing
expenses, net line in the condensed Statement of Operations and Comprehensive Loss, until such warrants are exercised or expired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_14" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock-c0_cont_1" escape="true" name="svre:IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><b>F.</b></td><td style="text-align: justify"><b>Issuance of units comprised of warrants and ordinary shares</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_15" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_14"><ix:continuation continuedAt="_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock-c0_cont_2" id="_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">At the
closing date, the Company allocated total gross proceeds to the issuance components as follows: (i) as the warrants were determined to
be classified as a financial derivative liability, the Company has initially recognized them at fair value and based an average quoted
market price of four business days of these warrants, (ii) the amount allocated to the </span>ADS <span style="font-size: 10pt">issued
and ADS to be issued under the pre-funded amount was calculated as the difference between the total gross proceeds received and the fair
value of the warrants issued at the closing date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_15"><ix:continuation id="_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">Incremental
and direct issuance costs were allocated to the components based on the same proportion as the allocation of the gross proceeds. The portion
of issuance costs that was allocated to the warrants was recognized immediately as finance expenses in the condensed statement of comprehensive
loss and the portion of issuance costs related to the </span>ADS <span style="font-size: 10pt">and pre-funded warrants was deducted from
additional-paid in capital.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE CONDENSED FINANCIAL STATEMENTS
(CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 3 - U.S. Initial public offering on Nasdaq
</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_2" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">As
noted in Note 1B above, on June 6, 2022, the Company completed an underwritten U.S. IPO under which the Company received gross proceeds
of approximately $<ix:nonFraction contextRef="c33" decimals="-6" format="ixt:num-dot-decimal" name="svre:ReceivedGrossProceedsAmount" scale="6" unitRef="usd">13</ix:nonFraction> million (approximately NIS <ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="svre:ReceivedGrossProceedsAmount" scale="3" unitRef="ils">43,441</ix:nonFraction>) for issuance of -</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_3" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><span style="font-weight: normal">A.</span></td><td style="text-align: justify"><span style="font-weight: normal">Number of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:NumberOfUnits" scale="0" unitRef="shares">2,941,918</ix:nonFraction> units at a price to the public of $<ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">4.13</ix:nonFraction> per unit,
each consisting of <ix:nonNumeric contextRef="c0" name="svre:WarrantExercisableDescription">(i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at
an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and</ix:nonNumeric></span></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_4" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 28.35pt"><span style="font-weight: normal">B.</span></td><td style="text-align: justify"><span style="font-weight: normal">Number of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:NumberOfPrefundedUnits" scale="0" unitRef="shares">208,282</ix:nonFraction>&#160;pre-funded units at a price to the public of
$<ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="svre:PublicOfPerPrefundedUnit" scale="0" unitRef="usdPershares">4.129</ix:nonFraction> per pre-funded unit, each consisting of <ix:nonNumeric contextRef="c0" name="svre:PrefundedWarrantExercisableDescription">(i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise
price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant
exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject
to a cashless exercise mechanism upon under certain events).</ix:nonNumeric> It is noted that all of the pre-funded warrants were fully paid at the Closing
Date, as defined below, however the related ADS were issued subsequent to the balance sheet. See also Note 7B. </span></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_5" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Each
ADS represents <ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">5</ix:nonFraction> ordinary shares of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_6" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">In
connection with the U.S. IPO, the Company engaged an U.S. underwriter which was granted as part of its compensation upon completion of
the U.S. IPO (i) a 45-day Over-Allotment Option to purchase up to an additional <ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="svre:PurchaseToAdditionalShares" scale="0" unitRef="shares">469,654</ix:nonFraction> ADS at an exercise price of $<ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="svre:PublicPricePerShares" scale="0" unitRef="usdPershares">4.129</ix:nonFraction> or pre-funded
warrants and/or <ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="svre:WarrantsExercisableShares" scale="0" unitRef="shares">469,654</ix:nonFraction> warrants exercisable for the same number of ADS at an exercise price of $<ix:nonFraction contextRef="c36" decimals="3" format="ixt:num-dot-decimal" name="svre:ExercisePrice" scale="0" unitRef="usdPershares">0.001</ix:nonFraction> (&#8220;Over-Allotment Option&#8221;)
and (ii) a Representative&#8217;s Warrant exercisable for <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:WarrantsExercisableShares" scale="0" unitRef="shares">157,510</ix:nonFraction> ADS at an exercise price of $<ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="svre:ExercisePrice" scale="0" unitRef="usdPershares">5.16</ix:nonFraction> per ADS over a limited period of <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="svre:OverALimitedPeriod">5</ix:nonNumeric>-years
from the issuance date. In connection with the closing of the offering, in June 2022, the underwriter partially exercised its Over-Allotment
Option to purchase an additional <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:PurchaseToAdditionalShares" scale="0" unitRef="shares">126,482</ix:nonFraction> warrants exercisable for the same number of ADS for de minimis consideration. The remaining <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:OverAllotmentOptionHasBeenExpired" scale="0" unitRef="shares">343,172</ix:nonFraction>
Over-Allotment Option has been expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_7" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Upon
satisfaction of customary closing conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#8220;Closing Date&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_8" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">As
the exercise price of the Warrants is determined in foreign currency and as the Warrants might be exercisable to a variable number of
shares due to the cashless exercise mechanism, the Warrants were accounted for as a derivative financial liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_9" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Moreover,
the Company receives substantially all of the pre-funded warrant&#8217;s proceeds upfront (without any conditions) as part of the pre-funded
warrant&#8217;s purchase price and in return the Company is obligated to issue fixed number of ADS to the holders. Consequently, pre-funded
warrants were accounted and were classified as additional paid-in capital as part of the Company&#8217;s shareholders&#8217; equity. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_10" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal"><ix:nonNumeric contextRef="c0" name="svre:WarrantDescription">As
the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative&#8217;s
Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted
for under IFRS 2 &#8220;Share-based Payment&#8221; in total amount of NIS 5, NIS 588 and NIS <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:ShareBasedPaymentWarrantAmount" scale="0" unitRef="ils">461</ix:nonFraction>, respectively.</ix:nonNumeric> These expenses were estimated
at fair value by using Black-Scholes-Merton pricing model in which the assumptions that have been used are as follows: expected dividend
yield of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="svre:ExpectedDividendYieldRate" scale="-2" unitRef="pure">0</ix:nonFraction>%; risk-free interest rate of <ix:nonFraction contextRef="c37" decimals="4" format="ixt:num-dot-decimal" name="svre:riskfreeInterestRate" scale="-2" unitRef="pure">2.16</ix:nonFraction>%-<ix:nonFraction contextRef="c38" decimals="4" format="ixt:num-dot-decimal" name="svre:riskfreeInterestRate" scale="-2" sign="-" unitRef="pure">3.11</ix:nonFraction>%; expected volatility of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="svre:ExpectedVolatility" scale="-2" unitRef="pure">52.92</ix:nonFraction>%, exercise period and exercise price based upon the
stated terms, ADS price of $2.76 which represents the quoted market price of the average four business days following the Closing Date.
These expenses were included as part of the incremental and direct issuance costs incurred through the U.S. IPO. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE CONDENSED FINANCIAL STATEMENTS
(CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 3 - U.S. Initial public offering on Nasdaq
(Cont.) </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_11" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Pursuant
to the above, at the initial recognition date the gross proceeds received was allocated to identified components as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_12" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDebtSecuritiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDebtSecuritiesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair<br/>
 value at<br/>
 Closing<br/>
 Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="ifrs-full:LeaseLiabilities" scale="3" unitRef="ils">3,947</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pre-funded warrant and ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="svre:PrefundedWarrants" scale="3" sign="-" unitRef="ils">39,494</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total gross consideration</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="3" unitRef="ils">43,441</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_13" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_12"><ix:continuation id="_DisclosureOfDebtSecuritiesExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-weight: normal">(*)</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-weight: normal">The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $<ix:nonFraction contextRef="c1" decimals="4" format="ixt:num-dot-decimal" name="svre:WarrantsPerShare" scale="0" unitRef="usdPershares">0.3508</ix:nonFraction> which
is an average quoted market trading price in the first four business days following the Closing Date.</span></ix:footnote></td>
</tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_14" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
total incremental and direct issuance costs amounted to NIS <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:TotalIncrementalAndDirectIssuanceCostsAmounted" scale="0" unitRef="ils">7,949</ix:nonFraction> were allocated to the Warrants (NIS <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:AllocatedToWarrantsAmount" scale="0" unitRef="ils">723</ix:nonFraction>) and the ADS (including pre-funded
warrants) (NIS <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="svre:PrefundedWarrantsAmount" scale="0" unitRef="ils">7,226</ix:nonFraction>), based on the relative value of such identified instruments at the Closing Date. The portion of issuance costs that
was allocated to the Warrants was recognized immediately as finance expenses in the condensed statement of comprehensive loss and the
portion of issuance costs related to the ADS (including pre-funded warrant) was deducted from additional paid-in capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_15" id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
following tabular presentation reflects the reconciliation of the fair value of derivative warrant liability during the period of six
months ended June 30, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_15"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Six months<br/>
 period&#160;ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30,</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 5.35pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of warranted issued at Effective Date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:IssuesFairValueMeasurementLiabilities" scale="3" unitRef="ils">3,947</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Warrants issued as result of partially exercised of over-allotment option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="svre:WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" scale="3" unitRef="ils">158</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Revaluation of derivative warrant liability exercisable for ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="svre:RevaluationOfDerivativeWarrantLiabilityExercisableForADS" scale="3" unitRef="ils">82</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDerivativeFinancialLiabilities" scale="3" unitRef="ils">4,023</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE
CONDENSED FINANCIAL STATEMENTS (CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 4 - Share
capital and reserves</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 18pt"><b>A.</b></td><td style="text-align: left"><b>Composition of share capital</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_3" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="svre:ScheduleOfCompositionOfShareCapitalTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Ordinary shares, par value NIS <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="svre:AuthorizedOrdinarySharesParValue" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="svre:IssuedAndOutstandingOrdinarySharesParShare" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="svre:AuthorizedOrdinarySharesParValue" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="svre:IssuedAndOutstandingOrdinarySharesParShare" scale="0" unitRef="ilsPershares">0.01</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> each</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesAuthorised" scale="0" unitRef="shares">100,000,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">22,694,296</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesAuthorised" scale="0" unitRef="shares">100,000,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">7,984,706</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_4" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 18pt"><b>B.</b></td><td style="text-align: left"><b>Rights attached to the ordinary shares</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_5" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
ordinary shares of the Company grant the holders thereof the right to participate and vote in shareholders meetings, the right to receive
a dividend, as declared, the right to participate in distributions of bonus shares and the right to participate in the distribution of
the assets of the Company upon liquidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_6" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 18pt"><b>C.</b></td><td style="text-align: left"><b>Changes in the issued and outstanding capital</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfIssuedCapitalExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months<br/> period<br/>
 ended<br/> June 30,<br/> 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">7,984,706</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Allotment of ordinary shares through U.S IPO (see Note 3 above)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="svre:AllotmentOfOrdinaryShares" scale="0" unitRef="shares">14,709,590</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">22,694,296</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -21.25pt"><span style="font-weight: normal">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEarningsPerShareExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 5 - Loss
per share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEarningsPerShareExplanatory-c0_cont_2" id="_DisclosureOfEarningsPerShareExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
following table presents a summary of the loss and number of shares (including adjustments to such data) that were taken into consideration
for purposes of computing the loss per share (both basic and diluted).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEarningsPerShareExplanatory-c0_cont_3" id="_DisclosureOfEarningsPerShareExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six months period ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-65; -sec-ix-hidden: hidden-fact-64; -sec-ix-hidden: hidden-fact-63">Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share</div></td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="3" sign="-" unitRef="ils">11,900</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="3" sign="-" unitRef="ils">13,301</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="3" sign="-" unitRef="ils">26,490</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="margin: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_DisclosureOfEarningsPerShareExplanatory-c0_cont_3"><ix:continuation id="_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares Six months period ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">10,178,955</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">7,935,366</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">7,960,239</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares to be issued upon full exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" scale="0" unitRef="shares">155,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-70; -sec-ix-hidden: hidden-fact-69; -sec-ix-hidden: hidden-fact-68">Weighted number of shares used in computing basic and diluted loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">10,334,303</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">7,935,366</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">7,960,239</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>







</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>SAVERONE 2014 LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTES TO THE
CONDENSED FINANCIAL STATEMENTS (CONT.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(New Israeli Shekels in thousands, except per
share and share data)</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6 - Financial risk factors</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company&#8217;s activities expose it to a variety of financial risks.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
condensed interim financial statements do not include all financial risk information and disclosures required in the annual financial
statements; they should be read in conjunction with the Company&#8217;s annual financial statements as of December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">There
have been no changes in the risk management policies since the year-end.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 7 - Subsequent
Events</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued (September 8, 2022). Based upon this review, the Company did not identify any other subsequent events that
would have required adjustment or disclosure in the financial statements, except as disclosed below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_3" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 18pt"><b>A.</b></td><td style="text-align: justify"><b>Options grant</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_4" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">On
July 7, 2022, the Company&#8217;s Board of Directors approved a grant of options to purchase an aggregate of <ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="svre:AggregateShares" scale="0" unitRef="shares">1,031,000</ix:nonFraction> ordinary shares
of the Company, to employees and officers. The options are exercisable at NIS <ix:nonFraction contextRef="c39" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" scale="0" unitRef="ilsPershares">1.639</ix:nonFraction> per share and will be vest over a limited period of
<ix:nonNumeric contextRef="c39" format="ixt-sec:duryear" name="svre:OverLimitedPeriod">4</ix:nonNumeric>-years. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_5" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"></td><td style="width: 18pt"><b>B.</b></td><td style="text-align: justify"><b>Issuance of ADS</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">In
August 2022, all of the pre-funded warrants were exercised into ADS. See also Note 3.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">F-13</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"></p><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-1" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="ilsPershares">1.15</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-2" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="ilsPershares">1.68</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-3" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="ilsPershares">3.33</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-4" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">10334303</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="INF" id="hidden-fact-5" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">7935366</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="INF" id="hidden-fact-6" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">7960239</ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-7" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-8" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-9" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-10" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-11" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-12" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-13" name="ifrs-full:IssueOfEquity" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-14" name="ifrs-full:IssueOfEquity" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-15" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-16" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-17" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-18" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-19" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-20" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-21" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-22" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-23" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-24" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-25" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-26" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-27" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-28" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-29" name="svre:SharebasedPaymentToServiceProvider" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-30" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-31" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-32" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-33" name="svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-34" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-35" name="ifrs-full:ComprehensiveIncome" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-36" name="ifrs-full:PaymentsOfOtherEquityInstruments" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-37" name="ifrs-full:PaymentsOfOtherEquityInstruments" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-38" name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-39" name="ifrs-full:ProceedsFromExerciseOfWarrants" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-40" name="ifrs-full:ProceedsFromExerciseOfWarrants" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-41" name="ifrs-full:ProceedsFromExerciseOfOptions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-42" name="ifrs-full:ProceedsFromExerciseOfOptions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-43" name="ifrs-full:ProceedsFromExerciseOfOptions" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-44" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-45" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-46" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-47" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-48" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-49" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-50" name="svre:ExchangeDifferencesOnCashAndCashEquivalent" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-51" name="svre:ExchangeDifferencesOnCashAndCashEquivalent" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-52" name="svre:ChangesInLiabilityInRespectOfGovernmentGrants" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-53" name="svre:RecognitionOfRightForUseAssetAgainstALeasingLiability" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-54" name="svre:DeferredOfferingExpensesNotYetPaid" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-55" name="svre:DeferredOfferingExpensesNotYetPaid" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-56" name="svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-57" name="svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-58" name="svre:OfferingCostsNotYetPaid" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-59" name="svre:OfferingCostsNotYetPaid" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-60" name="svre:PartialExerciseOfOverallotmentOptionIntoWarrants" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-61" name="svre:PartialExerciseOfOverallotmentOptionIntoWarrants" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-62" name="ifrs-full:CurrentDerivativeFinancialLiabilities" unitRef="ils" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="-3" id="hidden-fact-63" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" sign="-" unitRef="ils">11900000</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="-3" id="hidden-fact-64" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" sign="-" unitRef="ils">13301000</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="-3" id="hidden-fact-65" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" sign="-" unitRef="ils">26490000</ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-66" name="svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-67" name="svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-68" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">10334303</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="INF" id="hidden-fact-69" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">7935366</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="INF" id="hidden-fact-70" name="ifrs-full:AdjustedWeightedAverageShares" unitRef="shares">7960239</ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001894693</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="svre-20220630.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="hidden-fact-21 hidden-fact-23 hidden-fact-30 hidden-fact-33 hidden-fact-42 hidden-fact-43" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_0_fact" toRefs="ix_1_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ4anZpfsbNKYjHRmX16XFvLA==] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-11-01</xbrli:startDate>
    <xbrli:endDate>2020-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">svre:OrdinaryShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">svre:OverAllotmentOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">svre:OverAllotmentOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001894693</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">svre:SubsequentEventsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-07-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit><xbrli:unit id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>svre-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:svre="http://www.saver.com/20220630" targetNamespace="http://www.saver.com/20220630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="svre-20220630_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="svre-20220630_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="svre-20220630_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="svre-20220630_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.saver.com/role/ConsolidatedBalanceSheet" id="svre_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Condensed Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement" id="svre_r_ConsolidatedIncomeStatement">
        <link:definition>002 - Statement - Condensed Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals" id="svre_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>003 - Statement - Condensed Statements of Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ShareholdersEquityType2or3" id="svre_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Condensed Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ConsolidatedCashFlow" id="svre_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/General" id="svre_r_General">
        <link:definition>006 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/SignificantAccountingPolicies" id="svre_r_SignificantAccountingPolicies">
        <link:definition>007 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaq" id="svre_r_USInitialPublicOfferingonNasdaq">
        <link:definition>008 - Disclosure - U.S. Initial Public Offering on Nasdaq</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ShareCapitalandReserves" id="svre_r_ShareCapitalandReserves">
        <link:definition>009 - Disclosure - Share Capital and Reserves</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/LossPerShare" id="svre_r_LossPerShare">
        <link:definition>010 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/FinancialRiskFactors" id="svre_r_FinancialRiskFactors">
        <link:definition>011 - Disclosure - Financial Risk Factors</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/SubsequentEvents" id="svre_r_SubsequentEvents">
        <link:definition>012 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/AccountingPoliciesByPolicy" id="svre_r_AccountingPoliciesByPolicy">
        <link:definition>013 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables" id="svre_r_USInitialPublicOfferingonNasdaqTables">
        <link:definition>014 - Disclosure - U.S. Initial Public Offering on Nasdaq (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ShareCapitalandReservesTables" id="svre_r_ShareCapitalandReservesTables">
        <link:definition>015 - Disclosure - Share Capital and Reserves (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/LossPerShareTables" id="svre_r_LossPerShareTables">
        <link:definition>016 - Disclosure - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/GeneralDetails" id="svre_r_GeneralDetails">
        <link:definition>017 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/SignificantAccountingPoliciesDetails" id="svre_r_SignificantAccountingPoliciesDetails">
        <link:definition>018 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails" id="svre_r_USInitialPublicOfferingonNasdaqDetails">
        <link:definition>019 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable" id="svre_r_ScheduleofgrossproceedsreceivedTable">
        <link:definition>020 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable" id="svre_r_ScheduleoffairvalueofderivativewarrantliabilityTable">
        <link:definition>021 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable" id="svre_r_ScheduleofcompositionofsharecapitalTable">
        <link:definition>022 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ4PI2wbK5T0Nd6y5dkckVzsQ==] CSR-->
      <link:roleType roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals" id="svre_r_ScheduleofcompositionofsharecapitalTable_Parentheticals">
        <link:definition>023 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable" id="svre_r_ScheduleofchangesintheissuedandoutstandingcapitalTable">
        <link:definition>024 - Disclosure - Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable" id="svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable">
        <link:definition>025 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals" id="svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals">
        <link:definition>026 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/SubsequentEventsDetails" id="svre_r_SubsequentEventsDetails">
        <link:definition>027 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.saver.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="CondensedStatementsOfChangesInShareholdersEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_CondensedStatementsOfChangesInShareholdersEquityAbstract"/>
  <xs:element name="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
  <xs:element name="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
  <xs:element name="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
  <xs:element name="ScheduleOfGrossProceedsReceivedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfGrossProceedsReceivedAbstract"/>
  <xs:element name="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract"/>
  <xs:element name="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
  <xs:element name="ScheduleOfCompositionOfShareCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
  <xs:element name="ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract"/>
  <xs:element name="DisclosureOfEarningsPerShareTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
  <xs:element name="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
  <xs:element name="DisclosureOfFinancialRiskManagementTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract"/>
  <xs:element name="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract2"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract11"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract12"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract14"/>
  <xs:element name="AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract15"/>
  <xs:element name="IncomeAndExpensesNotInvolvingCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract16"/>
  <xs:element name="ChangesInAssetAndLiabilityItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ChangesInAssetAndLiabilityItemsAbstract"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract17"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract18"/>
  <xs:element name="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_UnlabeledAbstract19"/>
  <xs:element name="RestrictedDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_RestrictedDeposits"/>
  <xs:element name="FinancingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_FinancingExpense"/>
  <xs:element name="SharebasedPaymentToServiceProvider" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_SharebasedPaymentToServiceProvider"/>
  <xs:element name="ExerciseOfNonregisteredRightsIntoOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares"/>
  <xs:element name="SaleOfStockDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_SaleOfStockDomain"/>
  <xs:element name="ChangeInRestrictedDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_ChangeInRestrictedDeposits"/>
  <xs:element name="ExchangeDifferencesOnCashAndCashEquivalent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_ExchangeDifferencesOnCashAndCashEquivalent"/>
  <xs:element name="ChangesInLiabilityInRespectOfGovernmentGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_ChangesInLiabilityInRespectOfGovernmentGrants"/>
  <xs:element name="IncomeAndExpensesNotInvolvingCashFlows" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_IncomeAndExpensesNotInvolvingCashFlows"/>
  <xs:element name="ChangesinAssetAndLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ChangesinAssetAndLiability"/>
  <xs:element name="RecognitionOfRightForUseAssetAgainstALeasingLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability"/>
  <xs:element name="DeferredOfferingExpensesNotYetPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_DeferredOfferingExpensesNotYetPaid"/>
  <xs:element name="DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh"/>
  <xs:element name="OfferingCostsNotYetPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_OfferingCostsNotYetPaid"/>
  <xs:element name="PartialExerciseOfOverallotmentOptionIntoWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_PartialExerciseOfOverallotmentOptionIntoWarrants"/>
  <xs:element name="IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock"/>
  <xs:element name="ScheduleOfCompositionOfShareCapitalTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock"/>
  <xs:element name="PrefundedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_PrefundedWarrants"/>
  <xs:element name="WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption"/>
  <xs:element name="RevaluationOfDerivativeWarrantLiabilityExercisableForADS" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS"/>
  <xs:element name="AuthorizedOrdinarySharesParValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AuthorizedOrdinarySharesParValue"/>
  <xs:element name="IssuedAndOutstandingOrdinarySharesParShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="svre_IssuedAndOutstandingOrdinarySharesParShare"/>
  <xs:element name="AllotmentOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AllotmentOfOrdinaryShares"/>
  <xs:element name="WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants"/>
  <xs:element name="NumberOfOperatingSegment" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NumberOfOperatingSegment"/>
  <xs:element name="StockExchangeConsiderationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_StockExchangeConsiderationAmount"/>
  <xs:element name="AdditionalNetAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_AdditionalNetAmount"/>
  <xs:element name="NumberOfUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NumberOfUnit"/>
  <xs:element name="NumberOfPreFundUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NumberOfPreFundUnits"/>
  <xs:element name="GrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_GrossProceeds"/>
  <xs:element name="IssuanceOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_IssuanceOfWarrants"/>
  <xs:element name="OverAllomentOptionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OverAllomentOptionShares"/>
  <xs:element name="USInitialPublicOfferingonNasdaqDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="svre_USInitialPublicOfferingonNasdaqDetailsTable"/>
  <xs:element name="USInitialPublicOfferingonNasdaqDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_USInitialPublicOfferingonNasdaqDetailsLineItems"/>
  <xs:element name="ReceivedGrossProceedsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_ReceivedGrossProceedsAmount"/>
  <xs:element name="NumberOfUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NumberOfUnits"/>
  <xs:element name="WarrantExercisableDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_WarrantExercisableDescription"/>
  <xs:element name="NumberOfPrefundedUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_NumberOfPrefundedUnits"/>
  <xs:element name="PublicOfPerPrefundedUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_PublicOfPerPrefundedUnit"/>
  <xs:element name="PrefundedWarrantExercisableDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_PrefundedWarrantExercisableDescription"/>
  <xs:element name="PurchaseToAdditionalShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_PurchaseToAdditionalShares"/>
  <xs:element name="PublicPricePerShares" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_PublicPricePerShares"/>
  <xs:element name="WarrantsExercisableShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_WarrantsExercisableShares"/>
  <xs:element name="ExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="svre_ExercisePrice"/>
  <xs:element name="OverALimitedPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OverALimitedPeriod"/>
  <xs:element name="OverAllotmentOptionHasBeenExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OverAllotmentOptionHasBeenExpired"/>
  <xs:element name="WarrantDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_WarrantDescription"/>
  <xs:element name="ShareBasedPaymentWarrantAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_ShareBasedPaymentWarrantAmount"/>
  <xs:element name="ExpectedDividendYieldRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ExpectedDividendYieldRate"/>
  <xs:element name="riskfreeInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_riskfreeInterestRate"/>
  <xs:element name="ExpectedVolatility" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_ExpectedVolatility"/>
  <xs:element name="WarrantsPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="svre_WarrantsPerShare"/>
  <xs:element name="TotalIncrementalAndDirectIssuanceCostsAmounted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="svre_TotalIncrementalAndDirectIssuanceCostsAmounted"/>
  <xs:element name="AllocatedToWarrantsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_AllocatedToWarrantsAmount"/>
  <xs:element name="PrefundedWarrantsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="svre_PrefundedWarrantsAmount"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="svre_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_SubsequentEventsDetailsLineItems"/>
  <xs:element name="AggregateShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AggregateShares"/>
  <xs:element name="OverLimitedPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OverLimitedPeriod"/>
  <xs:element name="SaleOfStockAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="svre_SaleOfStockAxis"/>
  <xs:element name="AppendixAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_AppendixAMember"/>
  <xs:element name="OrdinaryShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OrdinaryShareMember"/>
  <xs:element name="OverAllotmentOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_OverAllotmentOptionsMember"/>
  <xs:element name="SubsequentEventsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_SubsequentEventsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="svre_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>svre-20220630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedBalanceSheet" roleURI="http://www.saver.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedIncomeStatement" roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedCashFlow" roleURI="http://www.saver.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofgrossproceedsreceivedTable" roleURI="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable" roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentRestrictedCashAndCashEquivalents" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_Inventories" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_DeferredTaxAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_RestrictedDeposits" xlink:href="svre-20220630.xsd#svre_RestrictedDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="svre_RestrictedDeposits" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_RightofuseAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_SharePremium" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CapitalReserve"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_CapitalReserve" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_RetainedEarnings" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_CostOfSales" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SalesAndMarketingExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:to="ifrs-full_FinanceIncome" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_FinancingExpense" xlink:href="svre-20220630.xsd#svre_FinancingExpense"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ416+8c5LD0Vu5nU5Gnoftfg==] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:to="svre_FinancingExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_ChangeInRestrictedDeposits" xlink:href="svre-20220630.xsd#svre_ChangeInRestrictedDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="svre_ChangeInRestrictedDeposits" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlows"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_PaymentsToAndOnBehalfOfEmployees" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:href="svre-20220630.xsd#svre_ChangesInLiabilityInRespectOfGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="svre_ChangesInLiabilityInRespectOfGovernmentGrants" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:href="svre-20220630.xsd#svre_ExchangeDifferencesOnCashAndCashEquivalent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="svre_ExchangeDifferencesOnCashAndCashEquivalent" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesinAssetAndLiability" xlink:href="svre-20220630.xsd#svre_ChangesinAssetAndLiability"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlows" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="svre_ChangesinAssetAndLiability" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GovernmentGrants"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_LeaseLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrants" xlink:href="svre-20220630.xsd#svre_PrefundedWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GovernmentGrants" xlink:to="svre_PrefundedWarrants" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:href="svre-20220630.xsd#svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>svre-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedBalanceSheet" roleURI="http://www.saver.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedIncomeStatement" roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareholdersEquityType2or3" roleURI="http://www.saver.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedCashFlow" roleURI="http://www.saver.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_General" roleURI="http://www.saver.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SignificantAccountingPolicies" roleURI="http://www.saver.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaq" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaq"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareCapitalandReserves" roleURI="http://www.saver.com/role/ShareCapitalandReserves"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_LossPerShare" roleURI="http://www.saver.com/role/LossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_FinancialRiskFactors" roleURI="http://www.saver.com/role/FinancialRiskFactors"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SubsequentEvents" roleURI="http://www.saver.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_AccountingPoliciesByPolicy" roleURI="http://www.saver.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaqTables" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareCapitalandReservesTables" roleURI="http://www.saver.com/role/ShareCapitalandReservesTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_LossPerShareTables" roleURI="http://www.saver.com/role/LossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofgrossproceedsreceivedTable" roleURI="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoffairvalueofderivativewarrantliabilityTable" roleURI="http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofcompositionofsharecapitalTable" roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofcompositionofsharecapitalTable_Parentheticals" roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofchangesintheissuedandoutstandingcapitalTable" roleURI="http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable" roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals" roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_GeneralDetails" roleURI="http://www.saver.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SignificantAccountingPoliciesDetails" roleURI="http://www.saver.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaqDetails" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SubsequentEventsDetails" roleURI="http://www.saver.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#DocumentAndEntityInformation" roleURI="http://www.saver.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentRestrictedCashAndCashEquivalents" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NonCurrentAssetsAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="svre_NonCurrentAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_RestrictedDeposits" xlink:href="svre-20220630.xsd#svre_RestrictedDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="svre_RestrictedDeposits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NonCurrentLiabilitiesAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="svre_NonCurrentLiabilitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_SharePremium" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CapitalReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_CapitalReserve" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_Equity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_CostOfSales" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SalesAndMarketingExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_FinancingExpense" xlink:href="svre-20220630.xsd#svre_FinancingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="svre_FinancingExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncome" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_SharebasedPaymentToServiceProvider" xlink:href="svre-20220630.xsd#svre_SharebasedPaymentToServiceProvider"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="svre_SharebasedPaymentToServiceProvider" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares" xlink:href="svre-20220630.xsd#svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_SaleOfStockAxis" xlink:href="svre-20220630.xsd#svre_SaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="svre_SaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_SaleOfStockDomain" xlink:href="svre-20220630.xsd#svre_SaleOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="svre_SaleOfStockAxis" xlink:to="svre_SaleOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_SaleOfStockDomain_0" xlink:href="svre-20220630.xsd#svre_SaleOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="svre_SaleOfStockAxis" xlink:to="svre_SaleOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AppendixAMember" xlink:href="svre-20220630.xsd#svre_AppendixAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_SaleOfStockDomain" xlink:to="svre_AppendixAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ChangeInRestrictedDeposits" xlink:href="svre-20220630.xsd#svre_ChangeInRestrictedDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="svre_ChangeInRestrictedDeposits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_PaymentsToAndOnBehalfOfEmployees" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:href="svre-20220630.xsd#svre_ExchangeDifferencesOnCashAndCashEquivalent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="svre_ExchangeDifferencesOnCashAndCashEquivalent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:href="svre-20220630.xsd#svre_ChangesInLiabilityInRespectOfGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="svre_ChangesInLiabilityInRespectOfGovernmentGrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlows"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlows" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:href="svre-20220630.xsd#svre_ChangesInAssetAndLiabilityItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="svre_ChangesInAssetAndLiabilityItemsAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesinAssetAndLiability" xlink:href="svre-20220630.xsd#svre_ChangesinAssetAndLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="svre_ChangesinAssetAndLiability" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:href="svre-20220630.xsd#svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:href="svre-20220630.xsd#svre_RecognitionOfRightForUseAssetAgainstALeasingLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_DeferredOfferingExpensesNotYetPaid" xlink:href="svre-20220630.xsd#svre_DeferredOfferingExpensesNotYetPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_DeferredOfferingExpensesNotYetPaid" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:href="svre-20220630.xsd#svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OfferingCostsNotYetPaid" xlink:href="svre-20220630.xsd#svre_OfferingCostsNotYetPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_OfferingCostsNotYetPaid" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:href="svre-20220630.xsd#svre_PartialExerciseOfOverallotmentOptionIntoWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/General">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ4kVG8k6ZCA99msNKZUKBUaw==] CSR-->
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaq">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareCapitalandReserves">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/FinancialRiskFactors">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfFinancialRiskManagementTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" xlink:href="svre-20220630.xsd#svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareCapitalandReservesTables">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIssuedCapitalExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfGrossProceedsReceivedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrants" xlink:href="svre-20220630.xsd#svre_PrefundedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:to="svre_PrefundedWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:to="ifrs-full_GovernmentGrants" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuesFairValueMeasurementLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="ifrs-full_IssuesFairValueMeasurementLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:href="svre-20220630.xsd#svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:href="svre-20220630.xsd#svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesAuthorised" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="svre_AuthorizedOrdinarySharesParValue" xlink:href="svre-20220630.xsd#svre_AuthorizedOrdinarySharesParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="svre_AuthorizedOrdinarySharesParValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_IssuedAndOutstandingOrdinarySharesParShare" xlink:href="svre-20220630.xsd#svre_IssuedAndOutstandingOrdinarySharesParShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="svre_IssuedAndOutstandingOrdinarySharesParShare" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AllotmentOfOrdinaryShares" xlink:href="svre-20220630.xsd#svre_AllotmentOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="svre_AllotmentOfOrdinaryShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:href="svre-20220630.xsd#svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_WeightedAverageShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfOperatingSegment" xlink:href="svre-20220630.xsd#svre_NumberOfOperatingSegment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_NumberOfOperatingSegment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_StockExchangeConsiderationAmount" xlink:href="svre-20220630.xsd#svre_StockExchangeConsiderationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_StockExchangeConsiderationAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AdditionalNetAmount" xlink:href="svre-20220630.xsd#svre_AdditionalNetAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_AdditionalNetAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfUnit" xlink:href="svre-20220630.xsd#svre_NumberOfUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_NumberOfUnit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfPreFundUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPreFundUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_NumberOfPreFundUnits" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_GrossProceeds" xlink:href="svre-20220630.xsd#svre_GrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_GrossProceeds" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_IssuanceOfWarrants" xlink:href="svre-20220630.xsd#svre_IssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_IssuanceOfWarrants" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllomentOptionShares" xlink:href="svre-20220630.xsd#svre_OverAllomentOptionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_OverAllomentOptionShares" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails">
    <loc xlink:type="locator" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_USInitialPublicOfferingonNasdaqDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllotmentOptionsMember" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="svre_OverAllotmentOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OrdinaryShareMember" xlink:href="svre-20220630.xsd#svre_OrdinaryShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="svre_OrdinaryShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ReceivedGrossProceedsAmount" xlink:href="svre-20220630.xsd#svre_ReceivedGrossProceedsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_ReceivedGrossProceedsAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfUnits" xlink:href="svre-20220630.xsd#svre_NumberOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_NumberOfUnits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_WarrantExercisableDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_WarrantExercisableDescription" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfPrefundedUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPrefundedUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_NumberOfPrefundedUnits" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PublicOfPerPrefundedUnit" xlink:href="svre-20220630.xsd#svre_PublicOfPerPrefundedUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_PublicOfPerPrefundedUnit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantExercisableDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_PrefundedWarrantExercisableDescription" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PurchaseToAdditionalShares" xlink:href="svre-20220630.xsd#svre_PurchaseToAdditionalShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_PurchaseToAdditionalShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PublicPricePerShares" xlink:href="svre-20220630.xsd#svre_PublicPricePerShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_PublicPricePerShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsExercisableShares" xlink:href="svre-20220630.xsd#svre_WarrantsExercisableShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_WarrantsExercisableShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ExercisePrice" xlink:href="svre-20220630.xsd#svre_ExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_ExercisePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OverALimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverALimitedPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_OverALimitedPeriod" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllotmentOptionHasBeenExpired" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionHasBeenExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_OverAllotmentOptionHasBeenExpired" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantDescription" xlink:href="svre-20220630.xsd#svre_WarrantDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_WarrantDescription" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ShareBasedPaymentWarrantAmount" xlink:href="svre-20220630.xsd#svre_ShareBasedPaymentWarrantAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_ShareBasedPaymentWarrantAmount" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ExpectedDividendYieldRate" xlink:href="svre-20220630.xsd#svre_ExpectedDividendYieldRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_ExpectedDividendYieldRate" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_riskfreeInterestRate" xlink:href="svre-20220630.xsd#svre_riskfreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_riskfreeInterestRate" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_ExpectedVolatility" xlink:href="svre-20220630.xsd#svre_ExpectedVolatility"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_ExpectedVolatility" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsPerShare" xlink:href="svre-20220630.xsd#svre_WarrantsPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_WarrantsPerShare" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:href="svre-20220630.xsd#svre_TotalIncrementalAndDirectIssuanceCostsAmounted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AllocatedToWarrantsAmount" xlink:href="svre-20220630.xsd#svre_AllocatedToWarrantsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_AllocatedToWarrantsAmount" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrantsAmount" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_PrefundedWarrantsAmount" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsDetailsLineItems" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsDetailsTable" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="svre_SubsequentEventsDetailsLineItems" xlink:to="svre_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="svre_SubsequentEventsDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsMember" xlink:href="svre-20220630.xsd#svre_SubsequentEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="svre_SubsequentEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_AggregateShares" xlink:href="svre-20220630.xsd#svre_AggregateShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_SubsequentEventsDetailsLineItems" xlink:to="svre_AggregateShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_SubsequentEventsDetailsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="svre_OverLimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverLimitedPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="svre_SubsequentEventsDetailsLineItems" xlink:to="svre_OverLimitedPeriod" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.saver.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="9" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>svre-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Financing income (expenses), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:to="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Loss for the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl0" xml:lang="en-US">Comprehensive loss for the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Comprehensive loss for the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl0" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investment activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Change in balance of cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Balance of cash and cash equivalents, beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl0" xml:lang="en-US">Balance of cash and cash equivalents, end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl1" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl1"/>
    <loc xlink:type="locator" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlows"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl" xml:lang="en-US">Income and expenses not involving cash flows total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesinAssetAndLiability" xlink:href="svre-20220630.xsd#svre_ChangesinAssetAndLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="svre_ChangesinAssetAndLiability_lbl" xml:lang="en-US">Changes in asset and liability total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="svre_ChangesinAssetAndLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xml:lang="en-US">Income and expenses and changes in asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SaleOfStockAxis" xlink:href="svre-20220630.xsd#svre_SaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_SaleOfStockAxis_lbl" xml:lang="en-US">SaleOfStockAxis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SaleOfStockAxis" xlink:to="svre_SaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract_lbl" xml:lang="en-US">U.S. Initial public offering on Nasdaq [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GovernmentGrants_lbl" xml:lang="en-US">Total gross consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl0" xml:lang="en-US">Closing balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl1" xml:lang="en-US">Derivative warrants liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted number of shares used in computing basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl0" xml:lang="en-US">Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentInvestments_lbl" xml:lang="en-US">Short-term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentInvestments" xlink:to="ifrs-full_CurrentInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_CurrentRestrictedCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract" xlink:to="svre_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NonCurrentAssetsAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="svre_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_RestrictedDeposits" xlink:href="svre-20220630.xsd#svre_RestrictedDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_RestrictedDeposits_lbl" xml:lang="en-US">Restricted deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RestrictedDeposits" xlink:to="svre_RestrictedDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right of use asset, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract0" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract0" xlink:to="svre_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract1" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract1" xlink:to="svre_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Current maturities of leasing liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_lbl" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl" xml:lang="en-US">Liability in respect of government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract2" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract2" xlink:to="svre_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NonCurrentLiabilitiesAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NonCurrentLiabilitiesAbstract" xlink:to="svre_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl" xml:lang="en-US">Liability in respect of government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Leasing liability, net current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract3" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract3" xlink:to="svre_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US">Share capital and premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CapitalReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CapitalReserve_lbl" xml:lang="en-US">Capital reserve in respect of share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserve" xlink:to="ifrs-full_CapitalReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract4" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract4" xlink:to="svre_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract5" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract5" xlink:to="svre_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract6" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract6" xlink:to="svre_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US">Financing income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract7" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract7" xlink:to="svre_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract8" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract8" xlink:to="svre_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic and diluted loss per share (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Basic and diluted loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl0" xml:lang="en-US">Weighted number of shares used in computing diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based payment to employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SharebasedPaymentToServiceProvider" xlink:href="svre-20220630.xsd#svre_SharebasedPaymentToServiceProvider"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_SharebasedPaymentToServiceProvider_lbl" xml:lang="en-US">Share-based payment to service provider</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SharebasedPaymentToServiceProvider" xlink:to="svre_SharebasedPaymentToServiceProvider_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Net proceed allocated to ADS and ADS to be issued through initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares" xlink:href="svre-20220630.xsd#svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares_lbl" xml:lang="en-US">Exercise of non-registered rights into ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares" xlink:to="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flow from operating activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US">Adjustments required to present cash flows from operating activities (Appendix A)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract9" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract9" xlink:to="svre_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investment activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl" xml:lang="en-US">Changes in short-term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract10" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract10" xlink:to="svre_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Receipt of government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants_lbl" xml:lang="en-US">Net proceeds from issuance of ADS, pre-funded warrants and warrants through initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US">Exercise of non-registered rights into ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract11" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract11" xlink:to="svre_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract12" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract12" xlink:to="svre_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Exchange differences on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract13" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract13" xlink:to="svre_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract14" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract14" xlink:to="svre_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract" xlink:href="svre-20220630.xsd#svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Appendix A - Adjustments required to present cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract" xlink:to="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract15" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract15" xlink:to="svre_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract_lbl" xml:lang="en-US">Income and expenses not involving cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl" xml:lang="en-US">Amortization of right for use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates_lbl" xml:lang="en-US">Interest expense in respect of leasing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:to="ifrs-full_ProceedsFromSalesOfInterestsInAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees_lbl" xml:lang="en-US">Share-based payment to employees and service providers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:to="ifrs-full_PaymentsToAndOnBehalfOfEmployees_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl" xml:lang="en-US">Direct and incremental issuance cost allocated to derivative warrant liability through U.S IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:href="svre-20220630.xsd#svre_ChangesInLiabilityInRespectOfGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl" xml:lang="en-US">Changes in liability in respect of government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:to="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract16" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract16" xlink:to="svre_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:href="svre-20220630.xsd#svre_ChangesInAssetAndLiabilityItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ChangesInAssetAndLiabilityItemsAbstract_lbl" xml:lang="en-US">Changes in asset and liability items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="svre_ChangesInAssetAndLiabilityItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase in other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract17" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract17" xlink:to="svre_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract18" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract18" xlink:to="svre_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:href="svre-20220630.xsd#svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract_lbl" xml:lang="en-US">Appendix B - Non-cash investment and financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_UnlabeledAbstract19" xlink:href="svre-20220630.xsd#svre_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract19" xlink:to="svre_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:href="svre-20220630.xsd#svre_RecognitionOfRightForUseAssetAgainstALeasingLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl" xml:lang="en-US">Recognition of right for use asset against a leasing liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:to="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_DeferredOfferingExpensesNotYetPaid" xlink:href="svre-20220630.xsd#svre_DeferredOfferingExpensesNotYetPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_DeferredOfferingExpensesNotYetPaid_lbl" xml:lang="en-US">Deferred offering expenses not yet paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DeferredOfferingExpensesNotYetPaid" xlink:to="svre_DeferredOfferingExpensesNotYetPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:href="svre-20220630.xsd#svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl" xml:lang="en-US">Direct and incremental stock-based payment expenses allocated to ADS and pre-fund warrants through U.S. IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:to="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OfferingCostsNotYetPaid" xlink:href="svre-20220630.xsd#svre_OfferingCostsNotYetPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OfferingCostsNotYetPaid_lbl" xml:lang="en-US">Offering costs not yet paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OfferingCostsNotYetPaid" xlink:to="svre_OfferingCostsNotYetPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:href="svre-20220630.xsd#svre_PartialExerciseOfOverallotmentOptionIntoWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl" xml:lang="en-US">Partial exercise of over-allotment option into warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:to="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_FinancingExpense" xlink:href="svre-20220630.xsd#svre_FinancingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="svre_FinancingExpense_lbl" xml:lang="en-US">Financing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_FinancingExpense" xlink:to="svre_FinancingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl" xml:lang="en-US">Partial exercise of over-allotment option into warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ChangeInRestrictedDeposits" xlink:href="svre-20220630.xsd#svre_ChangeInRestrictedDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="svre_ChangeInRestrictedDeposits_lbl" xml:lang="en-US">Change in restricted deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangeInRestrictedDeposits" xlink:to="svre_ChangeInRestrictedDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments_lbl" xml:lang="en-US">Deferred offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Repayment of principal in respect of lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Revaluation of derivative warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:href="svre-20220630.xsd#svre_ExchangeDifferencesOnCashAndCashEquivalent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl" xml:lang="en-US">Exchange differences on cash and cash equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:to="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">Increase in inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Increase (decrease) in trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US">Share capital and premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Capital reserve in respect of share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AppendixAMember" xlink:href="svre-20220630.xsd#svre_AppendixAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AppendixAMember_lbl" xml:lang="en-US">Appendix A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixAMember" xlink:to="svre_AppendixAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US">General</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Significant accounting policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl" xml:lang="en-US">U.S. Initial public offering on Nasdaq</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl" xml:lang="en-US">Schedule of gross proceeds received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Derivative warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of fair value of derivative warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuesFairValueMeasurementLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuesFairValueMeasurementLiabilities_lbl" xml:lang="en-US">Recognition of fair value of warranted issued at Effective Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuesFairValueMeasurementLiabilities" xlink:to="ifrs-full_IssuesFairValueMeasurementLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:href="svre-20220630.xsd#svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl" xml:lang="en-US">Warrants issued as result of partially exercised of over-allotment option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:to="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">Share capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock_lbl" xml:lang="en-US">Schedule of composition of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock" xlink:to="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl" xml:lang="en-US">Authorized, Ordinary shares, par value NIS 0.01 each</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Issued and outstanding, Ordinary shares, par value NIS 0.01 each</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl0" xml:lang="en-US">Issue ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_AuthorizedOrdinarySharesParValue" xlink:href="svre-20220630.xsd#svre_AuthorizedOrdinarySharesParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AuthorizedOrdinarySharesParValue_lbl" xml:lang="en-US">Authorized, Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AuthorizedOrdinarySharesParValue" xlink:to="svre_AuthorizedOrdinarySharesParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_IssuedAndOutstandingOrdinarySharesParShare" xlink:href="svre-20220630.xsd#svre_IssuedAndOutstandingOrdinarySharesParShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl" xml:lang="en-US">Issued and outstanding, Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuedAndOutstandingOrdinarySharesParShare" xlink:to="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl" xml:lang="en-US">Schedule of changes in the issued and outstanding capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AllotmentOfOrdinaryShares" xlink:href="svre-20220630.xsd#svre_AllotmentOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AllotmentOfOrdinaryShares_lbl" xml:lang="en-US">Allotment of ordinary shares through U.S IPO (see Note 3 above)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllotmentOfOrdinaryShares" xlink:to="svre_AllotmentOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of loss and number of shares basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US">Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl" xml:lang="en-US">Loss attributed to the shareholders of the Company for purposes of computing the diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xml:lang="en-US">Weighted number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:href="svre-20220630.xsd#svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl" xml:lang="en-US">Weighted number of shares to be issued upon full exercise of pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:to="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US">Financial risk factors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrants" xlink:href="svre-20220630.xsd#svre_PrefundedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="svre_PrefundedWarrants_lbl" xml:lang="en-US">Pre-funded warrant and ADS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrants" xlink:to="svre_PrefundedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:href="svre-20220630.xsd#svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl" xml:lang="en-US">Revaluation of derivative warrant liability exercisable for ADS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:to="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis_lbl" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfOperatingSegment" xlink:href="svre-20220630.xsd#svre_NumberOfOperatingSegment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NumberOfOperatingSegment_lbl" xml:lang="en-US">Operating segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfOperatingSegment" xlink:to="svre_NumberOfOperatingSegment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" xlink:to="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_StockExchangeConsiderationAmount" xlink:href="svre-20220630.xsd#svre_StockExchangeConsiderationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_StockExchangeConsiderationAmount_lbl" xml:lang="en-US">Stock exchange consideration amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_StockExchangeConsiderationAmount" xlink:to="svre_StockExchangeConsiderationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AdditionalNetAmount" xlink:href="svre-20220630.xsd#svre_AdditionalNetAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AdditionalNetAmount_lbl" xml:lang="en-US">Addition net amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AdditionalNetAmount" xlink:to="svre_AdditionalNetAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfUnit" xlink:href="svre-20220630.xsd#svre_NumberOfUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NumberOfUnit_lbl" xml:lang="en-US">Number of units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfUnit" xlink:to="svre_NumberOfUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl" xml:lang="en-US">Offering price per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfPreFundUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPreFundUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NumberOfPreFundUnits_lbl" xml:lang="en-US">Number of pre fund units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfPreFundUnits" xlink:to="svre_NumberOfPreFundUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xml:lang="en-US">Offering price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_GrossProceeds" xlink:href="svre-20220630.xsd#svre_GrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_GrossProceeds_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_GrossProceeds" xlink:to="svre_GrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_IssuanceOfWarrants" xlink:href="svre-20220630.xsd#svre_IssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_IssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuanceOfWarrants" xlink:to="svre_IssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllomentOptionShares" xlink:href="svre-20220630.xsd#svre_OverAllomentOptionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OverAllomentOptionShares_lbl" xml:lang="en-US">over-allotment option shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllomentOptionShares" xlink:to="svre_OverAllomentOptionShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl" xml:lang="en-US">Ordinary share par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl" xml:lang="en-US">Diluted loss per shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ReceivedGrossProceedsAmount" xlink:href="svre-20220630.xsd#svre_ReceivedGrossProceedsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ReceivedGrossProceedsAmount_lbl" xml:lang="en-US">Received gross proceeds amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ReceivedGrossProceedsAmount" xlink:to="svre_ReceivedGrossProceedsAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfUnits" xlink:href="svre-20220630.xsd#svre_NumberOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NumberOfUnits_lbl" xml:lang="en-US">Number of units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfUnits" xlink:to="svre_NumberOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Public of per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_WarrantExercisableDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WarrantExercisableDescription_lbl" xml:lang="en-US">Warrant exercisable description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantExercisableDescription" xlink:to="svre_WarrantExercisableDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_NumberOfPrefundedUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPrefundedUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_NumberOfPrefundedUnits_lbl" xml:lang="en-US">Number of pre-funded units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfPrefundedUnits" xlink:to="svre_NumberOfPrefundedUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PublicOfPerPrefundedUnit" xlink:href="svre-20220630.xsd#svre_PublicOfPerPrefundedUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PublicOfPerPrefundedUnit_lbl" xml:lang="en-US">Public of per pre-funded unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PublicOfPerPrefundedUnit" xlink:to="svre_PublicOfPerPrefundedUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantExercisableDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PrefundedWarrantExercisableDescription_lbl" xml:lang="en-US">Pre-funded warrant exercisable description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantExercisableDescription" xlink:to="svre_PrefundedWarrantExercisableDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PurchaseToAdditionalShares" xlink:href="svre-20220630.xsd#svre_PurchaseToAdditionalShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PurchaseToAdditionalShares_lbl" xml:lang="en-US">Purchase to additional shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PurchaseToAdditionalShares" xlink:to="svre_PurchaseToAdditionalShares_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PublicPricePerShares" xlink:href="svre-20220630.xsd#svre_PublicPricePerShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PublicPricePerShares_lbl" xml:lang="en-US">Public price per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PublicPricePerShares" xlink:to="svre_PublicPricePerShares_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsExercisableShares" xlink:href="svre-20220630.xsd#svre_WarrantsExercisableShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WarrantsExercisableShares_lbl" xml:lang="en-US">Warrants exercisable shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsExercisableShares" xlink:to="svre_WarrantsExercisableShares_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ExercisePrice" xlink:href="svre-20220630.xsd#svre_ExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ExercisePrice_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExercisePrice" xlink:to="svre_ExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OverALimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverALimitedPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OverALimitedPeriod_lbl" xml:lang="en-US">Over a limited period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverALimitedPeriod" xlink:to="svre_OverALimitedPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllotmentOptionHasBeenExpired" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionHasBeenExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OverAllotmentOptionHasBeenExpired_lbl" xml:lang="en-US">Over-allotment option has been expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllotmentOptionHasBeenExpired" xlink:to="svre_OverAllotmentOptionHasBeenExpired_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantDescription" xlink:href="svre-20220630.xsd#svre_WarrantDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WarrantDescription_lbl" xml:lang="en-US">Warrants descriptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantDescription" xlink:to="svre_WarrantDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ShareBasedPaymentWarrantAmount" xlink:href="svre-20220630.xsd#svre_ShareBasedPaymentWarrantAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ShareBasedPaymentWarrantAmount_lbl" xml:lang="en-US">Share based pay (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ShareBasedPaymentWarrantAmount" xlink:to="svre_ShareBasedPaymentWarrantAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ExpectedDividendYieldRate" xlink:href="svre-20220630.xsd#svre_ExpectedDividendYieldRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ExpectedDividendYieldRate_lbl" xml:lang="en-US">Expected dividend yield rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedDividendYieldRate" xlink:to="svre_ExpectedDividendYieldRate_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ41G1nU5uG2109FsLOz4c7Fg==] CSR-->
    <loc xlink:type="locator" xlink:label="svre_riskfreeInterestRate" xlink:href="svre-20220630.xsd#svre_riskfreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_riskfreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_riskfreeInterestRate" xlink:to="svre_riskfreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_ExpectedVolatility" xlink:href="svre-20220630.xsd#svre_ExpectedVolatility"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_ExpectedVolatility_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedVolatility" xlink:to="svre_ExpectedVolatility_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_WarrantsPerShare" xlink:href="svre-20220630.xsd#svre_WarrantsPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_WarrantsPerShare_lbl" xml:lang="en-US">Warrants per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsPerShare" xlink:to="svre_WarrantsPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:href="svre-20220630.xsd#svre_TotalIncrementalAndDirectIssuanceCostsAmounted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl" xml:lang="en-US">Total incremental and direct issuance costs amounted (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:to="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AllocatedToWarrantsAmount" xlink:href="svre-20220630.xsd#svre_AllocatedToWarrantsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AllocatedToWarrantsAmount_lbl" xml:lang="en-US">Allocated to warrants amount (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllocatedToWarrantsAmount" xlink:to="svre_AllocatedToWarrantsAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_PrefundedWarrantsAmount" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_PrefundedWarrantsAmount_lbl" xml:lang="en-US">Pre-funded warrants amount (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantsAmount" xlink:to="svre_PrefundedWarrantsAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_AggregateShares" xlink:href="svre-20220630.xsd#svre_AggregateShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_AggregateShares_lbl" xml:lang="en-US">Aggregate purchase shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AggregateShares" xlink:to="svre_AggregateShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares_lbl" xml:lang="en-US">Exercisable price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" xlink:to="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OverLimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverLimitedPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OverLimitedPeriod_lbl" xml:lang="en-US">Over limited period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverLimitedPeriod" xlink:to="svre_OverLimitedPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">Use of estimates in the preparation of financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US">Basic and diluted net loss per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl" xml:lang="en-US">Derivative Warrants Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" xlink:href="svre-20220630.xsd#svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock_lbl" xml:lang="en-US">Issuance of units comprised of warrants and ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" xlink:to="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OrdinaryShareMember" xlink:href="svre-20220630.xsd#svre_OrdinaryShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OrdinaryShareMember_lbl" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OrdinaryShareMember" xlink:to="svre_OrdinaryShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_OverAllotmentOptionsMember" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_OverAllotmentOptionsMember_lbl" xml:lang="en-US">Over Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllotmentOptionsMember" xlink:to="svre_OverAllotmentOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsMember" xlink:href="svre-20220630.xsd#svre_SubsequentEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="svre_SubsequentEventsMember_lbl" xml:lang="en-US">Subsequent Events [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SubsequentEventsMember" xlink:to="svre_SubsequentEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US">Equity [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SaleOfStockDomain" xlink:href="svre-20220630.xsd#svre_SaleOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SaleOfStockDomain_lbl" xml:lang="en-US">SaleOfStock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SaleOfStockDomain" xlink:to="svre_SaleOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US">Ranges [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesMember_lbl" xml:lang="en-US">Products and services [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="ifrs-full_ProductsAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsTable_lbl" xml:lang="en-US">U.S. Initial Public Offering on Nasdaq (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="svre_USInitialPublicOfferingonNasdaqDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_USInitialPublicOfferingonNasdaqDetailsLineItems_lbl" xml:lang="en-US">U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="svre_USInitialPublicOfferingonNasdaqDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsMember_lbl" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_NonadjustingEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsDetailsTable" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SubsequentEventsDetailsTable" xlink:to="svre_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="svre_SubsequentEventsDetailsLineItems" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SubsequentEventsDetailsLineItems" xlink:to="svre_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_AllocatedToWarrantsAmount_lbl0" xml:lang="en-US">Allocated to Warrants amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllocatedToWarrantsAmount" xlink:to="svre_AllocatedToWarrantsAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_AllotmentOfOrdinaryShares_lbl0" xml:lang="en-US">Allotment of ordinary shares through U.S IPO.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllotmentOfOrdinaryShares" xlink:to="svre_AllotmentOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl0" xml:lang="en-US">The amount of changes in liability in respect of government grants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:to="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ChangesinAssetAndLiability_lbl0" xml:lang="en-US">The amount of changes in asset and liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="svre_ChangesinAssetAndLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_DeferredOfferingExpensesNotYetPaid_lbl0" xml:lang="en-US">The amount of deferred offering expenses not yet paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DeferredOfferingExpensesNotYetPaid" xlink:to="svre_DeferredOfferingExpensesNotYetPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl0" xml:lang="en-US">The amount of direct and incremental stock-based payment expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:to="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl0" xml:lang="en-US">The amount of exchange differences on cash and cash equivalent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:to="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ExercisePrice_lbl0" xml:lang="en-US">Exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExercisePrice" xlink:to="svre_ExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ExpectedDividendYieldRate_lbl0" xml:lang="en-US">Percentage of Expected dividend yield rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedDividendYieldRate" xlink:to="svre_ExpectedDividendYieldRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ExpectedVolatility_lbl0" xml:lang="en-US">Expected volatility.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedVolatility" xlink:to="svre_ExpectedVolatility_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_FinancingExpense_lbl0" xml:lang="en-US">Amount of financing expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_FinancingExpense" xlink:to="svre_FinancingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl0" xml:lang="en-US">The amount of Income and expenses not involving cash flows.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl0" xml:lang="en-US">Issued and outstanding, Ordinary shares, par value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuedAndOutstandingOrdinarySharesParShare" xlink:to="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_NumberOfPrefundedUnits_lbl0" xml:lang="en-US">Number of pre-funded units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfPrefundedUnits" xlink:to="svre_NumberOfPrefundedUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_NumberOfUnits_lbl0" xml:lang="en-US">Number of units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfUnits" xlink:to="svre_NumberOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_OfferingCostsNotYetPaid_lbl0" xml:lang="en-US">The amount of offering costs not yet paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OfferingCostsNotYetPaid" xlink:to="svre_OfferingCostsNotYetPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_OverALimitedPeriod_lbl0" xml:lang="en-US">Over a limited period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverALimitedPeriod" xlink:to="svre_OverALimitedPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_OverAllotmentOptionHasBeenExpired_lbl0" xml:lang="en-US">Over-allotment option has been expired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllotmentOptionHasBeenExpired" xlink:to="svre_OverAllotmentOptionHasBeenExpired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl0" xml:lang="en-US">The amount of partial exercise of over-allotment option into warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:to="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_PrefundedWarrantExercisableDescription_lbl0" xml:lang="en-US">Pre-funded warrant exercisable description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantExercisableDescription" xlink:to="svre_PrefundedWarrantExercisableDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_PrefundedWarrantsAmount_lbl0" xml:lang="en-US">Pre-funded warrants amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantsAmount" xlink:to="svre_PrefundedWarrantsAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_PublicOfPerPrefundedUnit_lbl0" xml:lang="en-US">Public of per pre-funded unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PublicOfPerPrefundedUnit" xlink:to="svre_PublicOfPerPrefundedUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_PurchaseToAdditionalShares_lbl0" xml:lang="en-US">Shares of Purchase to additional.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PurchaseToAdditionalShares" xlink:to="svre_PurchaseToAdditionalShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_ReceivedGrossProceedsAmount_lbl0" xml:lang="en-US">Amount of Received gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ReceivedGrossProceedsAmount" xlink:to="svre_ReceivedGrossProceedsAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl0" xml:lang="en-US">The amount of recognition of right for use asset against a leasing liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:to="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_RestrictedDeposits_lbl0" xml:lang="en-US">Amount of restricted deposits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RestrictedDeposits" xlink:to="svre_RestrictedDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl0" xml:lang="en-US">Amount of revaluation of derivative warrant liability exercisable for ADS.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:to="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl0" xml:lang="en-US">Amount of total incremental and direct issuance costs amounted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:to="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_WarrantExercisableDescription_lbl0" xml:lang="en-US">Warrant exercisable description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantExercisableDescription" xlink:to="svre_WarrantExercisableDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_WarrantsExercisableShares_lbl0" xml:lang="en-US">Warrants exercisable shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsExercisableShares" xlink:to="svre_WarrantsExercisableShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl0" xml:lang="en-US">Amount of warrants issued as result of partially exercised of over-allotment option.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:to="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl0" xml:lang="en-US">The number of ordinary shares to be issued upon full exercise of pre-funded warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:to="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="svre_riskfreeInterestRate_lbl0" xml:lang="en-US">Risk-free interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_riskfreeInterestRate" xlink:to="svre_riskfreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WarrantsExercisableShares_lbl1" xml:lang="en-US">Warrants Exercisable Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsExercisableShares" xlink:to="svre_WarrantsExercisableShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AppendixAMember_lbl0" xml:lang="en-US">Appendix AMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixAMember" xlink:to="svre_AppendixAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AllotmentOfOrdinaryShares_lbl1" xml:lang="en-US">Allotment Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllotmentOfOrdinaryShares" xlink:to="svre_AllotmentOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl0" xml:lang="en-US">Non-current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuesFairValueMeasurementLiabilities_lbl0" xml:lang="en-US">Issues, fair value measurement, liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuesFairValueMeasurementLiabilities" xlink:to="ifrs-full_IssuesFairValueMeasurementLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PrefundedWarrantExercisableDescription_lbl1" xml:lang="en-US">Prefunded Warrant Exercisable Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantExercisableDescription" xlink:to="svre_PrefundedWarrantExercisableDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ChangeInRestrictedDeposits_lbl0" xml:lang="en-US">Change In Restricted Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangeInRestrictedDeposits" xlink:to="svre_ChangeInRestrictedDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl0" xml:lang="en-US">Increase (decrease) in number of shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_RestrictedDeposits_lbl1" xml:lang="en-US">Restricted Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RestrictedDeposits" xlink:to="svre_RestrictedDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AllocatedToWarrantsAmount_lbl1" xml:lang="en-US">Allocated To Warrants Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AllocatedToWarrantsAmount" xlink:to="svre_AllocatedToWarrantsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0" xml:lang="en-US">Disclosure of debt instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock_lbl0" xml:lang="en-US">Issuance Of Units Comprised Of Warrants And Ordinary Shares Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" xlink:to="svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0" xml:lang="en-US">Disclosure of financial risk management [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl0" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares_lbl0" xml:lang="en-US">Diluted earnings (loss) per instrument from discontinued operations, participating equity instruments other than ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" xlink:to="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl0" xml:lang="en-US">Other current non-financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0" xml:lang="en-US">Accumulated other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl0" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalReserve_lbl0" xml:lang="en-US">Capital reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalReserve" xlink:to="ifrs-full_CapitalReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_IssuanceOfWarrants_lbl0" xml:lang="en-US">Issuance Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuanceOfWarrants" xlink:to="svre_IssuanceOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract_lbl" xml:lang="en-US">Schedule Of Changes In The Issued And Outstanding Capital Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Finance income (expenses) from reinsurance contracts held recognised in profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:to="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PublicOfPerPrefundedUnit_lbl1" xml:lang="en-US">Public Of Per Prefunded Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PublicOfPerPrefundedUnit" xlink:to="svre_PublicOfPerPrefundedUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl0" xml:lang="en-US">Increase through other contributions by owners, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets_lbl0" xml:lang="en-US">Accumulated increase (decrease) in fair value of financial assets designated as measured at fair value through profit or loss, attributable to changes in credit risk of financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" xlink:to="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NonCurrentLiabilitiesAbstract" xlink:to="svre_NonCurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OverAllotmentOptionHasBeenExpired_lbl1" xml:lang="en-US">Over Allotment Option Has Been Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllotmentOptionHasBeenExpired" xlink:to="svre_OverAllotmentOptionHasBeenExpired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl0" xml:lang="en-US">Trade and other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl1" xml:lang="en-US">Recognition Of Right For Use Asset Against ALeasing Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:to="svre_RecognitionOfRightForUseAssetAgainstALeasingLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl1" xml:lang="en-US">Exchange Differences On Cash And Cash Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExchangeDifferencesOnCashAndCashEquivalent" xlink:to="svre_ExchangeDifferencesOnCashAndCashEquivalent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl1" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates_lbl0" xml:lang="en-US">Proceeds from sales of interests in associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:to="ifrs-full_ProceedsFromSalesOfInterestsInAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ExpectedVolatility_lbl1" xml:lang="en-US">Expected Volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedVolatility" xlink:to="svre_ExpectedVolatility_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl1" xml:lang="en-US">Partial Exercise Of Overallotment Option Into Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:to="svre_PartialExerciseOfOverallotmentOptionIntoWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PrefundedWarrants_lbl0" xml:lang="en-US">Prefunded Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrants" xlink:to="svre_PrefundedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_FinancingExpense_lbl1" xml:lang="en-US">Financing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_FinancingExpense" xlink:to="svre_FinancingExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PublicPricePerShares_lbl0" xml:lang="en-US">Public Price Per Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PublicPricePerShares" xlink:to="svre_PublicPricePerShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents_lbl0" xml:lang="en-US">Current restricted cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_CurrentRestrictedCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ShareBasedPaymentWarrantAmount_lbl0" xml:lang="en-US">Share Based Payment Warrant Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ShareBasedPaymentWarrantAmount" xlink:to="svre_ShareBasedPaymentWarrantAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl0" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract18" xlink:to="svre_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract19" xlink:to="svre_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GovernmentGrants_lbl0" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract16" xlink:to="svre_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl1" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract17" xlink:to="svre_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentInvestments_lbl0" xml:lang="en-US">Current investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentInvestments" xlink:to="ifrs-full_CurrentInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl0" xml:lang="en-US">Reserve of share-based payments [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl0" xml:lang="en-US">Current inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OverAllotmentOptionsMember_lbl0" xml:lang="en-US">Over Allotment Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllotmentOptionsMember" xlink:to="svre_OverAllotmentOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl0" xml:lang="en-US">Equity and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NumberOfUnits_lbl1" xml:lang="en-US">Number Of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfUnits" xlink:to="svre_NumberOfUnits_lbl1"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract_lbl" xml:lang="en-US">Schedule Of Loss And Number Of Shares Basic And Diluted Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares_lbl0" xml:lang="en-US">Exercise Of Nonregistered Rights Into Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares" xlink:to="svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SubsequentEventsMember_lbl0" xml:lang="en-US">Subsequent Events Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SubsequentEventsMember" xlink:to="svre_SubsequentEventsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl0" xml:lang="en-US">Adjustments for amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value measurement of liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SaleOfStockAxis_lbl0" xml:lang="en-US">Sale Of Stock Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SaleOfStockAxis" xlink:to="svre_SaleOfStockAxis_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Appendix AAdjustments Required To Present Cash Flows From Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract" xlink:to="svre_AppendixAAdjustmentsRequiredToPresentCashFlowsFromOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl1" xml:lang="en-US">Number of shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Selling, general and administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl0" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of Derivative Warrant Liability Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl0" xml:lang="en-US">Share premium [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl0" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Appendix BNon Cash Investment And Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NumberOfOperatingSegment_lbl0" xml:lang="en-US">Number Of Operating Segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfOperatingSegment" xlink:to="svre_NumberOfOperatingSegment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OverLimitedPeriod_lbl0" xml:lang="en-US">Over Limited Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverLimitedPeriod" xlink:to="svre_OverLimitedPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl1" xml:lang="en-US">Income And Expenses Not Involving Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlows" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlows_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NonCurrentAssetsAbstract" xlink:to="svre_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl0" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl0" xml:lang="en-US">Current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_CondensedStatementsOfChangesInShareholdersEquityAbstract" xlink:href="svre-20220630.xsd#svre_CondensedStatementsOfChangesInShareholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_CondensedStatementsOfChangesInShareholdersEquityAbstract_lbl" xml:lang="en-US">Condensed Statements Of Changes In Shareholders Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_CondensedStatementsOfChangesInShareholdersEquityAbstract" xlink:to="svre_CondensedStatementsOfChangesInShareholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ReceivedGrossProceedsAmount_lbl1" xml:lang="en-US">Received Gross Proceeds Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ReceivedGrossProceedsAmount" xlink:to="svre_ReceivedGrossProceedsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl0" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ChangesinAssetAndLiability_lbl1" xml:lang="en-US">Changesin Asset And Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesinAssetAndLiability" xlink:to="svre_ChangesinAssetAndLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OverAllomentOptionShares_lbl0" xml:lang="en-US">Over Alloment Option Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverAllomentOptionShares" xlink:to="svre_OverAllomentOptionShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl0" xml:lang="en-US">Trade and other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfEarningsPerShareTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Earnings Per Share Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfEarningsPerShareTextBlockAbstract" xlink:to="svre_DisclosureOfEarningsPerShareTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OfferingCostsNotYetPaid_lbl1" xml:lang="en-US">Offering Costs Not Yet Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OfferingCostsNotYetPaid" xlink:to="svre_OfferingCostsNotYetPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0" xml:lang="en-US">Increase (decrease) in number of ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract10" xlink:to="svre_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract11" xlink:to="svre_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_lbl0" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract14" xlink:to="svre_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract15" xlink:to="svre_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WarrantsPerShare_lbl0" xml:lang="en-US">Warrants Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsPerShare" xlink:to="svre_WarrantsPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract12" xlink:to="svre_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract13" xlink:to="svre_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl1" xml:lang="en-US">Number of shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NumberOfPreFundUnits_lbl0" xml:lang="en-US">Number Of Pre Fund Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfPreFundUnits" xlink:to="svre_NumberOfPreFundUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PurchaseToAdditionalShares_lbl1" xml:lang="en-US">Purchase To Additional Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PurchaseToAdditionalShares" xlink:to="svre_PurchaseToAdditionalShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl0" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl0" xml:lang="en-US">Dividends paid, ordinary shares per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_StockExchangeConsiderationAmount_lbl0" xml:lang="en-US">Stock Exchange Consideration Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_StockExchangeConsiderationAmount" xlink:to="svre_StockExchangeConsiderationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NumberOfPrefundedUnits_lbl1" xml:lang="en-US">Number Of Prefunded Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfPrefundedUnits" xlink:to="svre_NumberOfPrefundedUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl1" xml:lang="en-US">Changes In Liability In Respect Of Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesInLiabilityInRespectOfGovernmentGrants" xlink:to="svre_ChangesInLiabilityInRespectOfGovernmentGrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfGrossProceedsReceivedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfGrossProceedsReceivedAbstract_lbl" xml:lang="en-US">Schedule Of Gross Proceeds Received Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfGrossProceedsReceivedAbstract" xlink:to="svre_ScheduleOfGrossProceedsReceivedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in derivative financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ExpectedDividendYieldRate_lbl1" xml:lang="en-US">Expected Dividend Yield Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExpectedDividendYieldRate" xlink:to="svre_ExpectedDividendYieldRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl0" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract2" xlink:to="svre_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract1" xlink:to="svre_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants_lbl0" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract4" xlink:to="svre_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract3" xlink:to="svre_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract0" xlink:to="svre_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract9" xlink:to="svre_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl0" xml:lang="en-US">Number of shares authorised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract6" xlink:to="svre_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract5" xlink:to="svre_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract8" xlink:to="svre_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract7" xlink:to="svre_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ChangesInAssetAndLiabilityItemsAbstract_lbl0" xml:lang="en-US">Changes In Asset And Liability Items Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ChangesInAssetAndLiabilityItemsAbstract" xlink:to="svre_ChangesInAssetAndLiabilityItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl0" xml:lang="en-US">Sales and marketing expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_riskfreeInterestRate_lbl1" xml:lang="en-US">riskfree Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_riskfreeInterestRate" xlink:to="svre_riskfreeInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl2" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WarrantExercisableDescription_lbl1" xml:lang="en-US">Warrant Exercisable Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantExercisableDescription" xlink:to="svre_WarrantExercisableDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Proceeds from government grants, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl2" xml:lang="en-US">Current derivative financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DeferredOfferingExpensesNotYetPaid_lbl1" xml:lang="en-US">Deferred Offering Expenses Not Yet Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DeferredOfferingExpensesNotYetPaid" xlink:to="svre_DeferredOfferingExpensesNotYetPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl1" xml:lang="en-US">Issued And Outstanding Ordinary Shares Par Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IssuedAndOutstandingOrdinarySharesParShare" xlink:to="svre_IssuedAndOutstandingOrdinarySharesParShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl0" xml:lang="en-US">Disclosure of issued capital [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfIssuedCapitalExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl0" xml:lang="en-US">Adjustment to profit (loss) for preference share dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AdditionalNetAmount_lbl0" xml:lang="en-US">Additional Net Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AdditionalNetAmount" xlink:to="svre_AdditionalNetAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AuthorizedOrdinarySharesParValue_lbl0" xml:lang="en-US">Authorized Ordinary Shares Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AuthorizedOrdinarySharesParValue" xlink:to="svre_AuthorizedOrdinarySharesParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_UnlabeledAbstract" xlink:to="svre_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for warrants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees_lbl0" xml:lang="en-US">Payments to and on behalf of employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:to="ifrs-full_PaymentsToAndOnBehalfOfEmployees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl0" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_SharebasedPaymentToServiceProvider_lbl0" xml:lang="en-US">Sharebased Payment To Service Provider</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_SharebasedPaymentToServiceProvider" xlink:to="svre_SharebasedPaymentToServiceProvider_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfCompositionOfShareCapitalAbstract_lbl" xml:lang="en-US">Schedule Of Composition Of Share Capital Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="svre_ScheduleOfCompositionOfShareCapitalAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl0" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl0" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl1" xml:lang="en-US">Warrants Issued As Result Of Partially Exercised Of Overallotment Option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:to="svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Significant Accounting Policies Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OverALimitedPeriod_lbl1" xml:lang="en-US">Over ALimited Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OverALimitedPeriod" xlink:to="svre_OverALimitedPeriod_lbl1"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfFinancialRiskManagementTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Financial Risk Management Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:to="svre_DisclosureOfFinancialRiskManagementTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments_lbl0" xml:lang="en-US">Payments of other equity instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_PrefundedWarrantsAmount_lbl1" xml:lang="en-US">Prefunded Warrants Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_PrefundedWarrantsAmount" xlink:to="svre_PrefundedWarrantsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl0" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl1" xml:lang="en-US">Weighted Number Of Shares To Be Issued Upon Full Exercise Of Prefunded Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:to="svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_OrdinaryShareMember_lbl0" xml:lang="en-US">Ordinary Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_OrdinaryShareMember" xlink:to="svre_OrdinaryShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl0" xml:lang="en-US">Issue of equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_GrossProceeds_lbl0" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_GrossProceeds" xlink:to="svre_GrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl0" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl1" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl0" xml:lang="en-US">Assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_lbl0" xml:lang="en-US">Current liabilities other than liabilities included in disposal groups classified as held for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl1" xml:lang="en-US">Total Incremental And Direct Issuance Costs Amounted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:to="svre_TotalIncrementalAndDirectIssuanceCostsAmounted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl1" xml:lang="en-US">Revaluation Of Derivative Warrant Liability Exercisable For ADS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:to="svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl0" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract_lbl0" xml:lang="en-US">Income And Expenses Not Involving Cash Flows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl1" xml:lang="en-US">Profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl0" xml:lang="en-US">Other non-current non-financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_WarrantDescription_lbl0" xml:lang="en-US">Warrant Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_WarrantDescription" xlink:to="svre_WarrantDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl2" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl0" xml:lang="en-US">Cash flows from (used in) decrease (increase) in short-term deposits and investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Composition Of Share Capital Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock" xlink:to="svre_ScheduleOfCompositionOfShareCapitalTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in other operating receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl0" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl0" xml:lang="en-US">Adjustments for depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_ExercisePrice_lbl1" xml:lang="en-US">Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_ExercisePrice" xlink:to="svre_ExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_NumberOfUnit_lbl0" xml:lang="en-US">Number Of Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_NumberOfUnit" xlink:to="svre_NumberOfUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl1" xml:lang="en-US">Direct And Incremental Stockbased Payment Expenses Allocated To ADSAnd Prefund Warrants Th</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:to="svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_AggregateShares_lbl0" xml:lang="en-US">Aggregate Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_AggregateShares" xlink:to="svre_AggregateShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl0" xml:lang="en-US">Current prepayments and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl0" xml:lang="en-US">Finance income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained earnings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Share Capital Reserves And Other Equity Interest Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>svre-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Sep 09 11:35:33 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedBalanceSheet" roleURI="http://www.saver.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedIncomeStatement" roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareholdersEquityType2or3" roleURI="http://www.saver.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ConsolidatedCashFlow" roleURI="http://www.saver.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_General" roleURI="http://www.saver.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SignificantAccountingPolicies" roleURI="http://www.saver.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaq" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaq"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareCapitalandReserves" roleURI="http://www.saver.com/role/ShareCapitalandReserves"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_LossPerShare" roleURI="http://www.saver.com/role/LossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_FinancialRiskFactors" roleURI="http://www.saver.com/role/FinancialRiskFactors"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SubsequentEvents" roleURI="http://www.saver.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_AccountingPoliciesByPolicy" roleURI="http://www.saver.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaqTables" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ShareCapitalandReservesTables" roleURI="http://www.saver.com/role/ShareCapitalandReservesTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_LossPerShareTables" roleURI="http://www.saver.com/role/LossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofgrossproceedsreceivedTable" roleURI="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoffairvalueofderivativewarrantliabilityTable" roleURI="http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofcompositionofsharecapitalTable" roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofcompositionofsharecapitalTable_Parentheticals" roleURI="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleofchangesintheissuedandoutstandingcapitalTable" roleURI="http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable" roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals" roleURI="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_GeneralDetails" roleURI="http://www.saver.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SignificantAccountingPoliciesDetails" roleURI="http://www.saver.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_USInitialPublicOfferingonNasdaqDetails" roleURI="http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#svre_r_SubsequentEventsDetails" roleURI="http://www.saver.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="svre-20220630.xsd#DocumentAndEntityInformation" roleURI="http://www.saver.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentRestrictedCashAndCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RestrictedDeposits" xlink:href="svre-20220630.xsd#svre_RestrictedDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="RestrictedDeposits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="svre-20220630.xsd#svre_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_SharePremium" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalReserve" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CapitalReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_CapitalReserve" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_Equity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_CostOfSales" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SalesAndMarketingExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FinancingExpense" xlink:href="svre-20220630.xsd#svre_FinancingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="FinancingExpense" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncome" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="CondensedStatementsOfChangesInShareholdersEquityAbstract" xlink:href="svre-20220630.xsd#svre_CondensedStatementsOfChangesInShareholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CondensedStatementsOfChangesInShareholdersEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_SharePremiumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedPaymentToServiceProvider" xlink:href="svre-20220630.xsd#svre_SharebasedPaymentToServiceProvider"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharebasedPaymentToServiceProvider" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExerciseOfNonregisteredRightsIntoOrdinaryShares" xlink:href="svre-20220630.xsd#svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ExerciseOfNonregisteredRightsIntoOrdinaryShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockAxis" xlink:href="svre-20220630.xsd#svre_SaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="SaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockDomain" xlink:href="svre-20220630.xsd#svre_SaleOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockAxis" xlink:to="SaleOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AppendixAMember" xlink:href="svre-20220630.xsd#svre_AppendixAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockAxis" xlink:to="AppendixAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInRestrictedDeposits" xlink:href="svre-20220630.xsd#svre_ChangeInRestrictedDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ChangeInRestrictedDeposits" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="IncomeAndExpensesNotInvolvingCashFlowsAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfInterestsInAssociates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_PaymentsToAndOnBehalfOfEmployees" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeDifferencesOnCashAndCashEquivalent" xlink:href="svre-20220630.xsd#svre_ExchangeDifferencesOnCashAndCashEquivalent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ExchangeDifferencesOnCashAndCashEquivalent" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInLiabilityInRespectOfGovernmentGrants" xlink:href="svre-20220630.xsd#svre_ChangesInLiabilityInRespectOfGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="ChangesInLiabilityInRespectOfGovernmentGrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAndExpensesNotInvolvingCashFlows" xlink:href="svre-20220630.xsd#svre_IncomeAndExpensesNotInvolvingCashFlows"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAndExpensesNotInvolvingCashFlowsAbstract" xlink:to="IncomeAndExpensesNotInvolvingCashFlows" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInAssetAndLiabilityItemsAbstract" xlink:href="svre-20220630.xsd#svre_ChangesInAssetAndLiabilityItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangesInAssetAndLiabilityItemsAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesinAssetAndLiability" xlink:href="svre-20220630.xsd#svre_ChangesinAssetAndLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ChangesinAssetAndLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetAndLiabilityItemsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:href="svre-20220630.xsd#svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RecognitionOfRightForUseAssetAgainstALeasingLiability" xlink:href="svre-20220630.xsd#svre_RecognitionOfRightForUseAssetAgainstALeasingLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="RecognitionOfRightForUseAssetAgainstALeasingLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingExpensesNotYetPaid" xlink:href="svre-20220630.xsd#svre_DeferredOfferingExpensesNotYetPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="DeferredOfferingExpensesNotYetPaid" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" xlink:href="svre-20220630.xsd#svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsNotYetPaid" xlink:href="svre-20220630.xsd#svre_OfferingCostsNotYetPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="OfferingCostsNotYetPaid" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PartialExerciseOfOverallotmentOptionIntoWarrants" xlink:href="svre-20220630.xsd#svre_PartialExerciseOfOverallotmentOptionIntoWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AppendixBNonCashInvestmentAndFinancingActivitiesAbstract" xlink:to="PartialExerciseOfOverallotmentOptionIntoWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/General">
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYRDsM4IEaW6+TyqR4vj/dCAeIu63ztQz1jiaEIF2JXdJwW3RCql2nuKEyTWr5AdVcWblZtew8iMl3wC22YuwH7a9UNwHRNL3GFh4kc9LlryRIVOLuNgcHG4C59D0lNIFTrnhCyqFhpTWtFv2wTl5r3dTJAsKpR1ISyMufwj8M26hxSh1Y0WeQ4EV2xd8SFexGl5y0kAe6BKg==] CSR-->
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaq">
    <loc xlink:type="locator" xlink:label="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareCapitalandReserves">
    <loc xlink:type="locator" xlink:label="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:label="DisclosureOfEarningsPerShareTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEarningsPerShareTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/FinancialRiskFactors">
    <loc xlink:type="locator" xlink:label="DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfFinancialRiskManagementTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialRiskManagementTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" xlink:href="svre-20220630.xsd#svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ShareCapitalandReservesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCompositionOfShareCapitalTableTextBlock" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="ScheduleOfCompositionOfShareCapitalTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIssuedCapitalExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfEarningsPerShareTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEarningsPerShareTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEarningsPerShareTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGrossProceedsReceivedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfGrossProceedsReceivedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossProceedsReceivedAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedWarrants" xlink:href="svre-20220630.xsd#svre_PrefundedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossProceedsReceivedAbstract" xlink:to="PrefundedWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossProceedsReceivedAbstract" xlink:to="ifrs-full_GovernmentGrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuesFairValueMeasurementLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="ifrs-full_IssuesFairValueMeasurementLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" xlink:href="svre-20220630.xsd#svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfDerivativeWarrantLiabilityExercisableForADS" xlink:href="svre-20220630.xsd#svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="RevaluationOfDerivativeWarrantLiabilityExercisableForADS" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompositionOfShareCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesAuthorised" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesAuthorised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompositionOfShareCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfCompositionOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="AuthorizedOrdinarySharesParValue" xlink:href="svre-20220630.xsd#svre_AuthorizedOrdinarySharesParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="AuthorizedOrdinarySharesParValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingOrdinarySharesParShare" xlink:href="svre-20220630.xsd#svre_IssuedAndOutstandingOrdinarySharesParShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompositionOfShareCapitalAbstract" xlink:to="IssuedAndOutstandingOrdinarySharesParShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AllotmentOfOrdinaryShares" xlink:href="svre-20220630.xsd#svre_AllotmentOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="AllotmentOfOrdinaryShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" xlink:href="svre-20220630.xsd#svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_WeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:href="svre-20220630.xsd#svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="NumberOfOperatingSegment" xlink:href="svre-20220630.xsd#svre_NumberOfOperatingSegment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="NumberOfOperatingSegment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockExchangeConsiderationAmount" xlink:href="svre-20220630.xsd#svre_StockExchangeConsiderationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="StockExchangeConsiderationAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalNetAmount" xlink:href="svre-20220630.xsd#svre_AdditionalNetAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="AdditionalNetAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfUnit" xlink:href="svre-20220630.xsd#svre_NumberOfUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="NumberOfUnit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfPreFundUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPreFundUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="NumberOfPreFundUnits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceeds" xlink:href="svre-20220630.xsd#svre_GrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="GrossProceeds" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfWarrants" xlink:href="svre-20220630.xsd#svre_IssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="IssuanceOfWarrants" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverAllomentOptionShares" xlink:href="svre-20220630.xsd#svre_OverAllomentOptionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract" xlink:to="OverAllomentOptionShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="USInitialPublicOfferingonNasdaqDetailsTable" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsTable"/>
    <loc xlink:type="locator" xlink:label="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:href="svre-20220630.xsd#svre_USInitialPublicOfferingonNasdaqDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract" xlink:to="USInitialPublicOfferingonNasdaqDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinaryShareMember" xlink:href="svre-20220630.xsd#svre_OrdinaryShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="OrdinaryShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProductsAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OverAllotmentOptionsMember" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="OverAllotmentOptionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsTable" xlink:to="USInitialPublicOfferingonNasdaqDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReceivedGrossProceedsAmount" xlink:href="svre-20220630.xsd#svre_ReceivedGrossProceedsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ReceivedGrossProceedsAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfUnits" xlink:href="svre-20220630.xsd#svre_NumberOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="NumberOfUnits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_WarrantExercisableDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="WarrantExercisableDescription" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfPrefundedUnits" xlink:href="svre-20220630.xsd#svre_NumberOfPrefundedUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="NumberOfPrefundedUnits" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfPerPrefundedUnit" xlink:href="svre-20220630.xsd#svre_PublicOfPerPrefundedUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="PublicOfPerPrefundedUnit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedWarrantExercisableDescription" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantExercisableDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="PrefundedWarrantExercisableDescription" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseToAdditionalShares" xlink:href="svre-20220630.xsd#svre_PurchaseToAdditionalShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="PurchaseToAdditionalShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicPricePerShares" xlink:href="svre-20220630.xsd#svre_PublicPricePerShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="PublicPricePerShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisableShares" xlink:href="svre-20220630.xsd#svre_WarrantsExercisableShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="WarrantsExercisableShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice" xlink:href="svre-20220630.xsd#svre_ExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverALimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverALimitedPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="OverALimitedPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverAllotmentOptionHasBeenExpired" xlink:href="svre-20220630.xsd#svre_OverAllotmentOptionHasBeenExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="OverAllotmentOptionHasBeenExpired" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantDescription" xlink:href="svre-20220630.xsd#svre_WarrantDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="WarrantDescription" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentWarrantAmount" xlink:href="svre-20220630.xsd#svre_ShareBasedPaymentWarrantAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ShareBasedPaymentWarrantAmount" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpectedDividendYieldRate" xlink:href="svre-20220630.xsd#svre_ExpectedDividendYieldRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ExpectedDividendYieldRate" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="riskfreeInterestRate" xlink:href="svre-20220630.xsd#svre_riskfreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="riskfreeInterestRate" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpectedVolatility" xlink:href="svre-20220630.xsd#svre_ExpectedVolatility"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="ExpectedVolatility" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPerShare" xlink:href="svre-20220630.xsd#svre_WarrantsPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="WarrantsPerShare" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalIncrementalAndDirectIssuanceCostsAmounted" xlink:href="svre-20220630.xsd#svre_TotalIncrementalAndDirectIssuanceCostsAmounted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="TotalIncrementalAndDirectIssuanceCostsAmounted" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllocatedToWarrantsAmount" xlink:href="svre-20220630.xsd#svre_AllocatedToWarrantsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="AllocatedToWarrantsAmount" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedWarrantsAmount" xlink:href="svre-20220630.xsd#svre_PrefundedWarrantsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="USInitialPublicOfferingonNasdaqDetailsLineItems" xlink:to="PrefundedWarrantsAmount" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="svre-20220630.xsd#svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="svre-20220630.xsd#svre_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsMember" xlink:href="svre-20220630.xsd#svre_SubsequentEventsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="SubsequentEventsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AggregateShares" xlink:href="svre-20220630.xsd#svre_AggregateShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="AggregateShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverLimitedPeriod" xlink:href="svre-20220630.xsd#svre_OverLimitedPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="OverLimitedPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.saver.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="svre-20220630.xsd#svre_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494289664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SaverOne 2014 Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001894693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495003136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Financial Position - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8362; 41,075<span></span>
</td>
<td class="nump">&#8362; 8,683<span></span>
</td>
<td class="nump">&#8362; 14,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentInvestments', window );">Short-term bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">12,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentRestrictedCashAndCashEquivalents', window );">Restricted deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade receivables</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">855<span></span>
</td>
<td class="nump">825<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">43,262<span></span>
</td>
<td class="nump">16,180<span></span>
</td>
<td class="nump">28,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_RestrictedDeposits', window );">Restricted deposits</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right of use asset, net</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">1,188<span></span>
</td>
<td class="nump">2,576<span></span>
</td>
<td class="nump">1,591<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">44,450<span></span>
</td>
<td class="nump">18,756<span></span>
</td>
<td class="nump">30,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of leasing liabilities</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">942<span></span>
</td>
<td class="nump">825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Other current liabilities</a></td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">3,522<span></span>
</td>
<td class="nump">2,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Derivative warrants liability</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Liability in respect of government grants</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">9,019<span></span>
</td>
<td class="nump">5,040<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NonCurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentNonfinancialLiabilities', window );">Liability in respect of government grants</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Leasing liability, net current</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">605<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">1,568<span></span>
</td>
<td class="nump">1,664<span></span>
</td>
<td class="nump">1,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share capital and premium</a></td>
<td class="nump">112,708<span></span>
</td>
<td class="nump">80,440<span></span>
</td>
<td class="nump">80,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve in respect of share-based payment</a></td>
<td class="nump">9,868<span></span>
</td>
<td class="nump">8,425<span></span>
</td>
<td class="nump">7,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(88,713)<span></span>
</td>
<td class="num">(76,813)<span></span>
</td>
<td class="num">(63,624)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">33,863<span></span>
</td>
<td class="nump">12,052<span></span>
</td>
<td class="nump">24,465<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">&#8362; 44,450<span></span>
</td>
<td class="nump">&#8362; 18,756<span></span>
</td>
<td class="nump">&#8362; 30,099<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the capital reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_RestrictedDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_RestrictedDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494124064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Comprehensive Loss - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">&#8362; 382<span></span>
</td>
<td class="nump">&#8362; 201<span></span>
</td>
<td class="nump">&#8362; 450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of revenues</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(288)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses, net</a></td>
<td class="num">(10,184)<span></span>
</td>
<td class="num">(8,854)<span></span>
</td>
<td class="num">(18,847)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="num">(481)<span></span>
</td>
<td class="num">(1,677)<span></span>
</td>
<td class="num">(2,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(2,511)<span></span>
</td>
<td class="num">(2,690)<span></span>
</td>
<td class="num">(5,149)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(13,061)<span></span>
</td>
<td class="num">(13,185)<span></span>
</td>
<td class="num">(26,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_FinancingExpense', window );">Financing expenses</a></td>
<td class="num">(869)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financing income</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss', window );">Financing income (expenses), net</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(225)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(11,900)<span></span>
</td>
<td class="num">(13,301)<span></span>
</td>
<td class="num">(26,490)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the period</a></td>
<td class="num">&#8362; (11,900)<span></span>
</td>
<td class="num">&#8362; (13,301)<span></span>
</td>
<td class="num">&#8362; (26,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic and diluted loss per share (in New Shekels per share)</a></td>
<td class="num">&#8362; (1.15)<span></span>
</td>
<td class="num">&#8362; (1.68)<span></span>
</td>
<td class="num">&#8362; (3.33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)</a></td>
<td class="nump">10,334,303<span></span>
</td>
<td class="nump">7,935,366<span></span>
</td>
<td class="nump">7,960,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income (expenses) from reinsurance contracts held that is recognised in profit or loss. [Refer: Insurance finance income (expenses); Reinsurance contracts held [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph bc<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_bc&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2022-03-24<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_FinancingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financing expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_FinancingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494113520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Comprehensive Loss (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Basic and diluted loss per share (in Dollars per share)</a></td>
<td class="num">&#8362; (1.15)<span></span>
</td>
<td class="num">&#8362; (1.68)<span></span>
</td>
<td class="num">&#8362; (3.33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)</a></td>
<td class="nump">10,334,303<span></span>
</td>
<td class="nump">7,935,366<span></span>
</td>
<td class="nump">7,960,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495384016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Changes in Shareholders&#8217; Equity - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Share capital and premium</div></th>
<th class="th"><div>Capital reserve in respect of share-based payment</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">&#8362; 80,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8362; 5,077<span></span>
</td>
<td class="num">&#8362; (50,323)<span></span>
</td>
<td class="nump">&#8362; 35,194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payment to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,116<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_SharebasedPaymentToServiceProvider', window );">Share-based payment to service provider</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,456<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares', window );">Exercise of non-registered rights into ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(13,301)<span></span>
</td>
<td class="num">(13,301)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">80,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,649<span></span>
</td>
<td class="num">(63,624)<span></span>
</td>
<td class="nump">24,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">80,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,077<span></span>
</td>
<td class="num">(50,323)<span></span>
</td>
<td class="nump">35,194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payment to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,892<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_SharebasedPaymentToServiceProvider', window );">Share-based payment to service provider</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,456<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,456<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares', window );">Exercise of non-registered rights into ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(26,490)<span></span>
</td>
<td class="num">(26,490)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">80,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,425<span></span>
</td>
<td class="num">(76,813)<span></span>
</td>
<td class="nump">12,052<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payment to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">545<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">545<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_SharebasedPaymentToServiceProvider', window );">Share-based payment to service provider</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,056<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Partial exercise of over-allotment option into warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(158)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Net proceed allocated to ADS and ADS to be issued through initial public offering</a></td>
<td class="nump">32,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(11,900)<span></span>
</td>
<td class="num">(11,900)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">&#8362; 112,708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8362; 9,868<span></span>
</td>
<td class="num">&#8362; (88,713)<span></span>
</td>
<td class="nump">&#8362; 33,863<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than NIS 1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_SharebasedPaymentToServiceProvider">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_SharebasedPaymentToServiceProvider</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399492698640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flow from operating activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Comprehensive loss for the period</a></td>
<td class="num">&#8362; (11,900)<span></span>
</td>
<td class="num">&#8362; (13,301)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8362; (26,490)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">Adjustments required to present cash flows from operating activities (Appendix A)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(11,912)<span></span>
</td>
<td class="num">(10,659)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(23,133)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investment activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ChangeInRestrictedDeposits', window );">Change in restricted deposits</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(41)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments', window );">Changes in short-term deposits</a></td>
<td class="nump">5,012<span></span>
</td>
<td class="num">(12,006)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,012)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property and equipment</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(144)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by (used in) investment activity</a></td>
<td class="nump">5,002<span></span>
</td>
<td class="num">(12,155)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,197)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfOtherEquityInstruments', window );">Deferred offering expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities', window );">Receipt of government grants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Net proceeds from issuance of ADS, pre-funded warrants and warrants through initial public offering</a></td>
<td class="nump">37,578<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of principal in respect of lease liability</a></td>
<td class="num">(234)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Exercise of non-registered rights into ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by (used in) financing activity</a></td>
<td class="nump">37,344<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(611)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Change in balance of cash and cash equivalents</a></td>
<td class="nump">30,434<span></span>
</td>
<td class="num">(22,769)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,941)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Exchange differences on cash and cash equivalents</a></td>
<td class="nump">1,958<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents, beginning of period</a></td>
<td class="nump">8,683<span></span>
</td>
<td class="nump">37,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents, end of period</a></td>
<td class="nump">41,075<span></span>
</td>
<td class="nump">14,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,683<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_SaleOfStockAxis=svre_AppendixAMember', window );">Appendix A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract', window );"><strong>Income and expenses not involving cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization of right for use asset</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">398<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInterestsInAssociates', window );">Interest expense in respect of leasing</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToAndOnBehalfOfEmployees', window );">Share-based payment to employees and service providers</a></td>
<td class="nump">545<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Direct and incremental issuance cost allocated to derivative warrant liability through U.S IPO</a></td>
<td class="nump">723<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities', window );">Revaluation of derivative warrant liability</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExchangeDifferencesOnCashAndCashEquivalent', window );">Exchange differences on cash and cash equivalent</a></td>
<td class="num">(1,958)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ChangesInLiabilityInRespectOfGovernmentGrants', window );">Changes in liability in respect of government grants</a></td>
<td class="nump">114<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(213)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_IncomeAndExpensesNotInvolvingCashFlows', window );">Income and expenses not involving cash flows total</a></td>
<td class="num">(391)<span></span>
</td>
<td class="nump">2,815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ChangesInAssetAndLiabilityItemsAbstract', window );"><strong>Changes in asset and liability items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">201<span></span>
</td>
<td class="num">(376)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(647)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Decrease (increase) in trade receivables</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(142)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Increase in inventory</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(715)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase (decrease) in trade payables</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">54<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities', window );">Increase in other current liabilities</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ChangesinAssetAndLiability', window );">Changes in asset and liability total</a></td>
<td class="nump">379<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(298)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Income and expenses and changes in asset</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract', window );"><strong>Appendix B - Non-cash investment and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_RecognitionOfRightForUseAssetAgainstALeasingLiability', window );">Recognition of right for use asset against a leasing liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DeferredOfferingExpensesNotYetPaid', window );">Deferred offering expenses not yet paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh', window );">Direct and incremental stock-based payment expenses allocated to ADS and pre-fund warrants through U.S. IPO</a></td>
<td class="nump">960<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_OfferingCostsNotYetPaid', window );">Offering costs not yet paid</a></td>
<td class="nump">280<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PartialExerciseOfOverallotmentOptionIntoWarrants', window );">Partial exercise of over-allotment option into warrants</a></td>
<td class="nump">&#8362; 158<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than NIS 1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in derivative financial liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Derivative financial liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payments for equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAndOnBehalfOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to, and on behalf of, employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 14<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_14_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAndOnBehalfOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInterestsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInterestsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ChangeInRestrictedDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ChangeInRestrictedDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ChangesInAssetAndLiabilityItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ChangesInAssetAndLiabilityItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ChangesInLiabilityInRespectOfGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of changes in liability in respect of government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ChangesInLiabilityInRespectOfGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ChangesinAssetAndLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of changes in asset and liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ChangesinAssetAndLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DeferredOfferingExpensesNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred offering expenses not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DeferredOfferingExpensesNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of direct and incremental stock-based payment expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ExchangeDifferencesOnCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences on cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ExchangeDifferencesOnCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_IncomeAndExpensesNotInvolvingCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Income and expenses not involving cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_IncomeAndExpensesNotInvolvingCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_OfferingCostsNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering costs not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_OfferingCostsNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PartialExerciseOfOverallotmentOptionIntoWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of partial exercise of over-allotment option into warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PartialExerciseOfOverallotmentOptionIntoWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_RecognitionOfRightForUseAssetAgainstALeasingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of recognition of right for use asset against a leasing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_RecognitionOfRightForUseAssetAgainstALeasingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_SaleOfStockAxis=svre_AppendixAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_SaleOfStockAxis=svre_AppendixAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399500986720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 1 - General</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.6pt"/><td style="width: 28.3pt"><b>A.</b></td><td style="text-align: justify"><b>Incorporation and operations</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 82.15pt; text-align: justify; text-indent: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">Saverone 2014 Ltd.
(the &#8220;Company&#8221;) was founded in Israel on November 16, 2014 and commenced its business activity on that date (the &#8220;Inception
Date&#8221;). From the Inception Date, the Company has been active in one operating segment, i.e., development of the technology necessary
to create a life-saving system that prevents certain uses of cell phones while driving (the &#8220;Saverone System&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.6pt"/><td style="width: 28.3pt"><b>B.</b></td><td style="text-align: justify"><b>The Company&#8217;s business position</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"><br/>
The Company&#8217;s main activity is research and development and it has not yet shown any operating profits. From the Inception Date and through
June 30, 2022, the Company reported losses and a negative cash flow from current operating activity. As of June 30, 2022, the Company
has an accumulated deficit of NIS 88,713 and it had a comprehensive loss of NIS 11,900 for the period of six months ended June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The Company&#8217;s management
has been maintaining forecasts, monitoring its cash flows and has been actively involved in obtaining the financing it needs to continue
its operations and to realize its plans which include the implementation of a business plan formulated by the Company&#8217;s management to
complete the development and sale of products based on technologies that are still in their development stage. The ability of the Company
to meet its development targets and to realize its business plans, as above, are contingent upon the recruitment of sources of finance
which are not guaranteed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">	In June 2020,
the Company completed an initial public offering (&#8220;IPO&#8221;) on the Tel Aviv Stock Exchange, with a net consideration of NIS&#160;23,720.	In
addition, as part of the preparations of the Company for the above issuance, the entire balance of the bridging investments used to finance
Company activity were converted into shares by the date of the aforementioned issuance. Also, in November 2020, the Company completed
financing through a shelf offering, as part of which it raised an addition net amount of NIS 20,887.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -17.1pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"><span style="font-size: 10pt">In
June 2022, the Company completed an </span>underwritten <span style="font-size: 10pt">U.S. IPO (&#8220;U.S. IPO&#8221;) on the Nasdaq
under which the Company issued and sold&#160;(i) number of 2,941,918 units, each unit consisting of one American Depositary Share (&#8220;ADS&#8221;)
and one warrant to purchase one ADS (&#8220;Warrant&#8221;) at an offering price of $4.13&#160;per unit and (ii) number of 208,802 pre-funded
units, each unit consisting of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS at an offering price of
$4.129 per pre-funded unit. The Company received gross proceeds of approximately $13 million (approximately NIS 43,441)&#160;before direct
and incremental costs incurred. In addition, the Company allotted to the underwriter as share-based payment by issuance of 157,510 warrants
</span>(<span style="font-size: 10pt">&#8220;</span>Representative&#8217;s Warrant<span style="font-size: 10pt">&#8221;</span>) <span style="font-size: 10pt">and
469,654 over-allotment option </span>(<span style="font-size: 10pt">&#8220;Over-Allotment Option&#8221;</span>) <span style="font-size: 10pt">which
was partially exercised. See also Note 3 below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The ADSs and warrants
are traded on the Nasdaq under the symbols &#8220;SVRE&#8221; and &#8220;SVREW&#8221;, respectively. Upon satisfaction of customary closing
conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#8220;Closing Date&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">As of June 30, 2022,
management has determined that the balance of cash and cash equivalents are sufficient for the Company to continue its business plans
and operation at least for the 12-months period subsequent to the reporting period.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494375312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract', window );"><strong>Disclosure Of Significant Accounting Policies Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 2 - Significant accounting policies</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>A.</b></td><td style="text-align: justify"><b>Basis of presentation</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The accompanying unaudited condensed
financial statements and related notes should be read in conjunction with the Company&#8217;s financial statements and related notes included
elsewhere in the Company&#8217;s Registration Statement on Form F-1 for the fiscal year ended December 31, 2021, which was filed with
the Securities and Exchange Commission (&#8220;SEC&#8221;) and became effective on June 2, 2022. The unaudited condensed interim financial
statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. The interim
condensed financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial
statements for interim periods, as prescribed in IAS 34 &#8220;Interim Financial Reporting&#8221;. The financial information contained
herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results
of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring
nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The results for the six months ended
June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other interim
period or for any future period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The preparation of
financial statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment
and that affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>C.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>D.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Basic net loss per ordinary share is
computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of ordinary shares
outstanding during the period (including shares that were fully paid under the pre-funded amount). Diluted loss per share gives effect
to all potentially dilutive common shares outstanding during the period using the treasury stock method with respect to options and certain
warrants and using the if-converted method with respect to certain warrants accounted for as derivative financial liability. In computing
diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from
the exercise of options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">During the period of six months ended
June 30, 2022 and 2021, the total weighted average number of ordinary shares, par value NIS 0.01 per share, of the Company related to
outstanding options and warrants excluded from the calculation of the diluted loss per share was 4,352,144 and 1,098,938, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>E.</b></td><td style="text-align: justify"><b>Derivative Warrants Liability</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Certain warrants that were issued by
the Company to investors through an U.S. IPO transaction (see also Note 3) are exercisable into a number of ADS with a fixed exercise
price which is denominated in U.S. dollar currency which is different from the functional currency of the Company (New Israeli Shekels)
and are also might be exercisable to a variable number of shares due to the existence of cashless exercise mechanism under certain circumstances.
Accordingly, such warrants are considered as a current financial liability classified under &#8216;Fair value through profit or loss&#8217; category
(FVTPL). The fair value of the liability was determined at level 1 in the fair value hierarchy based on the quoted market price of the
warrants. Changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the financing
expenses, net line in the condensed Statement of Operations and Comprehensive Loss, until such warrants are exercised or expired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>F.</b></td><td style="text-align: justify"><b>Issuance of units comprised of warrants and ordinary shares</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">At the
closing date, the Company allocated total gross proceeds to the issuance components as follows: (i) as the warrants were determined to
be classified as a financial derivative liability, the Company has initially recognized them at fair value and based an average quoted
market price of four business days of these warrants, (ii) the amount allocated to the </span>ADS <span style="font-size: 10pt">issued
and ADS to be issued under the pre-funded amount was calculated as the difference between the total gross proceeds received and the fair
value of the warrants issued at the closing date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">Incremental
and direct issuance costs were allocated to the components based on the same proportion as the allocation of the gross proceeds. The portion
of issuance costs that was allocated to the warrants was recognized immediately as finance expenses in the condensed statement of comprehensive
loss and the portion of issuance costs related to the </span>ADS <span style="font-size: 10pt">and pre-funded warrants was deducted from
additional-paid in capital.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494375312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>U.S. Initial Public Offering on Nasdaq<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract', window );"><strong>U.S. Initial public offering on Nasdaq [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">U.S. Initial public offering on Nasdaq</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Note 3 - U.S. Initial public offering on Nasdaq
</b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">As
noted in Note 1B above, on June 6, 2022, the Company completed an underwritten U.S. IPO under which the Company received gross proceeds
of approximately $13 million (approximately NIS 43,441) for issuance of -</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><span style="font-weight: normal">A.</span></td><td style="text-align: justify"><span style="font-weight: normal">Number of 2,941,918 units at a price to the public of $4.13 per unit,
each consisting of (i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at
an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and</span></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><span style="font-weight: normal">B.</span></td><td style="text-align: justify"><span style="font-weight: normal">Number of 208,282&#160;pre-funded units at a price to the public of
$4.129 per pre-funded unit, each consisting of (i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise
price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant
exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject
to a cashless exercise mechanism upon under certain events). It is noted that all of the pre-funded warrants were fully paid at the Closing
Date, as defined below, however the related ADS were issued subsequent to the balance sheet. See also Note 7B. </span></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Each
ADS represents 5 ordinary shares of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">In
connection with the U.S. IPO, the Company engaged an U.S. underwriter which was granted as part of its compensation upon completion of
the U.S. IPO (i) a 45-day Over-Allotment Option to purchase up to an additional 469,654 ADS at an exercise price of $4.129 or pre-funded
warrants and/or 469,654 warrants exercisable for the same number of ADS at an exercise price of $0.001 (&#8220;Over-Allotment Option&#8221;)
and (ii) a Representative&#8217;s Warrant exercisable for 157,510 ADS at an exercise price of $5.16 per ADS over a limited period of 5-years
from the issuance date. In connection with the closing of the offering, in June 2022, the underwriter partially exercised its Over-Allotment
Option to purchase an additional 126,482 warrants exercisable for the same number of ADS for de minimis consideration. The remaining 343,172
Over-Allotment Option has been expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Upon
satisfaction of customary closing conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#8220;Closing Date&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">As
the exercise price of the Warrants is determined in foreign currency and as the Warrants might be exercisable to a variable number of
shares due to the cashless exercise mechanism, the Warrants were accounted for as a derivative financial liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Moreover,
the Company receives substantially all of the pre-funded warrant&#8217;s proceeds upfront (without any conditions) as part of the pre-funded
warrant&#8217;s purchase price and in return the Company is obligated to issue fixed number of ADS to the holders. Consequently, pre-funded
warrants were accounted and were classified as additional paid-in capital as part of the Company&#8217;s shareholders&#8217; equity. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">As
the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative&#8217;s
Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted
for under IFRS 2 &#8220;Share-based Payment&#8221; in total amount of NIS 5, NIS 588 and NIS 461, respectively. These expenses were estimated
at fair value by using Black-Scholes-Merton pricing model in which the assumptions that have been used are as follows: expected dividend
yield of 0%; risk-free interest rate of 2.16%-3.11%; expected volatility of 52.92%, exercise period and exercise price based upon the
stated terms, ADS price of $2.76 which represents the quoted market price of the average four business days following the Closing Date.
These expenses were included as part of the incremental and direct issuance costs incurred through the U.S. IPO. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">Pursuant
to the above, at the initial recognition date the gross proceeds received was allocated to identified components as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair<br/>
 value at<br/>
 Closing<br/>
 Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pre-funded warrant and ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39,494</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total gross consideration</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">43,441</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-weight: normal">(*)</span></td><td style="text-align: justify"><span style="font-weight: normal">The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.</span></td>
</tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
total incremental and direct issuance costs amounted to NIS 7,949 were allocated to the Warrants (NIS 723) and the ADS (including pre-funded
warrants) (NIS 7,226), based on the relative value of such identified instruments at the Closing Date. The portion of issuance costs that
was allocated to the Warrants was recognized immediately as finance expenses in the condensed statement of comprehensive loss and the
portion of issuance costs related to the ADS (including pre-funded warrant) was deducted from additional paid-in capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
following tabular presentation reflects the reconciliation of the fair value of derivative warrant liability during the period of six
months ended June 30, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Six months<br/>
 period&#160;ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30,</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 5.35pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of warranted issued at Effective Date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Warrants issued as result of partially exercised of over-allotment option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Revaluation of derivative warrant liability exercisable for ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(82</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,023</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 30<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399590857728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Reserves<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract', window );"><strong>Disclosure Of Share Capital Reserves And Other Equity Interest Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital and reserves</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 4 - Share
capital and reserves</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 18pt"><b>A.</b></td><td style="text-align: left"><b>Composition of share capital</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Ordinary shares, par value NIS 0.01 each</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">100,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">22,694,296</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">100,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">7,984,706</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 18pt"><b>B.</b></td><td style="text-align: left"><b>Rights attached to the ordinary shares</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
ordinary shares of the Company grant the holders thereof the right to participate and vote in shareholders meetings, the right to receive
a dividend, as declared, the right to participate in distributions of bonus shares and the right to participate in the distribution of
the assets of the Company upon liquidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 18pt"><b>C.</b></td><td style="text-align: left"><b>Changes in the issued and outstanding capital</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months<br/> period<br/>
 ended<br/> June 30,<br/> 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,984,706</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Allotment of ordinary shares through U.S IPO (see Note 3 above)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,709,590</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,694,296</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399501281696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfEarningsPerShareTextBlockAbstract', window );"><strong>Disclosure Of Earnings Per Share Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Loss per share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 5 - Loss
per share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
following table presents a summary of the loss and number of shares (including adjustments to such data) that were taken into consideration
for purposes of computing the loss per share (both basic and diluted).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six months period ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-65; -sec-ix-hidden: hidden-fact-64; -sec-ix-hidden: hidden-fact-63">Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share</div></td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(11,900</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(13,301</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(26,490</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares Six months period ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,178,955</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,935,366</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,960,239</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares to be issued upon full exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-70; -sec-ix-hidden: hidden-fact-69; -sec-ix-hidden: hidden-fact-68">Weighted number of shares used in computing basic and diluted loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,334,303</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,935,366</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,960,239</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A__IAS33_g70-73A_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfEarningsPerShareTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfEarningsPerShareTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399498754800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Factors<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfFinancialRiskManagementTextBlockAbstract', window );"><strong>Disclosure Of Financial Risk Management Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Financial risk factors</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6 - Financial risk factors</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company&#8217;s activities expose it to a variety of financial risks.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
condensed interim financial statements do not include all financial risk information and disclosures required in the annual financial
statements; they should be read in conjunction with the Company&#8217;s annual financial statements as of December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">There
have been no changes in the risk management policies since the year-end.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfFinancialRiskManagementTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfFinancialRiskManagementTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495916336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"><b>Note 7 - Subsequent
Events</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued (September 8, 2022). Based upon this review, the Company did not identify any other subsequent events that
would have required adjustment or disclosure in the financial statements, except as disclosed below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 18pt"><b>A.</b></td><td style="text-align: justify"><b>Options grant</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">On
July 7, 2022, the Company&#8217;s Board of Directors approved a grant of options to purchase an aggregate of 1,031,000 ordinary shares
of the Company, to employees and officers. The options are exercisable at NIS 1.639 per share and will be vest over a limited period of
4-years. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 18pt"><b>B.</b></td><td style="text-align: justify"><b>Issuance of ADS</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">In
August 2022, all of the pre-funded warrants were exercised into ADS. See also Note 3.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_IAS10_g17-22_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494873200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of presentation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>A.</b></td><td style="text-align: justify"><b>Basis of presentation</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The accompanying unaudited condensed
financial statements and related notes should be read in conjunction with the Company&#8217;s financial statements and related notes included
elsewhere in the Company&#8217;s Registration Statement on Form F-1 for the fiscal year ended December 31, 2021, which was filed with
the Securities and Exchange Commission (&#8220;SEC&#8221;) and became effective on June 2, 2022. The unaudited condensed interim financial
statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. The interim
condensed financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial
statements for interim periods, as prescribed in IAS 34 &#8220;Interim Financial Reporting&#8221;. The financial information contained
herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results
of the Company&#8217;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring
nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The results for the six months ended
June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other interim
period or for any future period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Use of estimates in the preparation of financial statements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">The preparation of
financial statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment
and that affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>C.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use that are readily convertible to cash with maturities of three months or less as of the date acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Basic and diluted net loss per ordinary share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>D.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share </b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Basic net loss per ordinary share is
computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of ordinary shares
outstanding during the period (including shares that were fully paid under the pre-funded amount). Diluted loss per share gives effect
to all potentially dilutive common shares outstanding during the period using the treasury stock method with respect to options and certain
warrants and using the if-converted method with respect to certain warrants accounted for as derivative financial liability. In computing
diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from
the exercise of options or warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">During the period of six months ended
June 30, 2022 and 2021, the total weighted average number of ordinary shares, par value NIS 0.01 per share, of the Company related to
outstanding options and warrants excluded from the calculation of the diluted loss per share was 4,352,144 and 1,098,938, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory', window );">Derivative Warrants Liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>E.</b></td><td style="text-align: justify"><b>Derivative Warrants Liability</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Certain warrants that were issued by
the Company to investors through an U.S. IPO transaction (see also Note 3) are exercisable into a number of ADS with a fixed exercise
price which is denominated in U.S. dollar currency which is different from the functional currency of the Company (New Israeli Shekels)
and are also might be exercisable to a variable number of shares due to the existence of cashless exercise mechanism under certain circumstances.
Accordingly, such warrants are considered as a current financial liability classified under &#8216;Fair value through profit or loss&#8217; category
(FVTPL). The fair value of the liability was determined at level 1 in the fair value hierarchy based on the quoted market price of the
warrants. Changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the financing
expenses, net line in the condensed Statement of Operations and Comprehensive Loss, until such warrants are exercised or expired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock', window );">Issuance of units comprised of warrants and ordinary shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 42.55pt"/><td style="width: 28.35pt"><b>F.</b></td><td style="text-align: justify"><b>Issuance of units comprised of warrants and ordinary shares</b></td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">At the
closing date, the Company allocated total gross proceeds to the issuance components as follows: (i) as the warrants were determined to
be classified as a financial derivative liability, the Company has initially recognized them at fair value and based an average quoted
market price of four business days of these warrants, (ii) the amount allocated to the </span>ADS <span style="font-size: 10pt">issued
and ADS to be issued under the pre-funded amount was calculated as the difference between the total gross proceeds received and the fair
value of the warrants issued at the closing date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"><span style="font-size: 10pt">Incremental
and direct issuance costs were allocated to the components based on the same proportion as the allocation of the gross proceeds. The portion
of issuance costs that was allocated to the warrants was recognized immediately as finance expenses in the condensed statement of comprehensive
loss and the portion of issuance costs related to the </span>ADS <span style="font-size: 10pt">and pre-funded warrants was deducted from
additional-paid in capital.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.
Effective 2023-01-01: The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.
Effective 2023-01-01: The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494912896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>U.S. Initial Public Offering on Nasdaq (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract', window );"><strong>U.S. Initial public offering on Nasdaq [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory', window );">Schedule of gross proceeds received</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair<br/>
 value at<br/>
 Closing<br/>
 Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Derivative warrant liability (*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pre-funded warrant and ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39,494</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total gross consideration</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">43,441</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-weight: normal">(*)</span></td><td style="text-align: justify"><span style="font-weight: normal">The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.</span></td>
</tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory', window );">Schedule of fair value of derivative warrant liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Six months<br/>
 period&#160;ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30,</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 5.35pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Recognition of fair value of warranted issued at Effective Date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt">Warrants issued as result of partially exercised of over-allotment option</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt">Revaluation of derivative warrant liability exercisable for ADS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(82</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt">Closing balance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,023</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDebtSecuritiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494301344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Reserves (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract', window );"><strong>Disclosure Of Share Capital Reserves And Other Equity Interest Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfCompositionOfShareCapitalTableTextBlock', window );">Schedule of composition of share capital</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Ordinary shares, par value NIS 0.01 each</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">100,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">22,694,296</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">100,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">7,984,706</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory', window );">Schedule of changes in the issued and outstanding capital</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months<br/> period<br/>
 ended<br/> June 30,<br/> 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,984,706</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Allotment of ordinary shares through U.S IPO (see Note 3 above)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,709,590</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">Balance as of June 30, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,694,296</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfCompositionOfShareCapitalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfCompositionOfShareCapitalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399590857728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfEarningsPerShareTextBlockAbstract', window );"><strong>Disclosure Of Earnings Per Share Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Schedule of loss and number of shares basic and diluted</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six months period ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-65; -sec-ix-hidden: hidden-fact-64; -sec-ix-hidden: hidden-fact-63">Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share</div></td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(11,900</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(13,301</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">(26,490</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares Six months period ended June&#160;30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Unaudited</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Audited</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,178,955</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,935,366</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,960,239</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Weighted number of shares to be issued upon full exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">155,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-70; -sec-ix-hidden: hidden-fact-69; -sec-ix-hidden: hidden-fact-68">Weighted number of shares used in computing basic and diluted loss per share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,334,303</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,935,366</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,960,239</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfEarningsPerShareTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfEarningsPerShareTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494983872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NumberOfOperatingSegment', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets', window );">Accumulated deficit | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 88,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccumulatedOtherComprehensiveIncome', window );">Comprehensive loss | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_StockExchangeConsiderationAmount', window );">Stock exchange consideration amount | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 23,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AdditionalNetAmount', window );">Addition net amount | &#8362;</a></td>
<td class="nump">&#8362; 20,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NumberOfUnit', window );">Number of units (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,941,918<span></span>
</td>
<td class="nump">2,941,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Offering price per shares (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NumberOfPreFundUnits', window );">Number of pre fund units (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,802<span></span>
</td>
<td class="nump">208,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends', window );">Offering price (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_GrossProceeds', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 43,441<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_IssuanceOfWarrants', window );">Issuance of warrants (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,510<span></span>
</td>
<td class="nump">157,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_OverAllomentOptionShares', window );">over-allotment option shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,654<span></span>
</td>
<td class="nump">469,654<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The accumulated increase (decrease) in the fair value of financial assets designated as measured at fair value through profit or loss that is attributable to changes in the credit risk of the assets determined either: (a) as the amount of change in their fair value that is not attributable to changes in market conditions that gave rise to market risk; or (b) using an alternative method that the entity believes more faithfully represents the amount of change in its fair value that is attributable to changes in the credit risk of the asset. [Refer: Credit risk [member]; Market risk [member]; Increase (decrease) in fair value of financial assets designated as measured at fair value through profit or loss, attributable to changes in credit risk of financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_9_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Section Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS33_ex12__IAS33_ex12_TI<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AdditionalNetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AdditionalNetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_GrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_GrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_IssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_IssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NumberOfOperatingSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NumberOfOperatingSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NumberOfPreFundUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NumberOfPreFundUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NumberOfUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NumberOfUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_OverAllomentOptionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_OverAllomentOptionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_StockExchangeConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_StockExchangeConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494908816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - &#8362; / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract', window );"><strong>Disclosure Of Significant Accounting Policies Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOrdinarySharesPerShare', window );">Ordinary share par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding', window );">Diluted loss per shares</a></td>
<td class="nump">4,352,144<span></span>
</td>
<td class="nump">1,098,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOrdinarySharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2022-03-24<br> -Paragraph 16A<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOrdinarySharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399492302224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>U.S. Initial Public Offering on Nasdaq (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 06, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems', window );"><strong>U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ReceivedGrossProceedsAmount', window );">Received gross proceeds amount</a></td>
<td class="nump">&#8362; 43,441,000<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NumberOfUnits', window );">Number of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,941,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Public of per unit (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantExercisableDescription', window );">Warrant exercisable description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at
an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_NumberOfPrefundedUnits', window );">Number of pre-funded units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PublicOfPerPrefundedUnit', window );">Public of per pre-funded unit (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PrefundedWarrantExercisableDescription', window );">Pre-funded warrant exercisable description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise
price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant
exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject
to a cashless exercise mechanism upon under certain events).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issue ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,694,296<span></span>
</td>
<td class="nump">7,984,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PurchaseToAdditionalShares', window );">Purchase to additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PublicPricePerShares', window );">Public price per shares (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantsExercisableShares', window );">Warrants exercisable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_OverALimitedPeriod', window );">Over a limited period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_OverAllotmentOptionHasBeenExpired', window );">Over-allotment option has been expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantDescription', window );">Warrants descriptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As
the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative&#8217;s
Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted
for under IFRS 2 &#8220;Share-based Payment&#8221; in total amount of NIS 5, NIS 588 and NIS 461, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ShareBasedPaymentWarrantAmount', window );">Share based pay (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExpectedDividendYieldRate', window );">Expected dividend yield rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExpectedVolatility', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantsPerShare', window );">Warrants per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_TotalIncrementalAndDirectIssuanceCostsAmounted', window );">Total incremental and direct issuance costs amounted (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 7,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AllocatedToWarrantsAmount', window );">Allocated to warrants amount (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PrefundedWarrantsAmount', window );">Pre-funded warrants amount (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 7,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=svre_OverAllotmentOptionsMember', window );">Over Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems', window );"><strong>U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PurchaseToAdditionalShares', window );">Purchase to additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantsExercisableShares', window );">Warrants exercisable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems', window );"><strong>U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_riskfreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems', window );"><strong>U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_riskfreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.11%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=svre_OrdinaryShareMember', window );">Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems', window );"><strong>U.S. Initial Public Offering on Nasdaq (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issue ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AllocatedToWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocated to Warrants amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AllocatedToWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ExpectedDividendYieldRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Expected dividend yield rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ExpectedDividendYieldRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ExpectedVolatility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected volatility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ExpectedVolatility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NumberOfPrefundedUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pre-funded units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NumberOfPrefundedUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_NumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_NumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_OverALimitedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over a limited period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_OverALimitedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_OverAllotmentOptionHasBeenExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over-allotment option has been expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_OverAllotmentOptionHasBeenExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PrefundedWarrantExercisableDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrant exercisable description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PrefundedWarrantExercisableDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PrefundedWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PrefundedWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PublicOfPerPrefundedUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public of per pre-funded unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PublicOfPerPrefundedUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PublicPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PublicPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PurchaseToAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of Purchase to additional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PurchaseToAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ReceivedGrossProceedsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Received gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ReceivedGrossProceedsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ShareBasedPaymentWarrantAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ShareBasedPaymentWarrantAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_TotalIncrementalAndDirectIssuanceCostsAmounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total incremental and direct issuance costs amounted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_TotalIncrementalAndDirectIssuanceCostsAmounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_USInitialPublicOfferingonNasdaqDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_USInitialPublicOfferingonNasdaqDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WarrantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WarrantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WarrantExercisableDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant exercisable description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WarrantExercisableDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WarrantsExercisableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WarrantsExercisableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WarrantsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WarrantsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_riskfreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_riskfreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=svre_OverAllotmentOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=svre_OverAllotmentOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=svre_OrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=svre_OrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495929808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2">
<div>Jun. 30, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfGrossProceedsReceivedAbstract', window );"><strong>Schedule Of Gross Proceeds Received Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Derivative warrant liability</a></td>
<td class="nump">&#8362; 3,947<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_PrefundedWarrants', window );">Pre-funded warrant and ADS</a></td>
<td class="nump">39,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">Total gross consideration</a></td>
<td class="nump">&#8362; 43,441<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-weight: normal">The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_PrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_PrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfGrossProceedsReceivedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfGrossProceedsReceivedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494275040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>ILS (&#8362;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract', window );"><strong>Schedule Of Fair Value Of Derivative Warrant Liability Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Opening balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuesFairValueMeasurementLiabilities', window );">Recognition of fair value of warranted issued at Effective Date</a></td>
<td class="nump">3,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption', window );">Warrants issued as result of partially exercised of over-allotment option</a></td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS', window );">Revaluation of derivative warrant liability exercisable for ADS</a></td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDerivativeFinancialLiabilities', window );">Closing balance</a></td>
<td class="nump">&#8362; 4,023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuesFairValueMeasurementLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in fair value measurement of liabilities resulting from issues of those liabilities. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuesFairValueMeasurementLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revaluation of derivative warrant liability exercisable for ADS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of warrants issued as result of partially exercised of over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494916976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Capital and Reserves (Details) - Schedule of composition of share capital - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfCompositionOfShareCapitalAbstract', window );"><strong>Schedule Of Composition Of Share Capital Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Authorized, Ordinary shares, par value NIS 0.01 each</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issued and outstanding, Ordinary shares, par value NIS 0.01 each</a></td>
<td class="nump">22,694,296<span></span>
</td>
<td class="nump">7,984,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfCompositionOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfCompositionOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495565776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfCompositionOfShareCapitalAbstract', window );"><strong>Schedule Of Composition Of Share Capital Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AuthorizedOrdinarySharesParValue', window );">Authorized, Ordinary shares, par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_IssuedAndOutstandingOrdinarySharesParShare', window );">Issued and outstanding, Ordinary shares, par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AuthorizedOrdinarySharesParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AuthorizedOrdinarySharesParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_IssuedAndOutstandingOrdinarySharesParShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued and outstanding, Ordinary shares, par value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_IssuedAndOutstandingOrdinarySharesParShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfCompositionOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfCompositionOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495720368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract', window );"><strong>Schedule Of Changes In The Issued And Outstanding Capital Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning balance</a></td>
<td class="nump">7,984,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AllotmentOfOrdinaryShares', window );">Allotment of ordinary shares through U.S IPO (see Note 3 above)</a></td>
<td class="nump">14,709,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending balance</a></td>
<td class="nump">22,694,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AllotmentOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allotment of ordinary shares through U.S IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AllotmentOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495207568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract', window );"><strong>Schedule Of Loss And Number Of Shares Basic And Diluted Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share (in New Shekels)</a></td>
<td class="num">&#8362; (11,900)<span></span>
</td>
<td class="num">&#8362; (13,301)<span></span>
</td>
<td class="num">&#8362; (26,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Weighted number of shares</a></td>
<td class="nump">10,178,955<span></span>
</td>
<td class="nump">7,935,366<span></span>
</td>
<td class="nump">7,960,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants', window );">Weighted number of shares to be issued upon full exercise of pre-funded warrants</a></td>
<td class="nump">155,348<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted number of shares used in computing basic and diluted loss per share</a></td>
<td class="nump">10,334,303<span></span>
</td>
<td class="nump">7,935,366<span></span>
</td>
<td class="nump">7,960,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares to be issued upon full exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399494908560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals) - ILS (&#8362;)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract', window );"><strong>Schedule Of Loss And Number Of Shares Basic And Diluted Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Loss attributed to the shareholders of the Company for purposes of computing the diluted loss per share</a></td>
<td class="num">&#8362; (11,900)<span></span>
</td>
<td class="num">&#8362; (13,301)<span></span>
</td>
<td class="num">&#8362; (26,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted number of shares used in computing diluted loss per share</a></td>
<td class="nump">10,334,303<span></span>
</td>
<td class="nump">7,935,366<span></span>
</td>
<td class="nump">7,960,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140399495531680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Events [Member]<br></strong></div></th>
<th class="th">
<div>Jul. 07, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_AggregateShares', window );">Aggregate purchase shares | shares</a></td>
<td class="nump">1,031,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares', window );">Exercisable price | &#8362; / shares</a></td>
<td class="nump">&#8362; 1.639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_svre_OverLimitedPeriod', window );">Over limited period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per instrument from discontinued operations for an equity instrument that participates in profit with ordinary shares according to a predetermined formula. [Refer: Diluted earnings (loss) per instrument, participating equity instruments other than ordinary shares; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph A14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_A14&amp;doctype=Appendix&amp;subtype=A<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_AggregateShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_AggregateShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_OverLimitedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_OverLimitedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_svre_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">svre_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>svre_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=svre_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=svre_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>ea165490-6k_saverone_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:svre="http://www.saver.com/20220630"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="svre-20220630.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="svre:SaleOfStockAxis">svre:AppendixAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">svre:OrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">svre:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">svre:OverAllotmentOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">svre:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-07</endDate>
        </period>
    </context>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="c0">6-K</dei:DocumentType>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber contextRef="c0">001-41334</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">SaverOne 2014 Ltd.</dei:EntityRegistrantName>
    <dei:DocumentPeriodEndDate contextRef="c0" id="hidden-fact-0">2022-06-30</dei:DocumentPeriodEndDate>
    <ifrs-full:CashAndCashEquivalents contextRef="c1" decimals="-3" unitRef="ils">41075000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c2" decimals="-3" unitRef="ils">14855000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="-3" unitRef="ils">8683000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentInvestments contextRef="c2" decimals="-3" unitRef="ils">12006000</ifrs-full:CurrentInvestments>
    <ifrs-full:CurrentInvestments contextRef="c3" decimals="-3" unitRef="ils">5012000</ifrs-full:CurrentInvestments>
    <ifrs-full:CurrentRestrictedCashAndCashEquivalents contextRef="c2" decimals="-3" unitRef="ils">40000</ifrs-full:CurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c1" decimals="-3" unitRef="ils">374000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c2" decimals="-3" unitRef="ils">347000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c3" decimals="-3" unitRef="ils">501000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c1" decimals="-3" unitRef="ils">958000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c2" decimals="-3" unitRef="ils">888000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c3" decimals="-3" unitRef="ils">1159000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:Inventories contextRef="c1" decimals="-3" unitRef="ils">855000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c2" decimals="-3" unitRef="ils">372000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c3" decimals="-3" unitRef="ils">825000</ifrs-full:Inventories>
    <ifrs-full:CurrentAssets contextRef="c1" decimals="-3" unitRef="ils">43262000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c2" decimals="-3" unitRef="ils">28508000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c3" decimals="-3" unitRef="ils">16180000</ifrs-full:CurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c1" decimals="-3" unitRef="ils">211000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c2" decimals="-3" unitRef="ils">199000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c3" decimals="-3" unitRef="ils">238000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DeferredTaxAssets contextRef="c3" decimals="-3" unitRef="ils">1155000</ifrs-full:DeferredTaxAssets>
    <svre:RestrictedDeposits contextRef="c1" decimals="-3" unitRef="ils">197000</svre:RestrictedDeposits>
    <svre:RestrictedDeposits contextRef="c2" decimals="-3" unitRef="ils">187000</svre:RestrictedDeposits>
    <svre:RestrictedDeposits contextRef="c3" decimals="-3" unitRef="ils">191000</svre:RestrictedDeposits>
    <ifrs-full:RightofuseAssets contextRef="c1" decimals="-3" unitRef="ils">780000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c2" decimals="-3" unitRef="ils">1205000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c3" decimals="-3" unitRef="ils">992000</ifrs-full:RightofuseAssets>
    <ifrs-full:NoncurrentAssets contextRef="c1" decimals="-3" unitRef="ils">1188000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c2" decimals="-3" unitRef="ils">1591000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c3" decimals="-3" unitRef="ils">2576000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="c1" decimals="-3" unitRef="ils">44450000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c2" decimals="-3" unitRef="ils">30099000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c3" decimals="-3" unitRef="ils">18756000</ifrs-full:Assets>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c1" decimals="-3" unitRef="ils">467000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c2" decimals="-3" unitRef="ils">467000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c3" decimals="-3" unitRef="ils">467000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c1" decimals="-3" unitRef="ils">778000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c2" decimals="-3" unitRef="ils">825000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c3" decimals="-3" unitRef="ils">942000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="c1" decimals="-3" unitRef="ils">3642000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="c2" decimals="-3" unitRef="ils">2481000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="c3" decimals="-3" unitRef="ils">3522000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="c1" decimals="-3" unitRef="ils">4023000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="c1" decimals="-3" unitRef="ils">109000</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="c2" decimals="-3" unitRef="ils">205000</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="c3" decimals="-3" unitRef="ils">109000</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c1" decimals="-3" unitRef="ils">9019000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c2" decimals="-3" unitRef="ils">3978000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c3" decimals="-3" unitRef="ils">5040000</ifrs-full:CurrentLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="c1" decimals="-3" unitRef="ils">1173000</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="c2" decimals="-3" unitRef="ils">848000</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="c3" decimals="-3" unitRef="ils">1059000</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c1" decimals="-3" unitRef="ils">395000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c2" decimals="-3" unitRef="ils">808000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c3" decimals="-3" unitRef="ils">605000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c1" decimals="-3" unitRef="ils">1568000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c2" decimals="-3" unitRef="ils">1656000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c3" decimals="-3" unitRef="ils">1664000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:SharePremium contextRef="c1" decimals="-3" unitRef="ils">112708000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c2" decimals="-3" unitRef="ils">80440000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c3" decimals="-3" unitRef="ils">80440000</ifrs-full:SharePremium>
    <ifrs-full:CapitalReserve contextRef="c1" decimals="-3" unitRef="ils">9868000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve contextRef="c2" decimals="-3" unitRef="ils">7649000</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve contextRef="c3" decimals="-3" unitRef="ils">8425000</ifrs-full:CapitalReserve>
    <ifrs-full:RetainedEarnings contextRef="c1" decimals="-3" unitRef="ils">-88713000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c2" decimals="-3" unitRef="ils">-63624000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c3" decimals="-3" unitRef="ils">-76813000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity contextRef="c1" decimals="-3" unitRef="ils">33863000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c2" decimals="-3" unitRef="ils">24465000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="-3" unitRef="ils">12052000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="c1" decimals="-3" unitRef="ils">44450000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c2" decimals="-3" unitRef="ils">30099000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c3" decimals="-3" unitRef="ils">18756000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue contextRef="c0" decimals="-3" unitRef="ils">382000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c4" decimals="-3" unitRef="ils">201000</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c5" decimals="-3" unitRef="ils">450000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c0" decimals="-3" unitRef="ils">267000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c4" decimals="-3" unitRef="ils">165000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c5" decimals="-3" unitRef="ils">288000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c0" decimals="-3" unitRef="ils">115000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c4" decimals="-3" unitRef="ils">36000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c5" decimals="-3" unitRef="ils">162000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" unitRef="ils">10184000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c4" decimals="-3" unitRef="ils">8854000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="-3" unitRef="ils">18847000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c0" decimals="-3" unitRef="ils">481000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c4" decimals="-3" unitRef="ils">1677000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c5" decimals="-3" unitRef="ils">2431000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="ils">2511000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c4" decimals="-3" unitRef="ils">2690000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c5" decimals="-3" unitRef="ils">5149000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c0" decimals="-3" unitRef="ils">-13061000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c4" decimals="-3" unitRef="ils">-13185000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c5" decimals="-3" unitRef="ils">-26265000</ifrs-full:ProfitLossFromOperatingActivities>
    <svre:FinancingExpense contextRef="c0" decimals="-3" unitRef="ils">869000</svre:FinancingExpense>
    <svre:FinancingExpense contextRef="c4" decimals="-3" unitRef="ils">117000</svre:FinancingExpense>
    <svre:FinancingExpense contextRef="c5" decimals="-3" unitRef="ils">228000</svre:FinancingExpense>
    <ifrs-full:FinanceIncome contextRef="c0" decimals="-3" unitRef="ils">2030000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c4" decimals="-3" unitRef="ils">1000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome contextRef="c5" decimals="-3" unitRef="ils">3000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss contextRef="c0" decimals="-3" unitRef="ils">1161000</ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss contextRef="c4" decimals="-3" unitRef="ils">-116000</ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss contextRef="c5" decimals="-3" unitRef="ils">-225000</ifrs-full:FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" unitRef="ils">-11900000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c4" decimals="-3" unitRef="ils">-13301000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="-3" unitRef="ils">-26490000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" unitRef="ils">-11900000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c4" decimals="-3" unitRef="ils">-13301000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="-3" unitRef="ils">-26490000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c0" decimals="2" unitRef="ilsPershares">-1.15</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c4" decimals="2" unitRef="ilsPershares">-1.68</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c5" decimals="2" unitRef="ilsPershares">-3.33</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:WeightedAverageShares contextRef="c0" decimals="INF" unitRef="shares">10334303</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c4" decimals="INF" unitRef="shares">7935366</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c5" decimals="INF" unitRef="shares">7960239</ifrs-full:WeightedAverageShares>
    <ifrs-full:Equity contextRef="c6" decimals="-3" unitRef="ils">80440000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c7" decimals="-3" unitRef="ils">8425000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c8" decimals="-3" unitRef="ils">-76813000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="-3" unitRef="ils">12052000</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c10" decimals="-3" unitRef="ils">545000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c0" decimals="-3" unitRef="ils">545000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <svre:SharebasedPaymentToServiceProvider contextRef="c10" decimals="-3" unitRef="ils">1056000</svre:SharebasedPaymentToServiceProvider>
    <svre:SharebasedPaymentToServiceProvider contextRef="c0" decimals="-3" unitRef="ils">1056000</svre:SharebasedPaymentToServiceProvider>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c10" decimals="-3" unitRef="ils">158000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c0" decimals="-3" unitRef="ils">158000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IssueOfEquity contextRef="c9" decimals="-3" unitRef="ils">32268000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c0" decimals="-3" unitRef="ils">32268000</ifrs-full:IssueOfEquity>
    <ifrs-full:ComprehensiveIncome contextRef="c11" decimals="-3" unitRef="ils">-11900000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="-3" unitRef="ils">-11900000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:Equity contextRef="c12" decimals="-3" unitRef="ils">112708000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c13" decimals="-3" unitRef="ils">9868000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c14" decimals="-3" unitRef="ils">-88713000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c1" decimals="-3" unitRef="ils">33863000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" unitRef="ils">80440000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c16" decimals="-3" unitRef="ils">5077000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c17" decimals="-3" unitRef="ils">-50323000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c18" decimals="-3" unitRef="ils">35194000</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c20" decimals="-3" unitRef="ils">1116000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c4" decimals="-3" unitRef="ils">1116000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <svre:SharebasedPaymentToServiceProvider contextRef="c20" decimals="-3" unitRef="ils">1456000</svre:SharebasedPaymentToServiceProvider>
    <svre:SharebasedPaymentToServiceProvider contextRef="c4" decimals="-3" unitRef="ils">1456000</svre:SharebasedPaymentToServiceProvider>
    <ifrs-full:ComprehensiveIncome contextRef="c21" decimals="-3" unitRef="ils">-13301000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c4" decimals="-3" unitRef="ils">-13301000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:Equity contextRef="c22" decimals="-3" unitRef="ils">80440000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c23" decimals="-3" unitRef="ils">7649000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c24" decimals="-3" unitRef="ils">-63624000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c2" decimals="-3" unitRef="ils">24465000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="-3" unitRef="ils">80440000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c16" decimals="-3" unitRef="ils">5077000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c17" decimals="-3" unitRef="ils">-50323000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c18" decimals="-3" unitRef="ils">35194000</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c26" decimals="-3" unitRef="ils">1892000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c5" decimals="-3" unitRef="ils">1892000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <svre:SharebasedPaymentToServiceProvider contextRef="c26" decimals="-3" unitRef="ils">1456000</svre:SharebasedPaymentToServiceProvider>
    <svre:SharebasedPaymentToServiceProvider contextRef="c5" decimals="-3" unitRef="ils">1456000</svre:SharebasedPaymentToServiceProvider>
    <ifrs-full:ComprehensiveIncome contextRef="c27" decimals="-3" unitRef="ils">-26490000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="-3" unitRef="ils">-26490000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:Equity contextRef="c6" decimals="-3" unitRef="ils">80440000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c7" decimals="-3" unitRef="ils">8425000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c8" decimals="-3" unitRef="ils">-76813000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="-3" unitRef="ils">12052000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="-3" unitRef="ils">-11900000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c4" decimals="-3" unitRef="ils">-13301000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="-3" unitRef="ils">-26490000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables contextRef="c0" decimals="-3" unitRef="ils">-12000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables contextRef="c4" decimals="-3" unitRef="ils">2642000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables contextRef="c5" decimals="-3" unitRef="ils">3357000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="ils">-11912000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c4" decimals="-3" unitRef="ils">-10659000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c5" decimals="-3" unitRef="ils">-23133000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <svre:ChangeInRestrictedDeposits contextRef="c0" decimals="-3" unitRef="ils">6000</svre:ChangeInRestrictedDeposits>
    <svre:ChangeInRestrictedDeposits contextRef="c4" decimals="-3" unitRef="ils">77000</svre:ChangeInRestrictedDeposits>
    <svre:ChangeInRestrictedDeposits contextRef="c5" decimals="-3" unitRef="ils">41000</svre:ChangeInRestrictedDeposits>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c0" decimals="-3" unitRef="ils">5012000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c4" decimals="-3" unitRef="ils">-12006000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c5" decimals="-3" unitRef="ils">-5012000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="-3" unitRef="ils">4000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c4" decimals="-3" unitRef="ils">72000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c5" decimals="-3" unitRef="ils">144000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="-3" unitRef="ils">5002000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c4" decimals="-3" unitRef="ils">-12155000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c5" decimals="-3" unitRef="ils">-5197000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:PaymentsOfOtherEquityInstruments contextRef="c5" decimals="-3" unitRef="ils">750000</ifrs-full:PaymentsOfOtherEquityInstruments>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities contextRef="c4" decimals="-3" unitRef="ils">251000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities contextRef="c5" decimals="-3" unitRef="ils">579000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromExerciseOfWarrants contextRef="c0" decimals="-3" unitRef="ils">37578000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c0" decimals="-3" unitRef="ils">234000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c4" decimals="-3" unitRef="ils">206000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c5" decimals="-3" unitRef="ils">440000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="-3" unitRef="ils">37344000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c4" decimals="-3" unitRef="ils">45000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c5" decimals="-3" unitRef="ils">-611000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c0" decimals="-3" unitRef="ils">30434000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c4" decimals="-3" unitRef="ils">-22769000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c5" decimals="-3" unitRef="ils">-28941000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="-3" unitRef="ils">1958000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="-3" unitRef="ils">8683000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c18" decimals="-3" unitRef="ils">37624000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c18" decimals="-3" unitRef="ils">37624000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c1" decimals="-3" unitRef="ils">41075000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c2" decimals="-3" unitRef="ils">14855000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="-3" unitRef="ils">8683000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c28" decimals="-3" unitRef="ils">31000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c29" decimals="-3" unitRef="ils">28000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c30" decimals="-3" unitRef="ils">61000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c28" decimals="-3" unitRef="ils">212000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c29" decimals="-3" unitRef="ils">185000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c30" decimals="-3" unitRef="ils">398000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:ProceedsFromSalesOfInterestsInAssociates contextRef="c28" decimals="-3" unitRef="ils">24000</ifrs-full:ProceedsFromSalesOfInterestsInAssociates>
    <ifrs-full:ProceedsFromSalesOfInterestsInAssociates contextRef="c29" decimals="-3" unitRef="ils">30000</ifrs-full:ProceedsFromSalesOfInterestsInAssociates>
    <ifrs-full:ProceedsFromSalesOfInterestsInAssociates contextRef="c30" decimals="-3" unitRef="ils">61000</ifrs-full:ProceedsFromSalesOfInterestsInAssociates>
    <ifrs-full:PaymentsToAndOnBehalfOfEmployees contextRef="c28" decimals="-3" unitRef="ils">545000</ifrs-full:PaymentsToAndOnBehalfOfEmployees>
    <ifrs-full:PaymentsToAndOnBehalfOfEmployees contextRef="c29" decimals="-3" unitRef="ils">2572000</ifrs-full:PaymentsToAndOnBehalfOfEmployees>
    <ifrs-full:PaymentsToAndOnBehalfOfEmployees contextRef="c30" decimals="-3" unitRef="ils">3348000</ifrs-full:PaymentsToAndOnBehalfOfEmployees>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c28" decimals="-3" unitRef="ils">723000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities contextRef="c28" decimals="-3" unitRef="ils">82000</ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities>
    <svre:ExchangeDifferencesOnCashAndCashEquivalent contextRef="c28" decimals="-3" unitRef="ils">1958000</svre:ExchangeDifferencesOnCashAndCashEquivalent>
    <svre:ChangesInLiabilityInRespectOfGovernmentGrants contextRef="c28" decimals="-3" unitRef="ils">114000</svre:ChangesInLiabilityInRespectOfGovernmentGrants>
    <svre:ChangesInLiabilityInRespectOfGovernmentGrants contextRef="c30" decimals="-3" unitRef="ils">-213000</svre:ChangesInLiabilityInRespectOfGovernmentGrants>
    <svre:IncomeAndExpensesNotInvolvingCashFlows contextRef="c28" decimals="-3" unitRef="ils">-391000</svre:IncomeAndExpensesNotInvolvingCashFlows>
    <svre:IncomeAndExpensesNotInvolvingCashFlows contextRef="c29" decimals="-3" unitRef="ils">2815000</svre:IncomeAndExpensesNotInvolvingCashFlows>
    <svre:IncomeAndExpensesNotInvolvingCashFlows contextRef="c30" decimals="-3" unitRef="ils">3655000</svre:IncomeAndExpensesNotInvolvingCashFlows>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c28" decimals="-3" unitRef="ils">201000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c29" decimals="-3" unitRef="ils">-376000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c30" decimals="-3" unitRef="ils">-647000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c28" decimals="-3" unitRef="ils">127000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c29" decimals="-3" unitRef="ils">12000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c30" decimals="-3" unitRef="ils">-142000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c28" decimals="-3" unitRef="ils">30000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c29" decimals="-3" unitRef="ils">262000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c30" decimals="-3" unitRef="ils">715000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c28" decimals="-3" unitRef="ils">164000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c29" decimals="-3" unitRef="ils">63000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c30" decimals="-3" unitRef="ils">-54000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="c28" decimals="-3" unitRef="ils">245000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="c29" decimals="-3" unitRef="ils">516000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="c30" decimals="-3" unitRef="ils">1152000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
    <svre:ChangesinAssetAndLiability contextRef="c28" decimals="-3" unitRef="ils">379000</svre:ChangesinAssetAndLiability>
    <svre:ChangesinAssetAndLiability contextRef="c29" decimals="-3" unitRef="ils">-173000</svre:ChangesinAssetAndLiability>
    <svre:ChangesinAssetAndLiability contextRef="c30" decimals="-3" unitRef="ils">-298000</svre:ChangesinAssetAndLiability>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c28" decimals="-3" unitRef="ils">-12000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c29" decimals="-3" unitRef="ils">2642000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c30" decimals="-3" unitRef="ils">3357000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <svre:RecognitionOfRightForUseAssetAgainstALeasingLiability contextRef="c29" decimals="-3" unitRef="ils">532000</svre:RecognitionOfRightForUseAssetAgainstALeasingLiability>
    <svre:RecognitionOfRightForUseAssetAgainstALeasingLiability contextRef="c30" decimals="-3" unitRef="ils">532000</svre:RecognitionOfRightForUseAssetAgainstALeasingLiability>
    <svre:DeferredOfferingExpensesNotYetPaid contextRef="c30" decimals="-3" unitRef="ils">405000</svre:DeferredOfferingExpensesNotYetPaid>
    <svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh contextRef="c28" decimals="-3" unitRef="ils">960000</svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh>
    <svre:OfferingCostsNotYetPaid contextRef="c28" decimals="-3" unitRef="ils">280000</svre:OfferingCostsNotYetPaid>
    <svre:PartialExerciseOfOverallotmentOptionIntoWarrants contextRef="c28" decimals="-3" unitRef="ils">158000</svre:PartialExerciseOfOverallotmentOptionIntoWarrants>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"&gt;&lt;b&gt;Note 1 - General&lt;/b&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.6pt"/&gt;&lt;td style="width: 28.3pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Incorporation and operations&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 82.15pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;Saverone 2014 Ltd.
(the &#x201c;Company&#x201d;) was founded in Israel on November 16, 2014 and commenced its business activity on that date (the &#x201c;Inception
Date&#x201d;). From the Inception Date, the Company has been active in one operating segment, i.e., development of the technology necessary
to create a life-saving system that prevents certain uses of cell phones while driving (the &#x201c;Saverone System&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.6pt"/&gt;&lt;td style="width: 28.3pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;The Company&#x2019;s business position&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&lt;br/&gt;
The Company&#x2019;s main activity is research and development and it has not yet shown any operating profits. From the Inception Date and through
June 30, 2022, the Company reported losses and a negative cash flow from current operating activity. As of June 30, 2022, the Company
has an accumulated deficit of NIS 88,713 and it had a comprehensive loss of NIS 11,900 for the period of six months ended June 30, 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;The Company&#x2019;s management
has been maintaining forecasts, monitoring its cash flows and has been actively involved in obtaining the financing it needs to continue
its operations and to realize its plans which include the implementation of a business plan formulated by the Company&#x2019;s management to
complete the development and sale of products based on technologies that are still in their development stage. The ability of the Company
to meet its development targets and to realize its business plans, as above, are contingent upon the recruitment of sources of finance
which are not guaranteed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;	In June 2020,
the Company completed an initial public offering (&#x201c;IPO&#x201d;) on the Tel Aviv Stock Exchange, with a net consideration of NIS&#160;23,720.	In
addition, as part of the preparations of the Company for the above issuance, the entire balance of the bridging investments used to finance
Company activity were converted into shares by the date of the aforementioned issuance. Also, in November 2020, the Company completed
financing through a shelf offering, as part of which it raised an addition net amount of NIS 20,887.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -17.1pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;In
June 2022, the Company completed an &lt;/span&gt;underwritten &lt;span style="font-size: 10pt"&gt;U.S. IPO (&#x201c;U.S. IPO&#x201d;) on the Nasdaq
under which the Company issued and sold&#160;(i) number of 2,941,918 units, each unit consisting of one American Depositary Share (&#x201c;ADS&#x201d;)
and one warrant to purchase one ADS (&#x201c;Warrant&#x201d;) at an offering price of $4.13&#160;per unit and (ii) number of 208,802 pre-funded
units, each unit consisting of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS at an offering price of
$4.129 per pre-funded unit. The Company received gross proceeds of approximately $13 million (approximately NIS 43,441)&#160;before direct
and incremental costs incurred. In addition, the Company allotted to the underwriter as share-based payment by issuance of 157,510 warrants
&lt;/span&gt;(&lt;span style="font-size: 10pt"&gt;&#x201c;&lt;/span&gt;Representative&#x2019;s Warrant&lt;span style="font-size: 10pt"&gt;&#x201d;&lt;/span&gt;) &lt;span style="font-size: 10pt"&gt;and
469,654 over-allotment option &lt;/span&gt;(&lt;span style="font-size: 10pt"&gt;&#x201c;Over-Allotment Option&#x201d;&lt;/span&gt;) &lt;span style="font-size: 10pt"&gt;which
was partially exercised. See also Note 3 below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;The ADSs and warrants
are traded on the Nasdaq under the symbols &#x201c;SVRE&#x201d; and &#x201c;SVREW&#x201d;, respectively. Upon satisfaction of customary closing
conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#x201c;Closing Date&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;As of June 30, 2022,
management has determined that the balance of cash and cash equivalents are sufficient for the Company to continue its business plans
and operation at least for the 12-months period subsequent to the reporting period.&lt;/p&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <svre:NumberOfOperatingSegment contextRef="c0" decimals="0" unitRef="pure">1</svre:NumberOfOperatingSegment>
    <ifrs-full:AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets contextRef="c1" decimals="0" unitRef="ils">88713</ifrs-full:AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c1" decimals="0" unitRef="ils">11900</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <svre:StockExchangeConsiderationAmount contextRef="c31" decimals="0" unitRef="ils">23720</svre:StockExchangeConsiderationAmount>
    <svre:AdditionalNetAmount contextRef="c32" decimals="0" unitRef="ils">20887</svre:AdditionalNetAmount>
    <svre:NumberOfUnit contextRef="c0" decimals="0" unitRef="shares">2941918</svre:NumberOfUnit>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="c0" decimals="2" unitRef="usdPershares">4.13</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <svre:NumberOfPreFundUnits contextRef="c0" decimals="0" unitRef="shares">208802</svre:NumberOfPreFundUnits>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends contextRef="c0" decimals="3" unitRef="usd">4.129</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <svre:GrossProceeds contextRef="c0" decimals="-6" unitRef="usd">13000000</svre:GrossProceeds>
    <svre:GrossProceeds contextRef="c0" decimals="0" unitRef="ils">43441</svre:GrossProceeds>
    <svre:IssuanceOfWarrants contextRef="c0" decimals="0" unitRef="shares">157510</svre:IssuanceOfWarrants>
    <svre:OverAllomentOptionShares contextRef="c0" decimals="0" unitRef="shares">469654</svre:OverAllomentOptionShares>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;Note 2 - Significant accounting policies&lt;/b&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of presentation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;The accompanying unaudited condensed
financial statements and related notes should be read in conjunction with the Company&#x2019;s financial statements and related notes included
elsewhere in the Company&#x2019;s Registration Statement on Form F-1 for the fiscal year ended December 31, 2021, which was filed with
the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and became effective on June 2, 2022. The unaudited condensed interim financial
statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. The interim
condensed financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial
statements for interim periods, as prescribed in IAS 34 &#x201c;Interim Financial Reporting&#x201d;. The financial information contained
herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results
of the Company&#x2019;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring
nature.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;The results for the six months ended
June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other interim
period or for any future period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;The preparation of
financial statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment
and that affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per ordinary share &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Basic net loss per ordinary share is
computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of ordinary shares
outstanding during the period (including shares that were fully paid under the pre-funded amount). Diluted loss per share gives effect
to all potentially dilutive common shares outstanding during the period using the treasury stock method with respect to options and certain
warrants and using the if-converted method with respect to certain warrants accounted for as derivative financial liability. In computing
diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from
the exercise of options or warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;During the period of six months ended
June 30, 2022 and 2021, the total weighted average number of ordinary shares, par value NIS 0.01 per share, of the Company related to
outstanding options and warrants excluded from the calculation of the diluted loss per share was 4,352,144 and 1,098,938, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Derivative Warrants Liability&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Certain warrants that were issued by
the Company to investors through an U.S. IPO transaction (see also Note 3) are exercisable into a number of ADS with a fixed exercise
price which is denominated in U.S. dollar currency which is different from the functional currency of the Company (New Israeli Shekels)
and are also might be exercisable to a variable number of shares due to the existence of cashless exercise mechanism under certain circumstances.
Accordingly, such warrants are considered as a current financial liability classified under &#x2018;Fair value through profit or loss&#x2019; category
(FVTPL). The fair value of the liability was determined at level 1 in the fair value hierarchy based on the quoted market price of the
warrants. Changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the financing
expenses, net line in the condensed Statement of Operations and Comprehensive Loss, until such warrants are exercised or expired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Issuance of units comprised of warrants and ordinary shares&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;At the
closing date, the Company allocated total gross proceeds to the issuance components as follows: (i) as the warrants were determined to
be classified as a financial derivative liability, the Company has initially recognized them at fair value and based an average quoted
market price of four business days of these warrants, (ii) the amount allocated to the &lt;/span&gt;ADS &lt;span style="font-size: 10pt"&gt;issued
and ADS to be issued under the pre-funded amount was calculated as the difference between the total gross proceeds received and the fair
value of the warrants issued at the closing date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Incremental
and direct issuance costs were allocated to the components based on the same proportion as the allocation of the gross proceeds. The portion
of issuance costs that was allocated to the warrants was recognized immediately as finance expenses in the condensed statement of comprehensive
loss and the portion of issuance costs related to the &lt;/span&gt;ADS &lt;span style="font-size: 10pt"&gt;and pre-funded warrants was deducted from
additional-paid in capital.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of presentation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;The accompanying unaudited condensed
financial statements and related notes should be read in conjunction with the Company&#x2019;s financial statements and related notes included
elsewhere in the Company&#x2019;s Registration Statement on Form F-1 for the fiscal year ended December 31, 2021, which was filed with
the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and became effective on June 2, 2022. The unaudited condensed interim financial
statements have been prepared in accordance with the rules and regulations of the SEC related to interim financial statements. The interim
condensed financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial
statements for interim periods, as prescribed in IAS 34 &#x201c;Interim Financial Reporting&#x201d;. The financial information contained
herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results
of the Company&#x2019;s financial position and operating results for the interim periods. All such adjustments are of a normal recurring
nature.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;The results for the six months ended
June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other interim
period or for any future period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;The preparation of
financial statements in conformity with IFRS requires management to make accounting estimates and assessments that involve use of judgment
and that affect the amounts of assets and liabilities presented in the financial statements, the disclosure of contingent assets and liabilities
at the dates of the financial statements, the amounts of revenues and expenses during the reporting periods and the accounting policies
adopted by the Company. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals
or use that are readily convertible to cash with maturities of three months or less as of the date acquired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per ordinary share &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Basic net loss per ordinary share is
computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of ordinary shares
outstanding during the period (including shares that were fully paid under the pre-funded amount). Diluted loss per share gives effect
to all potentially dilutive common shares outstanding during the period using the treasury stock method with respect to options and certain
warrants and using the if-converted method with respect to certain warrants accounted for as derivative financial liability. In computing
diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from
the exercise of options or warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;During the period of six months ended
June 30, 2022 and 2021, the total weighted average number of ordinary shares, par value NIS 0.01 per share, of the Company related to
outstanding options and warrants excluded from the calculation of the diluted loss per share was 4,352,144 and 1,098,938, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare contextRef="c0" decimals="2" unitRef="ilsPershares">0.01</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare contextRef="c4" decimals="2" unitRef="ilsPershares">0.01</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding contextRef="c0" decimals="0" unitRef="shares">4352144</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding contextRef="c4" decimals="0" unitRef="shares">1098938</ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding>
    <ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Derivative Warrants Liability&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;Certain warrants that were issued by
the Company to investors through an U.S. IPO transaction (see also Note 3) are exercisable into a number of ADS with a fixed exercise
price which is denominated in U.S. dollar currency which is different from the functional currency of the Company (New Israeli Shekels)
and are also might be exercisable to a variable number of shares due to the existence of cashless exercise mechanism under certain circumstances.
Accordingly, such warrants are considered as a current financial liability classified under &#x2018;Fair value through profit or loss&#x2019; category
(FVTPL). The fair value of the liability was determined at level 1 in the fair value hierarchy based on the quoted market price of the
warrants. Changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the financing
expenses, net line in the condensed Statement of Operations and Comprehensive Loss, until such warrants are exercised or expired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory>
    <svre:IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Issuance of units comprised of warrants and ordinary shares&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;At the
closing date, the Company allocated total gross proceeds to the issuance components as follows: (i) as the warrants were determined to
be classified as a financial derivative liability, the Company has initially recognized them at fair value and based an average quoted
market price of four business days of these warrants, (ii) the amount allocated to the &lt;/span&gt;ADS &lt;span style="font-size: 10pt"&gt;issued
and ADS to be issued under the pre-funded amount was calculated as the difference between the total gross proceeds received and the fair
value of the warrants issued at the closing date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Incremental
and direct issuance costs were allocated to the components based on the same proportion as the allocation of the gross proceeds. The portion
of issuance costs that was allocated to the warrants was recognized immediately as finance expenses in the condensed statement of comprehensive
loss and the portion of issuance costs related to the &lt;/span&gt;ADS &lt;span style="font-size: 10pt"&gt;and pre-funded warrants was deducted from
additional-paid in capital.&lt;/span&gt;&lt;/p&gt;</svre:IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;Note 3 - U.S. Initial public offering on Nasdaq
&lt;/b&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;As
noted in Note 1B above, on June 6, 2022, the Company completed an underwritten U.S. IPO under which the Company received gross proceeds
of approximately $13 million (approximately NIS 43,441) for issuance of -&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;span style="font-weight: normal"&gt;A.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Number of 2,941,918 units at a price to the public of $4.13 per unit,
each consisting of (i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at
an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 28.35pt"&gt;&lt;span style="font-weight: normal"&gt;B.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Number of 208,282&#160;pre-funded units at a price to the public of
$4.129 per pre-funded unit, each consisting of (i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise
price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant
exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject
to a cashless exercise mechanism upon under certain events). It is noted that all of the pre-funded warrants were fully paid at the Closing
Date, as defined below, however the related ADS were issued subsequent to the balance sheet. See also Note 7B. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;Each
ADS represents 5 ordinary shares of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;In
connection with the U.S. IPO, the Company engaged an U.S. underwriter which was granted as part of its compensation upon completion of
the U.S. IPO (i) a 45-day Over-Allotment Option to purchase up to an additional 469,654 ADS at an exercise price of $4.129 or pre-funded
warrants and/or 469,654 warrants exercisable for the same number of ADS at an exercise price of $0.001 (&#x201c;Over-Allotment Option&#x201d;)
and (ii) a Representative&#x2019;s Warrant exercisable for 157,510 ADS at an exercise price of $5.16 per ADS over a limited period of 5-years
from the issuance date. In connection with the closing of the offering, in June 2022, the underwriter partially exercised its Over-Allotment
Option to purchase an additional 126,482 warrants exercisable for the same number of ADS for de minimis consideration. The remaining 343,172
Over-Allotment Option has been expired.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;Upon
satisfaction of customary closing conditions, the closing date of the U.S. IPO was June 7, 2022 (the &#x201c;Closing Date&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;As
the exercise price of the Warrants is determined in foreign currency and as the Warrants might be exercisable to a variable number of
shares due to the cashless exercise mechanism, the Warrants were accounted for as a derivative financial liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;Moreover,
the Company receives substantially all of the pre-funded warrant&#x2019;s proceeds upfront (without any conditions) as part of the pre-funded
warrant&#x2019;s purchase price and in return the Company is obligated to issue fixed number of ADS to the holders. Consequently, pre-funded
warrants were accounted and were classified as additional paid-in capital as part of the Company&#x2019;s shareholders&#x2019; equity. &lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;As
the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative&#x2019;s
Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted
for under IFRS 2 &#x201c;Share-based Payment&#x201d; in total amount of NIS 5, NIS 588 and NIS 461, respectively. These expenses were estimated
at fair value by using Black-Scholes-Merton pricing model in which the assumptions that have been used are as follows: expected dividend
yield of 0%; risk-free interest rate of 2.16%-3.11%; expected volatility of 52.92%, exercise period and exercise price based upon the
stated terms, ADS price of $2.76 which represents the quoted market price of the average four business days following the Closing Date.
These expenses were included as part of the incremental and direct issuance costs incurred through the U.S. IPO. &lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;Pursuant
to the above, at the initial recognition date the gross proceeds received was allocated to identified components as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&lt;br/&gt;
 value at&lt;br/&gt;
 Closing&lt;br/&gt;
 Date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Derivative warrant liability (*)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Pre-funded warrant and ADS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total gross consideration&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;43,441&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-weight: normal"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
total incremental and direct issuance costs amounted to NIS 7,949 were allocated to the Warrants (NIS 723) and the ADS (including pre-funded
warrants) (NIS 7,226), based on the relative value of such identified instruments at the Closing Date. The portion of issuance costs that
was allocated to the Warrants was recognized immediately as finance expenses in the condensed statement of comprehensive loss and the
portion of issuance costs related to the ADS (including pre-funded warrant) was deducted from additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
following tabular presentation reflects the reconciliation of the fair value of derivative warrant liability during the period of six
months ended June 30, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Six months&lt;br/&gt;
 period&#160;ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 5.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unaudited&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of fair value of warranted issued at Effective Date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Warrants issued as result of partially exercised of over-allotment option&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Revaluation of derivative warrant liability exercisable for ADS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(82&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,023&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <svre:ReceivedGrossProceedsAmount contextRef="c33" decimals="-6" unitRef="usd">13000000</svre:ReceivedGrossProceedsAmount>
    <svre:ReceivedGrossProceedsAmount contextRef="c33" decimals="-3" unitRef="ils">43441000</svre:ReceivedGrossProceedsAmount>
    <svre:NumberOfUnits contextRef="c0" decimals="0" unitRef="shares">2941918</svre:NumberOfUnits>
    <ifrs-full:ParValuePerShare contextRef="c1" decimals="2" unitRef="usdPershares">4.13</ifrs-full:ParValuePerShare>
    <svre:WarrantExercisableDescription contextRef="c0">(i) one ADS and (ii) one Warrant exercisable for one ADS over a limited period of 5-years from the issuance date at
an exercise price of $5.00 (the warrants are subject to a cashless exercise mechanism upon under certain events) and</svre:WarrantExercisableDescription>
    <svre:NumberOfPrefundedUnits contextRef="c0" decimals="0" unitRef="shares">208282</svre:NumberOfPrefundedUnits>
    <svre:PublicOfPerPrefundedUnit contextRef="c0" decimals="3" unitRef="usdPershares">4.129</svre:PublicOfPerPrefundedUnit>
    <svre:PrefundedWarrantExercisableDescription contextRef="c0">(i) one pre-funded warrant exercisable for one ADS over unlimited period at an exercise
price of $0.001 (the pre-funded warrants are subject to a cashless exercise mechanism upon under certain events) and (ii) one warrant
exercisable for one ADS over a limited period of 5-years from the issuance date at an exercise price of $5.00 (the warrants are subject
to a cashless exercise mechanism upon under certain events).</svre:PrefundedWarrantExercisableDescription>
    <ifrs-full:NumberOfSharesIssued contextRef="c34" decimals="0" unitRef="shares">5</ifrs-full:NumberOfSharesIssued>
    <svre:PurchaseToAdditionalShares contextRef="c35" decimals="0" unitRef="shares">469654</svre:PurchaseToAdditionalShares>
    <svre:PublicPricePerShares contextRef="c0" decimals="3" unitRef="usdPershares">4.129</svre:PublicPricePerShares>
    <svre:WarrantsExercisableShares contextRef="c35" decimals="0" unitRef="shares">469654</svre:WarrantsExercisableShares>
    <svre:ExercisePrice contextRef="c36" decimals="3" unitRef="usdPershares">0.001</svre:ExercisePrice>
    <svre:WarrantsExercisableShares contextRef="c0" decimals="0" unitRef="shares">157510</svre:WarrantsExercisableShares>
    <svre:ExercisePrice contextRef="c1" decimals="2" unitRef="usdPershares">5.16</svre:ExercisePrice>
    <svre:OverALimitedPeriod contextRef="c0">P5Y</svre:OverALimitedPeriod>
    <svre:PurchaseToAdditionalShares contextRef="c0" decimals="0" unitRef="shares">126482</svre:PurchaseToAdditionalShares>
    <svre:OverAllotmentOptionHasBeenExpired contextRef="c0" decimals="0" unitRef="shares">343172</svre:OverAllotmentOptionHasBeenExpired>
    <svre:WarrantDescription contextRef="c0">As
the Over-Allotment Option exercisable for ADS, Over-Allotment Option exercisable for pre-funded warrants and/or warrants and the Representative&#x2019;s
Warrant were granted to the underwriter as compensation for its underwriting services rendered in respect to the U.S. IPO, they were accounted
for under IFRS 2 &#x201c;Share-based Payment&#x201d; in total amount of NIS 5, NIS 588 and NIS 461, respectively.</svre:WarrantDescription>
    <svre:ShareBasedPaymentWarrantAmount contextRef="c0" decimals="0" unitRef="ils">461</svre:ShareBasedPaymentWarrantAmount>
    <svre:ExpectedDividendYieldRate contextRef="c0" decimals="2" unitRef="pure">0</svre:ExpectedDividendYieldRate>
    <svre:riskfreeInterestRate contextRef="c37" decimals="4" unitRef="pure">0.0216</svre:riskfreeInterestRate>
    <svre:riskfreeInterestRate contextRef="c38" decimals="4" unitRef="pure">-0.0311</svre:riskfreeInterestRate>
    <svre:ExpectedVolatility contextRef="c0" decimals="4" unitRef="pure">0.5292</svre:ExpectedVolatility>
    <ifrs-full:DisclosureOfDebtSecuritiesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair&lt;br/&gt;
 value at&lt;br/&gt;
 Closing&lt;br/&gt;
 Date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Derivative warrant liability (*)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Pre-funded warrant and ADS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total gross consideration&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;43,441&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-weight: normal"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfDebtSecuritiesExplanatory>
    <ifrs-full:LeaseLiabilities contextRef="c1" decimals="-3" id="ix_0_fact" unitRef="ils">3947000</ifrs-full:LeaseLiabilities>
    <svre:PrefundedWarrants contextRef="c1" decimals="-3" unitRef="ils">-39494000</svre:PrefundedWarrants>
    <ifrs-full:GovernmentGrants contextRef="c1" decimals="-3" unitRef="ils">43441000</ifrs-full:GovernmentGrants>
    <svre:WarrantsPerShare contextRef="c1" decimals="4" unitRef="usdPershares">0.3508</svre:WarrantsPerShare>
    <svre:TotalIncrementalAndDirectIssuanceCostsAmounted contextRef="c0" decimals="0" unitRef="ils">7949</svre:TotalIncrementalAndDirectIssuanceCostsAmounted>
    <svre:AllocatedToWarrantsAmount contextRef="c0" decimals="0" unitRef="ils">723</svre:AllocatedToWarrantsAmount>
    <svre:PrefundedWarrantsAmount contextRef="c0" decimals="0" unitRef="ils">7226</svre:PrefundedWarrantsAmount>
    <ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Six months&lt;br/&gt;
 period&#160;ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 5.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unaudited&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Opening balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Recognition of fair value of warranted issued at Effective Date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Warrants issued as result of partially exercised of over-allotment option&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Revaluation of derivative warrant liability exercisable for ADS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(82&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -14.15pt; padding-left: 14.15pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,023&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:IssuesFairValueMeasurementLiabilities contextRef="c0" decimals="-3" unitRef="ils">3947000</ifrs-full:IssuesFairValueMeasurementLiabilities>
    <svre:WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption contextRef="c0" decimals="-3" unitRef="ils">158000</svre:WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption>
    <svre:RevaluationOfDerivativeWarrantLiabilityExercisableForADS contextRef="c0" decimals="-3" unitRef="ils">82000</svre:RevaluationOfDerivativeWarrantLiabilityExercisableForADS>
    <ifrs-full:CurrentDerivativeFinancialLiabilities contextRef="c1" decimals="-3" unitRef="ils">4023000</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"&gt;&lt;b&gt;Note 4 - Share
capital and reserves&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Composition of share capital&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Ordinary shares, par value NIS 0.01 each&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;100,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;22,694,296&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;100,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;7,984,706&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Rights attached to the ordinary shares&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
ordinary shares of the Company grant the holders thereof the right to participate and vote in shareholders meetings, the right to receive
a dividend, as declared, the right to participate in distributions of bonus shares and the right to participate in the distribution of
the assets of the Company upon liquidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Changes in the issued and outstanding capital&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six months&lt;br/&gt; period&lt;br/&gt;
 ended&lt;br/&gt; June 30,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Balance as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,984,706&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Allotment of ordinary shares through U.S IPO (see Note 3 above)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,709,590&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Balance as of June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,694,296&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <svre:ScheduleOfCompositionOfShareCapitalTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Ordinary shares, par value NIS 0.01 each&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;100,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;22,694,296&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;100,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;7,984,706&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</svre:ScheduleOfCompositionOfShareCapitalTableTextBlock>
    <svre:AuthorizedOrdinarySharesParValue contextRef="c0" decimals="2" unitRef="ilsPershares">0.01</svre:AuthorizedOrdinarySharesParValue>
    <svre:IssuedAndOutstandingOrdinarySharesParShare contextRef="c1" decimals="2" unitRef="ilsPershares">0.01</svre:IssuedAndOutstandingOrdinarySharesParShare>
    <svre:AuthorizedOrdinarySharesParValue contextRef="c5" decimals="2" unitRef="ilsPershares">0.01</svre:AuthorizedOrdinarySharesParValue>
    <svre:IssuedAndOutstandingOrdinarySharesParShare contextRef="c3" decimals="2" unitRef="ilsPershares">0.01</svre:IssuedAndOutstandingOrdinarySharesParShare>
    <ifrs-full:NumberOfSharesAuthorised contextRef="c1" decimals="INF" unitRef="shares">100000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesIssued contextRef="c1" decimals="INF" unitRef="shares">22694296</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesAuthorised contextRef="c3" decimals="INF" unitRef="shares">100000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesIssued contextRef="c3" decimals="INF" unitRef="shares">7984706</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DisclosureOfIssuedCapitalExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six months&lt;br/&gt; period&lt;br/&gt;
 ended&lt;br/&gt; June 30,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Balance as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,984,706&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Allotment of ordinary shares through U.S IPO (see Note 3 above)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,709,590&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt"&gt;Balance as of June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;22,694,296&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIssuedCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">7984706</ifrs-full:NumberOfSharesOutstanding>
    <svre:AllotmentOfOrdinaryShares contextRef="c0" decimals="INF" unitRef="shares">14709590</svre:AllotmentOfOrdinaryShares>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares">22694296</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"&gt;&lt;b&gt;Note 5 - Loss
per share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
following table presents a summary of the loss and number of shares (including adjustments to such data) that were taken into consideration
for purposes of computing the loss per share (both basic and diluted).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six months period ended&lt;br/&gt; June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Audited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65; -sec-ix-hidden: hidden-fact-64; -sec-ix-hidden: hidden-fact-63"&gt;Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(11,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(13,301&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(26,490&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of shares Six months period ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Audited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted number of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,178,955&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,935,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,960,239&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted number of shares to be issued upon full exercise of pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155,348&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70; -sec-ix-hidden: hidden-fact-69; -sec-ix-hidden: hidden-fact-68"&gt;Weighted number of shares used in computing basic and diluted loss per share&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,334,303&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,935,366&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,960,239&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six months period ended&lt;br/&gt; June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Audited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65; -sec-ix-hidden: hidden-fact-64; -sec-ix-hidden: hidden-fact-63"&gt;Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(11,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(13,301&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;(26,490&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of shares Six months period ended June&#160;30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Unaudited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Audited&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted number of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,178,955&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,935,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,960,239&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted number of shares to be issued upon full exercise of pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;155,348&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70; -sec-ix-hidden: hidden-fact-69; -sec-ix-hidden: hidden-fact-68"&gt;Weighted number of shares used in computing basic and diluted loss per share&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,334,303&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,935,366&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,960,239&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c0" decimals="-3" unitRef="ils">-11900000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c4" decimals="-3" unitRef="ils">-13301000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c5" decimals="-3" unitRef="ils">-26490000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c0" decimals="INF" unitRef="shares">10178955</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c4" decimals="INF" unitRef="shares">7935366</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c5" decimals="INF" unitRef="shares">7960239</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants contextRef="c0" decimals="INF" unitRef="shares">155348</svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants>
    <ifrs-full:WeightedAverageShares contextRef="c0" decimals="INF" unitRef="shares">10334303</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c4" decimals="INF" unitRef="shares">7935366</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c5" decimals="INF" unitRef="shares">7960239</ifrs-full:WeightedAverageShares>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 6 - Financial risk factors&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
Company&#x2019;s activities expose it to a variety of financial risks.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
condensed interim financial statements do not include all financial risk information and disclosures required in the annual financial
statements; they should be read in conjunction with the Company&#x2019;s annual financial statements as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;There
have been no changes in the risk management policies since the year-end.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.8pt; text-align: justify; text-indent: -53.8pt"&gt;&lt;b&gt;Note 7 - Subsequent
Events&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.35pt; text-align: justify; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were available to be issued (September 8, 2022). Based upon this review, the Company did not identify any other subsequent events that
would have required adjustment or disclosure in the financial statements, except as disclosed below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.55pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Options grant&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;On
July 7, 2022, the Company&#x2019;s Board of Directors approved a grant of options to purchase an aggregate of 1,031,000 ordinary shares
of the Company, to employees and officers. The options are exercisable at NIS 1.639 per share and will be vest over a limited period of
4-years. &lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 42.55pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Issuance of ADS&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;In
August 2022, all of the pre-funded warrants were exercised into ADS. See also Note 3.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <svre:AggregateShares contextRef="c39" decimals="0" unitRef="shares">1031000</svre:AggregateShares>
    <ifrs-full:DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares contextRef="c39" decimals="3" unitRef="ilsPershares">1.639</ifrs-full:DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares>
    <svre:OverLimitedPeriod contextRef="c39">P4Y</svre:OverLimitedPeriod>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="hidden-fact-1"
      unitRef="ilsPershares">-1.15</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c4"
      decimals="2"
      id="hidden-fact-2"
      unitRef="ilsPershares">-1.68</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c5"
      decimals="2"
      id="hidden-fact-3"
      unitRef="ilsPershares">-3.33</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-4"
      unitRef="shares">10334303</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c4"
      decimals="INF"
      id="hidden-fact-5"
      unitRef="shares">7935366</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c5"
      decimals="INF"
      id="hidden-fact-6"
      unitRef="shares">7960239</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c9"
      id="hidden-fact-7"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c11"
      id="hidden-fact-8"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c9"
      id="hidden-fact-9"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c11"
      id="hidden-fact-10"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c9"
      id="hidden-fact-11"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c11"
      id="hidden-fact-12"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c10"
      id="hidden-fact-13"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c11"
      id="hidden-fact-14"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c9"
      id="hidden-fact-15"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c10"
      id="hidden-fact-16"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c19"
      id="hidden-fact-17"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c21"
      id="hidden-fact-18"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c19"
      id="hidden-fact-19"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c21"
      id="hidden-fact-20"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c19"
      id="hidden-fact-21"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c21"
      id="hidden-fact-22"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c4"
      id="hidden-fact-23"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c19"
      id="hidden-fact-24"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c20"
      id="hidden-fact-25"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c25"
      id="hidden-fact-26"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c27"
      id="hidden-fact-27"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c25"
      id="hidden-fact-28"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:SharebasedPaymentToServiceProvider
      contextRef="c27"
      id="hidden-fact-29"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c25"
      id="hidden-fact-30"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c26"
      id="hidden-fact-31"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c27"
      id="hidden-fact-32"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExerciseOfNonregisteredRightsIntoOrdinaryShares
      contextRef="c5"
      id="hidden-fact-33"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c25"
      id="hidden-fact-34"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="c26"
      id="hidden-fact-35"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:PaymentsOfOtherEquityInstruments
      contextRef="c0"
      id="hidden-fact-36"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:PaymentsOfOtherEquityInstruments
      contextRef="c4"
      id="hidden-fact-37"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities
      contextRef="c0"
      id="hidden-fact-38"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="c4"
      id="hidden-fact-39"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="c5"
      id="hidden-fact-40"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="c0"
      id="hidden-fact-41"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="c4"
      id="hidden-fact-42"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="c5"
      id="hidden-fact-43"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c4"
      id="hidden-fact-44"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c5"
      id="hidden-fact-45"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="c29"
      id="hidden-fact-46"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="c30"
      id="hidden-fact-47"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities
      contextRef="c29"
      id="hidden-fact-48"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities
      contextRef="c30"
      id="hidden-fact-49"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExchangeDifferencesOnCashAndCashEquivalent
      contextRef="c29"
      id="hidden-fact-50"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ExchangeDifferencesOnCashAndCashEquivalent
      contextRef="c30"
      id="hidden-fact-51"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:ChangesInLiabilityInRespectOfGovernmentGrants
      contextRef="c29"
      id="hidden-fact-52"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:RecognitionOfRightForUseAssetAgainstALeasingLiability
      contextRef="c28"
      id="hidden-fact-53"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:DeferredOfferingExpensesNotYetPaid
      contextRef="c28"
      id="hidden-fact-54"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:DeferredOfferingExpensesNotYetPaid
      contextRef="c29"
      id="hidden-fact-55"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh
      contextRef="c29"
      id="hidden-fact-56"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh
      contextRef="c30"
      id="hidden-fact-57"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:OfferingCostsNotYetPaid
      contextRef="c29"
      id="hidden-fact-58"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:OfferingCostsNotYetPaid
      contextRef="c30"
      id="hidden-fact-59"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:PartialExerciseOfOverallotmentOptionIntoWarrants
      contextRef="c29"
      id="hidden-fact-60"
      unitRef="ils"
      xsi:nil="true"/>
    <svre:PartialExerciseOfOverallotmentOptionIntoWarrants
      contextRef="c30"
      id="hidden-fact-61"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="c3"
      id="hidden-fact-62"
      unitRef="ils"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c0"
      decimals="-3"
      id="hidden-fact-63"
      unitRef="ils">-11900000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c4"
      decimals="-3"
      id="hidden-fact-64"
      unitRef="ils">-13301000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c5"
      decimals="-3"
      id="hidden-fact-65"
      unitRef="ils">-26490000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants
      contextRef="c4"
      id="hidden-fact-66"
      unitRef="shares"
      xsi:nil="true"/>
    <svre:WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants
      contextRef="c5"
      id="hidden-fact-67"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-68"
      unitRef="shares">10334303</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c4"
      decimals="INF"
      id="hidden-fact-69"
      unitRef="shares">7935366</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c5"
      decimals="INF"
      id="hidden-fact-70"
      unitRef="shares">7960239</ifrs-full:AdjustedWeightedAverageShares>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001894693</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-21"
          xlink:label="hidden-fact-21"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-33"
          xlink:label="hidden-fact-33"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-43"
          xlink:label="hidden-fact-43"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-23"
          xlink:label="hidden-fact-23"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-42"
          xlink:label="hidden-fact-42"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-30"
          xlink:label="hidden-fact-30"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount lower than NIS 1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-21"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-33"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-43"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-23"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-42"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-30"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-weight: normal">The fair value of the derivate
warrant liability was determined and estimated at level 1 in the fair value hierarchy based on the price of the Warrants of $0.3508 which
is an average quoted market trading price in the first four business days following the Closing Date.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>38
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /-%*54'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #S12E5 VO$'>\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O285Q=#U9<,G!<&!XEM(;EM8DX;DI-VW-ZU;A^@'$/*2NW]^
M]SM(HX/4?<27V >,9#'=C*[S2>JP8@>B( &2/J!3J<P)GYN[/CI%^1KW$)0^
MJCV"J*H[<$C**%(P 8NP$%G;&"UU1$5]/..-7O#A,W8SS&C #AUZ2L!+#JR=
M)H;3V#5P!4PPPNC2=P'-0IRK?V+G#K!S<DQV20W#4 [UG,L[<'A_?GJ=URVL
M3Z2\QOPJ64FG@"MVF?Q6KS?;1]:*2HBB>LAGRX6\O9<U_YA<?_A=A5UO[,[^
M8^.+8-O KW_1?@%02P,$%     @ \T4I59E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M T(;X/<UY^K0T1.8]U/T%U!+ P04    " #S12E5C8IA.H4&   T(0  &
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M(@ &:YC4Q'@1AL>=G,>=V-<.$W+GO1[[Q%RU'@ZUC%^8*!2BV-5HF"@<!^[
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MZ&HVXHMC([LJ^GP*A3I-DP_8TJS9/]=L3WFE!)^S;H(&A@I0-FZB1^H&4 J
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MO\; Q6;D^,YVX2E;I=HLN-&P9"N8@_Y:SB3.W)8ER7(H5"8*(F$Y<A[\N^G
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M44C2CR\5Z*BVJ12/K[^A+\O@93#/B.,Y3?XD:Q'?CL(16.,-*A+QD>Y^QE5
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M[1OH6^]T6^9 D2P'PGF\D)%&'OAU'OA&E#E-I1>Q>DV3E2:A7#O'1HP+ELU
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MNW*.$_J./G);-47-D</+O=W[9O@1EQ.FCC!0!E!*"[D3)G2'F5RF<N3#^Q6
M5[KWQ\G1"4J*V;8\'.,@4@C[KZGUZ/X [AY>S\MSJM;X$EX_ZL;O;.OZ48:G
M>U*?Y4T.IO<G@;\AMB49!PG>2#>LJT#RR/:':_L;0?/R;.>9"D'3\C+&2%91
M)2"?;R@5WVZ4@?J(<_8/4$L#!!0    ( /-%*57E(KA=+0H  % U   8
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MU@%2&\#?YT*H[1=]@]V/J"[^ 5!+ P04    " #S12E51^F?1RP'  !I$
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M)!+-\ 9\WVBD9_?"!PS_7;C["U!+ P04    " #S12E525OXG64*  !:&@
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M%;W"J)T![9>*&GH[<0'Z=WW^ U!+ P04    " #S12E5P'8CN^("  !T!@
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MTHQ=!%(#C@)%L%T=83?4#N:\I0)'T*".)QOT7"3U&-K@3/2X:(:?08;:QS
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M]7XK9=V"$F1$:UUJ'A"@5CAJ+C;J[S/*'R*T[8?=@$_^]_/$)4]:"4UGW''
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M4+L ^KY5)+ 9N 7:!W+Z&U!+ P04    " #S12E5<W?/$R #   F!P  &0
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MAMH;T'ZKE'U>^ "'IW'Q%5!+ P04    " #S12E5B-I;G(P$  "8%P  &0
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M[A'DN9!HP-]O,68O!=%!?1F_^!]02P,$%     @ \T4I52H4F+R. @  >@8
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MHG8*=%XH2E.W<0[Z,9W^ E!+ P04    " #S12E5 3^/2P\#  "R!P  &0
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M    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;'U5;6_:,!#^*Z=,FEII(R%
M6CJ(!+33F-05E77[;)(CL>K8F>U ]^]W3D+&5LH7XI>[YYY[SG=,]DH_FQS1
MPDLAI)EZN;7EC>^;),>"F9XJ4=+-5NF"6=KJS#>E1I;63H7PPR"(_()QZ<63
M^FREXXFJK. 25QI,511,_YZC4/NIU_<.!X\\RZT[\.-)R3)<HWTJ5YIV?H>2
M\@*EX4J"QNW4F_5OYI&SKPU^<-R;HS6X3#9*/;O-,IUZ@2.$ A/K$!A]=KA
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M@#ONN>-#ZNE%42 4S "I&\Q*^Z?MCN;7X.&TQ*WFS&NZ!MRDXS >AV&8T,T
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MP9]UOXQFGU!+ 0(4 Q0    ( /-%*54'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ \T4I50-KQ!WO
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ \T4I59E<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #S12E5O9G'5M\"  !+"0
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ \T4I58V*83J%!@  -"$  !@              ("!(PL  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( /-%*55==R;[Q00
M ,81   8              " @=X1  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " #S12E5NU>?Y?0"   B"   &               @('9
M%@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ \T4I5?S0
MY_6G!0  [AP  !@              ("! QH  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( /-%*57E(KA=+0H  % U   8
M  " @> ?  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #S
M12E51^F?1RP'  !I$   &               @(%#*@  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ \T4I54E;^)UE"@  6AH  !@
M         ("!I3$  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( /-%*56X=FHAX0D  (4:   8              " @4 \  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #S12E5R->L7)4#   R"
M&0              @(%71@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( /-%*56XJ]JE:P,  .,'   9              " @2-*  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ \T4I5<!V([OB
M @  = 8  !D              ("!Q4T  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " #S12E5VSR0B*X#  "[!P  &0
M@('>4   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( /-%
M*57/??OUR H  )D=   9              " @<-4  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ \T4I58D#%HVI P  5P@  !D
M         ("!PE\  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " #S12E5?&5$YPP#   L!P  &0              @(&B8P  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( /-%*55S=\\3( ,  "8'
M   9              " @>5F  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ \T4I58C:6YR,!   F!<  !D              ("!/&H
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #S12E5*A28
MO(X"  !Z!@  &0              @('_;@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( /-%*56[P!- QPD  '1-   9
M  " @<1Q  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
M\T4I5: \?]Y; P  L@<  !D              ("!PGL  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " #S12E5 3^/2P\#  "R!P  &0
M            @(%4?P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( /-%*54Y[%_W>0(  #(&   9              " @9J"  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ \T4I5:9%3:2? @
M[08  !D              ("!2H4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " #S12E5MH?R+ZL"   C!@  &0              @($@
MB   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /-%*54)
MASK9B@,  ,0*   9              " @0*+  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ \T4I5:6K[3,@ P  D0@  !D
M     ("!PXX  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /-%*54O ()43 $  &L1   :
M          "  4:<  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( /-%*54BX&C7>P$  #H2   3              "  <J=  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     D "0 LPD  ':?      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>40</ContextCount>
  <ElementCount>165</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Condensed Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Condensed Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Condensed Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Statements of Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Condensed Statements of Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Statements of Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Condensed Statements of Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - U.S. Initial Public Offering on Nasdaq</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/USInitialPublicOfferingonNasdaq</Role>
      <ShortName>U.S. Initial Public Offering on Nasdaq</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Share Capital and Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ShareCapitalandReserves</Role>
      <ShortName>Share Capital and Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Financial Risk Factors</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/FinancialRiskFactors</Role>
      <ShortName>Financial Risk Factors</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.saver.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - U.S. Initial Public Offering on Nasdaq (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables</Role>
      <ShortName>U.S. Initial Public Offering on Nasdaq (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.saver.com/role/USInitialPublicOfferingonNasdaq</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Share Capital and Reserves (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ShareCapitalandReservesTables</Role>
      <ShortName>Share Capital and Reserves (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.saver.com/role/ShareCapitalandReserves</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.saver.com/role/LossPerShare</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/General</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails</Role>
      <ShortName>U.S. Initial Public Offering on Nasdaq (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable</Role>
      <ShortName>U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable</Role>
      <ShortName>U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable</Role>
      <ShortName>Share Capital and Reserves (Details) - Schedule of composition of share capital</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/ShareCapitalandReservesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals</Role>
      <ShortName>Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/ShareCapitalandReservesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable</Role>
      <ShortName>Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/ShareCapitalandReservesTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable</Role>
      <ShortName>Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/LossPerShareTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals</Role>
      <ShortName>Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/LossPerShareTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea165490-6k_saverone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.saver.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.saver.com/role/SubsequentEvents</ParentRole>
      <Position>28</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 12 fact(s) appearing in ix:hidden were eligible for transformation: ifrs-full:AdjustedWeightedAverageShares, ifrs-full:DilutedEarningsLossPerShare, ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects -  ea165490ex99-2_saverone.htm 1818, 1819, 1820, 1821, 1822, 1823, 1880, 1881, 1882, 1885, 1886, 1887</Log>
  </Logs>
  <InputFiles>
    <File doctype="6-K" original="ea165490-6k_saverone.htm">ea165490-6k_saverone.htm</File>
    <File doctype="6-K" original="ea165490ex99-2_saverone.htm">ea165490ex99-2_saverone.htm</File>
    <File>ea165490ex99-1_saverone.htm</File>
    <File>svre-20220630.xsd</File>
    <File>svre-20220630_cal.xml</File>
    <File>svre-20220630_def.xml</File>
    <File>svre-20220630_lab.xml</File>
    <File>svre-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
    <BaseTaxonomy items="309">https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>44
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea165490-6k_saverone.htm ea165490ex99-2_saverone.htm": {
   "axisCustom": 1,
   "axisStandard": 5,
   "contextCount": 40,
   "dts": {
    "calculationLink": {
     "local": [
      "svre-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "svre-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea165490-6k_saverone.htm",
      "ea165490ex99-2_saverone.htm"
     ]
    },
    "labelLink": {
     "local": [
      "svre-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "svre-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "svre-20220630.xsd",
      "reference-2009-12-16.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 224,
   "entityCount": 1,
   "hidden": {
    "http://www.saver.com/20220630": 27,
    "http://xbrl.sec.gov/dei/2022": 5,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 43,
    "total": 75
   },
   "keyCustom": 54,
   "keyStandard": 111,
   "memberCustom": 4,
   "memberStandard": 5,
   "nsprefix": "svre",
   "nsuri": "http://www.saver.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490-6k_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.saver.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490-6k_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Share Capital and Reserves",
     "role": "http://www.saver.com/role/ShareCapitalandReserves",
     "shortName": "Share Capital and Reserves",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Loss Per Share",
     "role": "http://www.saver.com/role/LossPerShare",
     "shortName": "Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Financial Risk Factors",
     "role": "http://www.saver.com/role/FinancialRiskFactors",
     "shortName": "Financial Risk Factors",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Subsequent Events",
     "role": "http://www.saver.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.saver.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - U.S. Initial Public Offering on Nasdaq (Tables)",
     "role": "http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables",
     "shortName": "U.S. Initial Public Offering on Nasdaq (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Share Capital and Reserves (Tables)",
     "role": "http://www.saver.com/role/ShareCapitalandReservesTables",
     "shortName": "Share Capital and Reserves (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Loss Per Share (Tables)",
     "role": "http://www.saver.com/role/LossPerShareTables",
     "shortName": "Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "svre:NumberOfOperatingSegment",
      "reportCount": 1,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - General (Details)",
     "role": "http://www.saver.com/role/GeneralDetails",
     "shortName": "General (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://www.saver.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Condensed Statements of Financial Position",
     "role": "http://www.saver.com/role/ConsolidatedBalanceSheet",
     "shortName": "Condensed Statements of Financial Position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "svre:ReceivedGrossProceedsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details)",
     "role": "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails",
     "shortName": "U.S. Initial Public Offering on Nasdaq (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "svre:ReceivedGrossProceedsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received",
     "role": "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable",
     "shortName": "U.S. Initial Public Offering on Nasdaq (Details) - Schedule of gross proceeds received",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuesFairValueMeasurementLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability",
     "role": "http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable",
     "shortName": "U.S. Initial Public Offering on Nasdaq (Details) - Schedule of fair value of derivative warrant liability",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuesFairValueMeasurementLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesAuthorised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital",
     "role": "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable",
     "shortName": "Share Capital and Reserves (Details) - Schedule of composition of share capital",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesAuthorised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "svre:AuthorizedOrdinarySharesParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals)",
     "role": "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals",
     "shortName": "Share Capital and Reserves (Details) - Schedule of composition of share capital (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "svre:ScheduleOfCompositionOfShareCapitalTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "svre:AuthorizedOrdinarySharesParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital",
     "role": "http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable",
     "shortName": "Share Capital and Reserves (Details) - Schedule of changes in the issued and outstanding capital",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted",
     "role": "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable",
     "shortName": "Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals)",
     "role": "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals",
     "shortName": "Loss Per Share (Details) - Schedule of loss and number of shares basic and diluted (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c39",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "svre:AggregateShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.saver.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c39",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "svre:AggregateShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Condensed Statements of Comprehensive Loss",
     "role": "http://www.saver.com/role/ConsolidatedIncomeStatement",
     "shortName": "Condensed Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Condensed Statements of Comprehensive Loss (Parentheticals)",
     "role": "http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Condensed Statements of Comprehensive Loss (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c15",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Condensed Statements of Changes in Shareholders\u2019 Equity",
     "role": "http://www.saver.com/role/ShareholdersEquityType2or3",
     "shortName": "Condensed Statements of Changes in Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c20",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "ils",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Condensed Statements of Cash Flows",
     "role": "http://www.saver.com/role/ConsolidatedCashFlow",
     "shortName": "Condensed Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ils",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - General",
     "role": "http://www.saver.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Significant Accounting Policies",
     "role": "http://www.saver.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - U.S. Initial Public Offering on Nasdaq",
     "role": "http://www.saver.com/role/USInitialPublicOfferingonNasdaq",
     "shortName": "U.S. Initial Public Offering on Nasdaq",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea165490ex99-2_saverone.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 9,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.saver.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ifrs-full_AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The accumulated increase (decrease) in the fair value of financial assets designated as measured at fair value through profit or loss that is attributable to changes in the credit risk of the assets determined either: (a) as the amount of change in their fair value that is not attributable to changes in market conditions that gave rise to market risk; or (b) using an alternative method that the entity believes more faithfully represents the amount of change in its fair value that is attributable to changes in the credit risk of the asset. [Refer: Credit risk [member]; Market risk [member]; Increase (decrease) in fair value of financial assets designated as measured at fair value through profit or loss, attributable to changes in credit risk of financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated increase (decrease) in fair value of financial assets designated as measured at fair value through profit or loss, attributable to changes in credit risk of financial assets",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)",
        "verboseLabel": "Weighted number of shares used in computing diluted loss per share"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends": {
     "auth_ref": [
      "r45",
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustment to profit (loss) for preference share dividends",
        "terseLabel": "Offering price (in Dollars)"
       }
      }
     },
     "localname": "AdjustmentToProfitLossForPreferenceShareDividends",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for amortisation expense",
        "terseLabel": "Amortization of right for use asset"
       }
      }
     },
     "localname": "AdjustmentsForAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "svre_ChangesinAssetAndLiability",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "negatedLabel": "Increase in inventory"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "svre_ChangesinAssetAndLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other assets",
        "terseLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other operating receivables",
        "terseLabel": "Adjustments required to present cash flows from operating activities (Appendix A)"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "svre_ChangesinAssetAndLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "Decrease (increase) in trade receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation expense",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in derivative financial liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Derivative financial liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in derivative financial liabilities",
        "negatedLabel": "Revaluation of derivative warrant liability"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "svre_ChangesinAssetAndLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in other current liabilities",
        "terseLabel": "Increase in other current liabilities"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "svre_ChangesinAssetAndLiability",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "negatedLabel": "Increase (decrease) in trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Direct and incremental issuance cost allocated to derivative warrant liability through U.S IPO"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r17",
      "r79",
      "r80",
      "r82",
      "r95",
      "r98"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r42",
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic and diluted loss per share (in New Shekels per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": {
     "auth_ref": [
      "r43",
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share from discontinued operations",
        "terseLabel": "Offering price per shares (in Dollars per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r90",
      "r92",
      "r105"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range [member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalReserve": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the capital reserves."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital reserve",
        "terseLabel": "Capital reserve in respect of share-based payment"
       }
      }
     },
     "localname": "CapitalReserve",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r14",
      "r63",
      "r78"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Balance of cash and cash equivalents, end of period",
        "periodStartLabel": "Balance of cash and cash equivalents, beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet",
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) decrease (increase) in short-term deposits and investments",
        "terseLabel": "Changes in short-term deposits"
       }
      }
     },
     "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r52",
      "r65"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by (used in) financing activity"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash flows from financing activity"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r52",
      "r65"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash provided by (used in) investment activity"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flows from investment activity"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r52",
      "r65"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Cash flow from operating activity"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      }
     },
     "localname": "ClassesOfOrdinarySharesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r3",
      "r30",
      "r68",
      "r70",
      "r71",
      "r76"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "terseLabel": "Comprehensive loss",
        "totalLabel": "Comprehensive loss for the period"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement",
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r2",
      "r33"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r19",
      "r71",
      "r72"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial liabilities",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance",
        "terseLabel": "Derivative warrants liability"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet",
      "http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentInvestments": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Current investments",
        "terseLabel": "Short-term bank deposits"
       }
      }
     },
     "localname": "CurrentInvestments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Current maturities of leasing liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r21",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities other than liabilities included in disposal groups classified as held for sale",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepayments and other current assets",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "CurrentPrepaymentsAndOtherCurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentRestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current restricted cash and cash equivalents",
        "terseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "CurrentRestrictedCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r16",
      "r18",
      "r37"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r102",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.\nEffective 2023-01-01: The description of the entity's material accounting policy information for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Basic and diluted net loss per ordinary share"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": {
     "auth_ref": [
      "r102",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.\nEffective 2023-01-01: The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for warrants [text block]",
        "terseLabel": "Derivative Warrants Liability"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "terseLabel": "U.S. Initial public offering on Nasdaq"
       }
      }
     },
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaq"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per instrument from discontinued operations for an equity instrument that participates in profit with ordinary shares according to a predetermined formula. [Refer: Diluted earnings (loss) per instrument, participating equity instruments other than ordinary shares; Discontinued operations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per instrument from discontinued operations, participating equity instruments other than ordinary shares",
        "terseLabel": "Exercisable price"
       }
      }
     },
     "localname": "DilutedEarningsLossPerInstrumentFromDiscontinuedOperationsParticipatingEquityInstrumentsOtherThanOrdinaryShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r42",
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Basic and diluted loss per share (in Dollars per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Use of estimates in the preparation of financial statements"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDebtSecuritiesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of debt instruments [text block]",
        "terseLabel": "Schedule of gross proceeds received"
       }
      }
     },
     "localname": "DisclosureOfDebtSecuritiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/LossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of liabilities [text block]",
        "terseLabel": "Schedule of fair value of derivative warrant liability"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "Financial risk factors"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/FinancialRiskFactors"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "General"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of issued capital [text block]",
        "terseLabel": "Schedule of changes in the issued and outstanding capital"
       }
      }
     },
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareCapitalandReservesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]",
        "terseLabel": "Schedule of loss and number of shares basic and diluted"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/LossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Share capital and reserves"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareCapitalandReserves"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DividendsPaidOrdinarySharesPerShare": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends paid per ordinary share."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid, ordinary shares per share",
        "terseLabel": "Ordinary share par value"
       }
      }
     },
     "localname": "DividendsPaidOrdinarySharesPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r61",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Exchange differences on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r17",
      "r23",
      "r67",
      "r69",
      "r79",
      "r80",
      "r82"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet",
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "terseLabel": "Financing income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r103",
      "r106"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance income (expenses) from reinsurance contracts held that is recognised in profit or loss. [Refer: Insurance finance income (expenses); Reinsurance contracts held [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (expenses) from reinsurance contracts held recognised in profit or loss",
        "totalLabel": "Financing income (expenses), net"
       }
      }
     },
     "localname": "FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GovernmentGrants": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Government grants",
        "totalLabel": "Total gross consideration"
       }
      }
     },
     "localname": "GovernmentGrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Change in balance of cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Income and expenses and changes in asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_WeightedAverageShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "Weighted number of shares"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of shares outstanding",
        "terseLabel": "Diluted loss per shares"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfSharesOutstanding",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase through other contributions by owners, equity",
        "negatedLabel": "Partial exercise of over-allotment option into warrants"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherContributionsByOwners",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based payment to employees"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r12",
      "r20",
      "r39"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Net proceed allocated to ADS and ADS to be issued through initial public offering"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuesFairValueMeasurementLiabilities": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in fair value measurement of liabilities resulting from issues of those liabilities. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Issues, fair value measurement, liabilities",
        "terseLabel": "Recognition of fair value of warranted issued at Effective Date"
       }
      }
     },
     "localname": "IssuesFairValueMeasurementLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_GovernmentGrants",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "terseLabel": "Derivative warrant liability"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r19",
      "r71",
      "r73"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Leasing liability, net current"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r21",
      "r71",
      "r75"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares authorised",
        "terseLabel": "Authorized, Ordinary shares, par value NIS 0.01 each"
       }
      }
     },
     "localname": "NumberOfSharesAuthorised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Issued and outstanding, Ordinary shares, par value NIS 0.01 each",
        "verboseLabel": "Issue ordinary shares"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable",
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r27",
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherCurrentNonfinancialLiabilities": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current non-financial liabilities",
        "terseLabel": "Liability in respect of government grants"
       }
      }
     },
     "localname": "OtherCurrentNonfinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentNonfinancialLiabilities": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current non-financial liabilities",
        "terseLabel": "Liability in respect of government grants"
       }
      }
     },
     "localname": "OtherNoncurrentNonfinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Public of per unit (in Dollars per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Repayment of principal in respect of lease liability"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfOtherEquityInstruments": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payments for equity instruments that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of other equity instruments",
        "negatedLabel": "Deferred offering expenses"
       }
      }
     },
     "localname": "PaymentsOfOtherEquityInstruments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsToAndOnBehalfOfEmployees": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to, and on behalf of, employees."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments to and on behalf of employees",
        "terseLabel": "Share-based payment to employees and service providers"
       }
      }
     },
     "localname": "PaymentsToAndOnBehalfOfEmployees",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Exercise of non-registered rights into ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfWarrants": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of share purchase warrants."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of warrants",
        "terseLabel": "Net proceeds from issuance of ADS, pre-funded warrants and warrants through initial public offering"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfWarrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from government grants, classified as financing activities",
        "terseLabel": "Receipt of government grants"
       }
      }
     },
     "localname": "ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfInterestsInAssociates": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of interests in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of interests in associates",
        "terseLabel": "Interest expense in respect of leasing"
       }
      }
     },
     "localname": "ProceedsFromSalesOfInterestsInAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r87",
      "r99"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r87",
      "r99"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [member]"
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r29",
      "r58",
      "r68",
      "r70",
      "r71",
      "r95",
      "r97",
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Comprehensive loss for the period",
        "totalLabel": "Loss for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow",
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share",
        "terseLabel": "Loss attributed to the shareholders of the Company for purposes of computing the basic and diluted loss per share (in New Shekels)"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share",
        "terseLabel": "Loss attributed to the shareholders of the Company for purposes of computing the diluted loss per share"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r32",
      "r41"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r11",
      "r38"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r90",
      "r92",
      "r105"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r90",
      "r92",
      "r105"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research and development expenses, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]",
        "terseLabel": "Capital reserve in respect of share-based payment"
       }
      }
     },
     "localname": "ReserveOfSharebasedPaymentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r23",
      "r34"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r7",
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r31",
      "r71",
      "r77",
      "r91",
      "r94",
      "r96",
      "r99",
      "r100",
      "r101"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "terseLabel": "Right of use asset, net"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      },
      "en-us": {
       "role": {
        "label": "Sales and marketing expense",
        "negatedLabel": "Selling and marketing expenses"
       }
      }
     },
     "localname": "SalesAndMarketingExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Share capital and premium"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium [member]",
        "terseLabel": "Share capital and premium"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r90",
      "r92",
      "r105"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range [member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "auth_ref": [
      "r13",
      "r22"
     ],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Weighted average of number of shares used to calculate the basic and diluted loss per share (in Shares)",
        "totalLabel": "Weighted number of shares used in computing basic and diluted loss per share"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement",
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_AdditionalNetAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Net Amount",
        "terseLabel": "Addition net amount"
       }
      }
     },
     "localname": "AdditionalNetAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_AggregateShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Shares",
        "terseLabel": "Aggregate purchase shares"
       }
      }
     },
     "localname": "AggregateShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_AllocatedToWarrantsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated to Warrants amount.",
        "label": "Allocated To Warrants Amount",
        "terseLabel": "Allocated to warrants amount (in New Shekels)"
       }
      }
     },
     "localname": "AllocatedToWarrantsAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_AllotmentOfOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allotment of ordinary shares through U.S IPO.",
        "label": "Allotment Of Ordinary Shares",
        "terseLabel": "Allotment of ordinary shares through U.S IPO (see Note 3 above)"
       }
      }
     },
     "localname": "AllotmentOfOrdinaryShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleofchangesintheissuedandoutstandingcapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_AppendixAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Appendix AMember",
        "terseLabel": "Appendix A [Member]"
       }
      }
     },
     "localname": "AppendixAMember",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "domainItemType"
    },
    "svre_AppendixBNonCashInvestmentAndFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Appendix BNon Cash Investment And Financing Activities Abstract",
        "terseLabel": "Appendix B - Non-cash investment and financing activities"
       }
      }
     },
     "localname": "AppendixBNonCashInvestmentAndFinancingActivitiesAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_AuthorizedOrdinarySharesParValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Authorized Ordinary Shares Par Value",
        "terseLabel": "Authorized, Ordinary shares, par value"
       }
      }
     },
     "localname": "AuthorizedOrdinarySharesParValue",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_ChangeInRestrictedDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Restricted Deposits",
        "negatedLabel": "Change in restricted deposits"
       }
      }
     },
     "localname": "ChangeInRestrictedDeposits",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_ChangesInAssetAndLiabilityItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Asset And Liability Items Abstract",
        "terseLabel": "Changes in asset and liability items"
       }
      }
     },
     "localname": "ChangesInAssetAndLiabilityItemsAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_ChangesInLiabilityInRespectOfGovernmentGrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of changes in liability in respect of government grants.",
        "label": "Changes In Liability In Respect Of Government Grants",
        "terseLabel": "Changes in liability in respect of government grants"
       }
      }
     },
     "localname": "ChangesInLiabilityInRespectOfGovernmentGrants",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_ChangesinAssetAndLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of changes in asset and liability.",
        "label": "Changesin Asset And Liability",
        "totalLabel": "Changes in asset and liability total"
       }
      }
     },
     "localname": "ChangesinAssetAndLiability",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_CondensedStatementsOfChangesInShareholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statements Of Changes In Shareholders Equity Abstract"
       }
      }
     },
     "localname": "CondensedStatementsOfChangesInShareholdersEquityAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DeferredOfferingExpensesNotYetPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred offering expenses not yet paid.",
        "label": "Deferred Offering Expenses Not Yet Paid",
        "terseLabel": "Deferred offering expenses not yet paid"
       }
      }
     },
     "localname": "DeferredOfferingExpensesNotYetPaid",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of direct and incremental stock-based payment expenses.",
        "label": "Direct And Incremental Stockbased Payment Expenses Allocated To ADSAnd Prefund Warrants Th",
        "terseLabel": "Direct and incremental stock-based payment expenses allocated to ADS and pre-fund warrants through U.S. IPO"
       }
      }
     },
     "localname": "DirectAndIncrementalStockbasedPaymentExpensesAllocatedToADSAndPrefundWarrantsTh",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_DisclosureOfEarningsPerShareTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Earnings Per Share Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. Initial public offering on Nasdaq [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfFinancialRiskManagementTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Financial Risk Management Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Share Capital Reserves And Other Equity Interest Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Significant Accounting Policies Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfSignificantAccountingPoliciesTextBlockAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ExchangeDifferencesOnCashAndCashEquivalent": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "svre_IncomeAndExpensesNotInvolvingCashFlows",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exchange differences on cash and cash equivalent.",
        "label": "Exchange Differences On Cash And Cash Equivalent",
        "negatedLabel": "Exchange differences on cash and cash equivalent"
       }
      }
     },
     "localname": "ExchangeDifferencesOnCashAndCashEquivalent",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_ExerciseOfNonregisteredRightsIntoOrdinaryShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Of Nonregistered Rights Into Ordinary Shares",
        "terseLabel": "Exercise of non-registered rights into ordinary shares"
       }
      }
     },
     "localname": "ExerciseOfNonregisteredRightsIntoOrdinaryShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_ExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price.",
        "label": "Exercise Price",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePrice",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_ExpectedDividendYieldRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Expected dividend yield rate.",
        "label": "Expected Dividend Yield Rate",
        "terseLabel": "Expected dividend yield rate"
       }
      }
     },
     "localname": "ExpectedDividendYieldRate",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "svre_ExpectedVolatility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected volatility.",
        "label": "Expected Volatility",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ExpectedVolatility",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "svre_FinancingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of financing expenses.",
        "label": "Financing Expense",
        "negatedLabel": "Financing expenses"
       }
      }
     },
     "localname": "FinancingExpense",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_GrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Proceeds",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "GrossProceeds",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_IncomeAndExpensesNotInvolvingCashFlows": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Income and expenses not involving cash flows.",
        "label": "Income And Expenses Not Involving Cash Flows",
        "totalLabel": "Income and expenses not involving cash flows total"
       }
      }
     },
     "localname": "IncomeAndExpensesNotInvolvingCashFlows",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_IncomeAndExpensesNotInvolvingCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income And Expenses Not Involving Cash Flows Abstract",
        "terseLabel": "Income and expenses not involving cash flows"
       }
      }
     },
     "localname": "IncomeAndExpensesNotInvolvingCashFlowsAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Units Comprised Of Warrants And Ordinary Shares Policy Text Block",
        "terseLabel": "Issuance of units comprised of warrants and ordinary shares"
       }
      }
     },
     "localname": "IssuanceOfUnitsComprisedOfWarrantsAndOrdinarySharesPolicyTextBlock",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "svre_IssuanceOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Warrants",
        "terseLabel": "Issuance of warrants (in Shares)"
       }
      }
     },
     "localname": "IssuanceOfWarrants",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_IssuedAndOutstandingOrdinarySharesParShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and outstanding, Ordinary shares, par value.",
        "label": "Issued And Outstanding Ordinary Shares Par Share",
        "terseLabel": "Issued and outstanding, Ordinary shares, par value"
       }
      }
     },
     "localname": "IssuedAndOutstandingOrdinarySharesParShare",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleofcompositionofsharecapitalTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_NonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Assets Abstract",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NonCurrentAssetsAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_NonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities Abstract",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_NumberOfOperatingSegment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Operating Segment",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegment",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "svre_NumberOfPreFundUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Pre Fund Units",
        "terseLabel": "Number of pre fund units (in Shares)"
       }
      }
     },
     "localname": "NumberOfPreFundUnits",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_NumberOfPrefundedUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pre-funded units.",
        "label": "Number Of Prefunded Units",
        "terseLabel": "Number of pre-funded units"
       }
      }
     },
     "localname": "NumberOfPrefundedUnits",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_NumberOfUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Unit",
        "terseLabel": "Number of units (in Shares)"
       }
      }
     },
     "localname": "NumberOfUnit",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_NumberOfUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units.",
        "label": "Number Of Units",
        "terseLabel": "Number of units"
       }
      }
     },
     "localname": "NumberOfUnits",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_OfferingCostsNotYetPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of offering costs not yet paid.",
        "label": "Offering Costs Not Yet Paid",
        "terseLabel": "Offering costs not yet paid"
       }
      }
     },
     "localname": "OfferingCostsNotYetPaid",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_OrdinaryShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Share Member",
        "terseLabel": "Ordinary shares [member]"
       }
      }
     },
     "localname": "OrdinaryShareMember",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "svre_OverALimitedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over a limited period.",
        "label": "Over ALimited Period",
        "terseLabel": "Over a limited period"
       }
      }
     },
     "localname": "OverALimitedPeriod",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "svre_OverAllomentOptionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over Alloment Option Shares",
        "terseLabel": "over-allotment option shares (in Shares)"
       }
      }
     },
     "localname": "OverAllomentOptionShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_OverAllotmentOptionHasBeenExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-allotment option has been expired.",
        "label": "Over Allotment Option Has Been Expired",
        "terseLabel": "Over-allotment option has been expired"
       }
      }
     },
     "localname": "OverAllotmentOptionHasBeenExpired",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_OverAllotmentOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over Allotment Options Member",
        "terseLabel": "Over Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionsMember",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "svre_OverLimitedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over Limited Period",
        "terseLabel": "Over limited period"
       }
      }
     },
     "localname": "OverLimitedPeriod",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "svre_PartialExerciseOfOverallotmentOptionIntoWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of partial exercise of over-allotment option into warrants.",
        "label": "Partial Exercise Of Overallotment Option Into Warrants",
        "terseLabel": "Partial exercise of over-allotment option into warrants"
       }
      }
     },
     "localname": "PartialExerciseOfOverallotmentOptionIntoWarrants",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_PrefundedWarrantExercisableDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrant exercisable description.",
        "label": "Prefunded Warrant Exercisable Description",
        "terseLabel": "Pre-funded warrant exercisable description"
       }
      }
     },
     "localname": "PrefundedWarrantExercisableDescription",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_PrefundedWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_GovernmentGrants",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prefunded Warrants",
        "negatedLabel": "Pre-funded warrant and ADS"
       }
      }
     },
     "localname": "PrefundedWarrants",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleofgrossproceedsreceivedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_PrefundedWarrantsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants amount.",
        "label": "Prefunded Warrants Amount",
        "terseLabel": "Pre-funded warrants amount (in New Shekels)"
       }
      }
     },
     "localname": "PrefundedWarrantsAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_PublicOfPerPrefundedUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public of per pre-funded unit.",
        "label": "Public Of Per Prefunded Unit",
        "terseLabel": "Public of per pre-funded unit (in Dollars per share)"
       }
      }
     },
     "localname": "PublicOfPerPrefundedUnit",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_PublicPricePerShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Price Per Shares",
        "terseLabel": "Public price per shares (in Dollars per share)"
       }
      }
     },
     "localname": "PublicPricePerShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_PurchaseToAdditionalShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of Purchase to additional.",
        "label": "Purchase To Additional Shares",
        "terseLabel": "Purchase to additional shares"
       }
      }
     },
     "localname": "PurchaseToAdditionalShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_ReceivedGrossProceedsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Received gross proceeds.",
        "label": "Received Gross Proceeds Amount",
        "terseLabel": "Received gross proceeds amount"
       }
      }
     },
     "localname": "ReceivedGrossProceedsAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_RecognitionOfRightForUseAssetAgainstALeasingLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of recognition of right for use asset against a leasing liability.",
        "label": "Recognition Of Right For Use Asset Against ALeasing Liability",
        "terseLabel": "Recognition of right for use asset against a leasing liability"
       }
      }
     },
     "localname": "RecognitionOfRightForUseAssetAgainstALeasingLiability",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_RestrictedDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted deposits.",
        "label": "Restricted Deposits",
        "terseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "RestrictedDeposits",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_RevaluationOfDerivativeWarrantLiabilityExercisableForADS": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revaluation of derivative warrant liability exercisable for ADS.",
        "label": "Revaluation Of Derivative Warrant Liability Exercisable For ADS",
        "negatedLabel": "Revaluation of derivative warrant liability exercisable for ADS"
       }
      }
     },
     "localname": "RevaluationOfDerivativeWarrantLiabilityExercisableForADS",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_SaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale Of Stock Axis",
        "terseLabel": "SaleOfStockAxis"
       }
      }
     },
     "localname": "SaleOfStockAxis",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_SaleOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SaleOfStock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockDomain",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "domainItemType"
    },
    "svre_ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In The Issued And Outstanding Capital Abstract"
       }
      }
     },
     "localname": "ScheduleOfChangesInTheIssuedAndOutstandingCapitalAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ScheduleOfCompositionOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Composition Of Share Capital Abstract"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfShareCapitalAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ScheduleOfCompositionOfShareCapitalTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Composition Of Share Capital Table Text Block",
        "terseLabel": "Schedule of composition of share capital"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfShareCapitalTableTextBlock",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ShareCapitalandReservesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "svre_ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of Derivative Warrant Liability Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfDerivativeWarrantLiabilityAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ScheduleOfGrossProceedsReceivedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Gross Proceeds Received Abstract"
       }
      }
     },
     "localname": "ScheduleOfGrossProceedsReceivedAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Loss And Number Of Shares Basic And Diluted Abstract"
       }
      }
     },
     "localname": "ScheduleOfLossAndNumberOfSharesBasicAndDilutedAbstract",
     "nsuri": "http://www.saver.com/20220630",
     "xbrltype": "stringItemType"
    },
    "svre_ShareBasedPaymentWarrantAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment Warrant Amount",
        "terseLabel": "Share based pay (in New Shekels)"
       }
      }
     },
     "localname": "ShareBasedPaymentWarrantAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_SharebasedPaymentToServiceProvider": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Sharebased Payment To Service Provider",
        "terseLabel": "Share-based payment to service provider"
       }
      }
     },
     "localname": "SharebasedPaymentToServiceProvider",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_StockExchangeConsiderationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Exchange Consideration Amount",
        "terseLabel": "Stock exchange consideration amount"
       }
      }
     },
     "localname": "StockExchangeConsiderationAmount",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_SubsequentEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events Member",
        "terseLabel": "Subsequent Events [Member]"
       }
      }
     },
     "localname": "SubsequentEventsMember",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "svre_TotalIncrementalAndDirectIssuanceCostsAmounted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total incremental and direct issuance costs amounted.",
        "label": "Total Incremental And Direct Issuance Costs Amounted",
        "terseLabel": "Total incremental and direct issuance costs amounted (in New Shekels)"
       }
      }
     },
     "localname": "TotalIncrementalAndDirectIssuanceCostsAmounted",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_USInitialPublicOfferingonNasdaqDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. Initial Public Offering on Nasdaq (Details) [Line Items]"
       }
      }
     },
     "localname": "USInitialPublicOfferingonNasdaqDetailsLineItems",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_USInitialPublicOfferingonNasdaqDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. Initial Public Offering on Nasdaq (Details) [Table]"
       }
      }
     },
     "localname": "USInitialPublicOfferingonNasdaqDetailsTable",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_WarrantDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Description",
        "terseLabel": "Warrants descriptions"
       }
      }
     },
     "localname": "WarrantDescription",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_WarrantExercisableDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant exercisable description.",
        "label": "Warrant Exercisable Description",
        "terseLabel": "Warrant exercisable description"
       }
      }
     },
     "localname": "WarrantExercisableDescription",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "svre_WarrantsExercisableShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable shares.",
        "label": "Warrants Exercisable Shares",
        "terseLabel": "Warrants exercisable shares"
       }
      }
     },
     "localname": "WarrantsExercisableShares",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of warrants issued as result of partially exercised of over-allotment option.",
        "label": "Warrants Issued As Result Of Partially Exercised Of Overallotment Option",
        "terseLabel": "Warrants issued as result of partially exercised of over-allotment option"
       }
      }
     },
     "localname": "WarrantsIssuedAsResultOfPartiallyExercisedOfOverallotmentOption",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleoffairvalueofderivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "svre_WarrantsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Per Share",
        "terseLabel": "Warrants per share (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantsPerShare",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "svre_WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_WeightedAverageShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of ordinary shares to be issued upon full exercise of pre-funded warrants.",
        "label": "Weighted Number Of Shares To Be Issued Upon Full Exercise Of Prefunded Warrants",
        "terseLabel": "Weighted number of shares to be issued upon full exercise of pre-funded warrants"
       }
      }
     },
     "localname": "WeightedNumberOfSharesToBeIssuedUponFullExerciseOfPrefundedWarrants",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/ScheduleoflossandnumberofsharesbasicanddilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "svre_riskfreeInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk-free interest rate.",
        "label": "riskfree Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "riskfreeInterestRate",
     "nsuri": "http://www.saver.com/20220630",
     "presentation": [
      "http://www.saver.com/role/USInitialPublicOfferingonNasdaqDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.saver.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r1": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r10": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r100": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r101": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r102": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Effective 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r103": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Effective 2023-01-01",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "bc",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_bc&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r104": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r105": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r106": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "82",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_82&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r107": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r108": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24"
  },
  "r109": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r11": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r110": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r12": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r13": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r14": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r15": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r16": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r17": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r18": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r19": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r2": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r20": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r21": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r22": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r23": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r24": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r25": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r26": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r27": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r28": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r29": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r3": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r30": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r31": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r32": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r33": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r34": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24"
  },
  "r35": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r36": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI",
   "URIDate": "2022-03-24"
  },
  "r37": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r38": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r39": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r4": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r40": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r41": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24"
  },
  "r42": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r43": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r44": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r45": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r46": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r47": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "A14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_A14&doctype=Appendix&subtype=A",
   "URIDate": "2022-03-24"
  },
  "r48": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS33_g70-73A__IAS33_g70-73A_TI",
   "URIDate": "2022-03-24"
  },
  "r49": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Section": "Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS33_ex12__IAS33_ex12_TI",
   "URIDate": "2022-03-24"
  },
  "r5": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r50": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "34",
   "Paragraph": "16A",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2022-en-r&anchor=para_16A_f&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r51": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r52": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r53": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r54": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r55": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r56": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r57": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r58": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r59": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r6": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r60": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r61": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r62": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r63": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r64": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r65": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r66": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r67": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r68": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r69": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r7": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r70": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r71": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r72": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r73": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r74": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r75": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r76": {
   "Clause": "ix",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r77": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r78": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r79": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r8": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r80": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r81": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e_iii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r82": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r83": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r84": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r85": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24"
  },
  "r86": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r87": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r88": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r89": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r9": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r90": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r91": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r92": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r93": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "9",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_9_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r94": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r95": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r96": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r97": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r98": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r99": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2022-03-24"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>45
<FILENAME>0001213900-22-054910-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-054910-xbrl.zip
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MY:3\#1C7!I'GQ=-Y,E\^5^@%G@9^,)HI*,VPM%Q>3X%2+#S(Y\S]>QB<ST@
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M>)TF*R:YFL@<GH)OR##,\@@>4C3S=@MG=_KN[#P04L-XNH3G^C.:].G)^:M
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MQ"25N7:]^];67G\(];L[5_F]RU\0V1EC&[?8-5_*ZYFF:]>&1)T1K+;MU7H
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M8"K]5+#W0XHJ316K4\E*,97L\%/)$F52Y3@+VC5<$[*O"#,$G__D*;Z+)?K
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M[2YL.>F\:(@N[FXOKV['5Y=H_#AZO/KUZO9QC.ZNT<5H_#.Z_GKW^WC'*/H
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MZ4I\R"&Y%()[JB)-%+5XHZK04)NCG7V%-7WE2R+"./VQUXEVZY<M3IY1>R@
MB>\NV:  ),;ISUM"7V%@6D&V 1Z5=5C'/I&"IVR\M]!,;)2)84,R8F/M_> K
M=*A(B6L*<W,R!S29CXA7!SNB@W!7W7;.N8>J$YUYQ"SJI,BK.-Q>Z+L-4B?3
M3^J>]7L+2T<0*B LW1>B77K)&MJ7)R1M/Y4> J;R'^CE',$PWDO3OL*7'9+?
M6*^IJFNJF KDKF&;\.$ZQ"*CZ@_X;.D?D.G]3*3)#@(ZQ2DCFQ-X;S20I"--
MAG^NUBL,44?:S6XJ?U )XI[9E(,TN NJ6A>;@WZ: $B5_4%YXF_8/-U-P5R=
M-E8#4[WC[.IUR@XT68%P(LRH,!'LYL,[T:[( J?6W<Q>\H-D85YQ>I?X<!.:
MI[W*1R"[W<I&((/GG)8W%Z"T4JL&YD#D>6#XZ$L,6Z6))OA)T31PU4( W+=G
M<O7<^\6-WTMZ9@R;_6&.#:@.)5X51B AV\#*Q";KH-D7<ZQ,K$E4*1+5RD$-
MS'M2#KKQ50.LR?&5@E('F\*%V4YE65=HM@=U(# F;<2=TD;H-H<IBH??*6VJ
MH$CO>ZRU]^7.L&7[_?7,ZDPSJ^..H+9V-G3:#6;LT:,)QTBCPQDCW:_'2/N,
MD>[58Z3K,=)TO3M]:3TI^AU.BDZ4&E3/?B[+[.?RC7[>,2/5PYQ+,][X?:UV
M#SLD7YE:CV=VT2:.H_F@)RW'2AA:CYE$+93'Y,JX:X[MO$^(RW(]MSB14BT\
ME ^_L7;'C3;5%\SRL'MF@?L&FK;JZC,P_GI+5!.!^R9,NF!:V.3PP)B:;P0.
MVJ,1\395)' Z![@S=SVH.3QNDBU OSFF<[WX*\;A(;'ZC'.P0U%1+AR?[@O'
M8G06ZH'@N)/OW.<$..[GR,=9<DRR2J[10B>O^@]=-,0/*-8!BS ,%DFFB:U0
M(9\]S6)W@HJMU8RYB<H[0&=W8B<1QH1A=&R\C!C+58@DPECG-&N]0+$J4E;A
M<@/6.C8M6_'UZ9NUYV9U&>6+NUO=F-#8O)O9:S9OM)%IZG">A'9V*FTU9)%2
M)CO>.FEZ.>T?;QEE37:\Q=!;RJNLC"%RUYI(T$?&[LMGZ0@OEJK^AC'KD6EB
MXUF98KOUC+'7\K2L\H5W07O41YI\IWW!<TF=W<VN[ 6'M$B-T4VDC!LDJV!)
MC3"QV8LQ1ZJ,*,LJ4U*CK-/L= ];@;E4#-!50*PH4( .B(+VGW:_WJE.E!M)
M5?6I9#$W-Q$XRC/1_IZQW:QWW1C4Z=K[[7B,;N[O*BR8O$KO=G'^HR')&/@)
MFKP3#H/<A] );M&YF_O:>G'+3RL[@*";=@#!/E6!!_PLJ2O';1&V[0I&<WC7
MBX+WV:6S[FL[W]/5*C4D73K#A-7],VSY9A'$A3QM?^]R'Y-).T94;T?2R>SV
M,B_7JPSH$I%_DXBR[+U>VC[O^X<\N!_P+H^YL"K4V!N.]R@!?]I:N_0ZUP('
MR83F-U6VY#C]KN:XO-'L@_/M1GM@>+R;;8XL"=G80ETDGGIKBG6K[EAG5RI3
M/QN7!S51$W)L6[&3(5T%B>)WP7?II2O+?H(!X3SWZ5:W;NS,)Z<1;PR&ZYPF
M[[5[P&-[\W>BIB37IA=U*.0X7OE -E=!,CTKL3K-?IZSL,OB&MJ)U1%]8<D[
ME90*F&)/_EB-4%(;8#1'BGHY7*:8A1=%QQTK3_12 ;-/@66[<]$'A3MX/P)C
MZ1 [0=.588 13]FLRK'LS61+VX5M_TM#12.ZRK!!:*4=HAJA0>>;#1P3>4&Z
M]*!ZX^1R3O7-AL!^=U#66=0%"2,+ KK(@$'5SS28>\"2B 6OIU/H%_/@K#C$
M]2>FX8;])XX4+).2H[&L6-RK9(I&8X"0$KH9@KS[U(?LM8/<4;1G<I-N'% 4
M?YO$-WR1X:/<,DPO/4RE)Q;:Q'X94QWV*E%BX6T0PX]7417'D2\?9+REXBQY
MLMKAR)N@[#QVI/#DO)!CN5^] =ZY"IZ,^.NG26TL/-UC9^(G,?8"M)E>UD*9
M$J9QN!4=K[='72?Q'7;THV!)1\WZ"X;46(F18HHIK.\Z?%6PJ$U,P)X0[=NJ
M";@[:9^8@$)3Z$6K["4<KAY]2'2+2B^I;I?PS'E[BD:]MB--=C*;PB:%1,_-
M?#_MVPO0H1-0)LAK-<BMC7MDED^%J9,Y$S ==<08'0MV-_$\WTP13[K 04S2
MKM=4C375>DGY!&Q&PS3NO.HOM U_R!S:.$=F<G7Y($_,(NW40NBYF3O;CQ&Q
M>S_J:9%6ZP[(V6EV>M%Y 1DF$F75F/B<G#J]]N"!J5QZK=-1^@MJH5M=:]$"
M8L@%8*XFFF[+)QS%[QQ=<T*Y@,DBR I@NM+BJ0;F@ RG!SS5GXBB$-QO%4E/
MDJ)!8R'$.R1N]S*IID(7MQRX$[L<^)UJO^E]LR[VNYL]P*NN=>.;B9DSD#'>
MZ"MCNQ@.]5ZGMEB*M%@J1+-B\RM22-I+/,,&3!_1H5T+B%'/_(4W(FF7DE+Q
MR=5Q16JW%JGQD=6KD564++,WY1W?DZ[2Y3^P=4_V8\AL]'8AP[<KJ$0&]*4T
M+7WZ?:,_KB/S/&TJ1Y=C>O?2P*T968_=-<]T]Z@\=C>I/#PF3I]ZP- _TN2;
M-?+'@'N*>MY0U>;LD8WW1YU@G=QT;V! ^>\<XX_S8(X_[4<G_;\CD117?@>W
MXJR1M86LX.Z?AZ $VN<,;=5[2(I?,9+-1M<%8"O.F2P.:PF58M,%=S"MD;6%
MK."FJ>]#V[N7"(!$O<.OV)@J)@:_(71L:X%*Q^(A^I)* 44CNIVMRE6;.8J1
M;QR55QR3=[,[@D<'C7<4BS<$B;9R%I*F'*.-:[V7-_=R/[A];(VL+60%=ZS-
M(/A.+*BXHD"<-QH-_ORE.[!VAH0V6<*CLB!VXRU^00_Z0M*:[(LF&A,58?8)
M+23C2=%:EKXDL@K>S[^P86IOPF1/;[:A6MI [ &&SY/SQSE&TG2J+Y:2]@8J
M(E$.L=F0#!C6"J(4/Q'1 ,*6"%5KCHG@G=E-U@FDQ*2C50_'GT\FY_M=S!9"
M;2#^J]5"UPI6Y3-T+ST1;ASCOU?0N/H,#3ZAWR1U!0F*J-7B-])=PFYU\:@;
M+D'T :P/WT5/64^#D^WEQL+3T?EUR[UZ>]V?T./;DJQY9$@39?H)W9*C@>'F
M5@<T]-TWG=AW400!=AW4!*%J8F#I>VM"LX;.R'D..'>#V_<!%U#J1@[[F2_#
M15K_E[OAA76LB5D.5MPA#$SFD9T]'OUV]7!W>X7$MM!%7Q\OR[A'7?3\+"%%
M_O%(^K/=[I$%G$CG^Y&(MW>/5V/T>(<>?[Y"%W>WEU>WXZM+='US.[J]N!E]
M1>/'T>/5KU>WC^/](Y3 ^P&>>F,:$E85-)[C[UBE+?FLN;XR)4TF;\&O4TR
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MX'"H8*Q4;*/Y"3+YW/DR!%H'^Y:^_4IW-P,**+^BL0;3EZKQP'MBKB<5$FI
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MWK71E2WM:]Z1!G:=;'J:JZ,>;5?)YE:PS3=#GA#:AC^^UL\"]U&^=1Q"-S)
MG^-&M&VW7/?V3IRPH=W[1C0/N^%N>K;=D7+*XQD0F-KH)\H5'J<#Y=3)Y$-T
M@)P*\RO.$#0TAGRU.5[O':J-NGMNZ8T)=FLJ5*M9:S.NT+*C96R/@^.]\=4W
M]Z%.+EJ !N)2"6BMK63W-^=!-J9P-#85CIF^,M9=NV3IS<Z),]?+:;)^O.ML
M=0_FZ/>\Z2&HPN%$82HZU4CA8A:SYGI[2"X"5;GL^!%/$*3AHQEO.DL>8[U
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MO[?@9H$=U.+1@(#I8S ;G,VZ.>2F@<6PBF\50)Z<F),ZUFT?#V+6)BN:GZG
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M-@0YFSRYD>@&8KI-Q+3 Y+2?BSY'D;T^B_C3&_F?12C-6=3(L+#CS8,(W4"
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MQEM8D8Y<G7Y*>O%58DJQ&(2BZN[V*C_$F$',RC*H$BNA\ '06\@JQ'A+1^G
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M')33CT8V>(,E@<2+;;)4$>8?*RPSA.I=KG['(TV^I-#8+9TO )81!R4X4V1
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M5??-%L@WGNY*0A@KKXCM%1ZZ8-N(P4IWCQT[1\4!8>]/)TSO@[(,D9 8'L4
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M719B]79$[JOJ!M.0GYA% WAGSA(;73!;]N^58C#'"NV I1$*N9[06+_I$UP
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MD.5S3!0)@Q]?^1P&X!DS\!QKIO*,"?'T!<X;&7X$\1'[>4 2!8H?4O8G\*/
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MOQ_:@HB/EW6FT?+_3G3YC?PSMQ;J^?\/4$L#!!0    ( /-%*565E32NZ0\
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M7MP1T-^4E EM0IW3^BD!S@BTD$W)(MT"78?PSA\J26H9W_(HI8[]D?].#N6
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M;&_$1G<<RY;D^^S,;I0ERZT96])*Y>GM=4QT4$64Q#&+K"99LM1??Y  [P1
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MI]$JWM#W]UL:I91_ZI(&4;I+X!^/XBA+O%66_DQ#_Y*NXILH2*E_&@GDSA-
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M4MFXME4$[40U%4*]R$UM&C&,,5$CI0G<Z6$397^5, CSUAO/HWT$<[,:&UE
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M_"T]88OXG$)RWCE3JCU0M1?L:KY#*O8P#"V< A"#<%2&:J6W9,V@$) B$A<
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M]&!1\]-?YH$,R_A"A#$T#&;&X50*29CVBX[# "=%7A534D:#D#TR18 ):J#
MHPA8N1NFY\=D$2<'E@59#EZB'XR]]5CP#T:#8BP'+\<<C*+, [26O6<BEM+T
M+,Y.H[LXO&.R4TK4H)-O($A7T7$6N"F;RP,0T5XX!T.B.(- $0&H=ERAJ-,C
M.%O*F06E)@S_9.?^*O# 8I1_WMD;L1\3C,".7JR4/8RKD<@O.V,6ZP,KY2NW
MC[9KPE]LXB0+TAE(G@P3?,F38*52[_C(/_A(,'IS*S=9QTG5-A??NFW,?)U,
MJFAB+Y-U"SJT5$K/UZ<1. M2R"99I&D,6P#)<:Y%"-F;J,-->9F+L<55WJJZ
MFW=DQ!?5H3*A]LGT$LG>92C2.]-E#%WZHG?TU@O7Y^OW1::T.WGM0\1]2D8?
M2I;)YUP+;2<(H_?O,A6$EI":D&B".B_%P=U.>#^-&ATFG3<9M<,.7RDPQ%2E
MH@8)G+4@QP$  JA>6$5WK&)V.#?REIF$!W?LNKVC16A'U:^EC/'X_/2*G%Z<
MHX<TC1(YG=HQA.I6D<>YM^2T[ 7Y<!I=BIOQ?-T.IC*R# R#Z-#S-AR[_BCY
MT*+9HG,C@16/2QO!<(I-TG?QP+)F\,$K=)-C;\E@?).C0;W@@U=C3(ZEU"S@
M$<C.JTIZ,KH99FLTA>66[X98]9\A_)G,K\;::0(@\,R* [G7/2L,:#(F_L0H
M$9?C,+/4\1PG?'5.BY_2SBC&0GT^\=-/(+]QH\<VEV;TMXF%@%BD>M>H-95M
MLOLEH?"M5O$NRJJ4\MF(M0(]S$*60Y$=)NX9P&"Z7IG<CQM1/DY\A@F]AGS3
MG>;=)T^]WS=&PU-;_!#LI):HJGV@8@=T3GG\1M*3B<^PY[>.@-.\>RQ;*!R\
M1G_W]'90P'_W&+1/.'@];4RA90N%@S?H_.SMH(#/3X/V"0=OIH@I? ==Z+WT
MMDKW9Z\;XW3NGO#!P<"=AM/88MD7$OB.[!$&<H_'T=3KK["7<"=7>RZA?[9R
MT(GRLZ+F5''KEA6D#MZBGTF]!:3PSR2#ZE$';\><24SUCF\@NS6.SM>\_"13
M53ZG5!A=;KP@2K-%WN2^-, 8<=P.LO.R8E9HJE/E"UB*"!;B"8C$*P(%*D,=
MGHENE!"4DFE/22MOTS%=4Z8Z^^=Y,G8M[/!7FEUX@6\DI@9@W)Y3_0@I;0QB
M8IF>W@PV?8!\>#8;]>HS9UHI5H;TL#S_A#.9UUXJ7<F\YWV]_'CQR47A5%[&
MB^,K-NF"2=8N\HO\^>6MF<A-_$W'\CDM]L.<_"E\J!7=4DJYM%9Y4>.A6]3A
M\].KIRV/O_/M\#C25^V=1^"5Y48KMN]1G&9#SVC57.?*@@(1A0P7HWE$BNH0
M=BUR/7PH14>W5*O[^L)+H(9*K< #=,%A,L<?+*+: U0^E]>[44C&8*#.168H
MA@I9RL&PPZXJ"P+Q$GLE*!)S6*(L2''8H5[VMAPO9="*=B/JZ#)1/U_S:%=G
M_H#Z-R>,7WHK1#.B-W"@Z^W\-114 08040</FG8/>9Q2=UTVM>K8M18T(LWH
MDJ:4(0>Y_\=L\6&\K=V8SH1$C\641]H0N=%BI7PABSFB8U\UJU3BGI"HEN>!
M(E]&/&]*7#\IQO@TN20ST)^\Y"O-JB>0,_E3(H E>BJ$5#'Q- RY_9<)W::8
M4HH<=GQ)'WN;HJ9=^B@I$T3Z0".X8]D7%OXFB (P,D+DM'.9,T-GNNBG0?)G
MA)Q"&O-97!J]QCR)2.)(Y"!1:,FG.6FLGA&E6T,JD(IG0F?25$ZO?J&1?E\A
M&>4PY+-)2^A2.Y<N:H2NI6@G*:(DXBA+@NL=+PGX[N'\&Y,N]!:F&LRP+L;!
MF#[:<Q/EX+(6(:/&ICU4'!7=SO,@&. 58W'1$<#H:--,=WS(J3'1QJWGV2[Y
M%&F#")R0=1U+6E'JRD6/J8_.^'/K@=7C(H'J1=G#!:,>&'.A AU_8-0+4DM:
ML3@['R= %<GV,1YSU0&: X:#<YN#%@5@"KCHL8[3"5@K*W<:FH[9.GE>\/F:
M']FBK>MIQ';HSFU?H%Y$W!W1YD@-=B\COU9,N2W/'==2853N>/4%"'J@M0C?
MV;2WL,805VX'8JNT118>9'Y&!VS6%O+(.^4\J"Q&!UO6+65*M0EL2/JHE16.
MRYS]_/->.,=\C1XT,?;).)25F^7."W=E<29=105TQ68:T1J6RV% 5-L*FD5!
MZN.J(+>B(+71@W$ .)?&U8&X352]'/.5.9ROM?;Q@^@TX4'=3>0#_3UB /!.
M93U..!Z" 1@:),P%^6AT_<-"&(:EA;;I,E4NM*KXC4A S6O?S$:KD.&&9"&Q
M0+5/H'_T:2<'>IM7'YI5S=%!0F-3>JE+MA%6#U[Y[2*AFV"W^40WUS1Q)L^2
M3V.4I>BBH2N2QW2!;9#ECMBMF(5?ME'-Q9:?5;Y6^_,28EB2.WJ^YI#K <*I
M8VGJQP1#N'JQ4K:.%5*6B/DM^T+:+=>(_GXREH1N$%0_@<8(:.8%$?7?>TD4
M1#?NI5+Z>?>%0>6(J#)D5ZO=9A=ZPK6V#E9!AJU#ZOG8EBGE6FV?TV5K#)G\
M]/5FJ9\_&.U5]+RN&J1\$0/_@9;*JJ!RMT%)DZ-V)\-QD*[".-TE[/#) X].
MHW6<;+B]:G$=[[+2*G.5L;W #Z7W]UM&/@#\X.P0&8\I0B&8T4CK ^'0[[O)
MQ*=Y=DU#MDDVQ=5NL_&2!_9#<!,%[!8 ?ZQX?+!3]2(.V;U T3?$<"Q1>BV.
M0EGU(*FF$Z^<3[8Y@%EM$6MA4F\/.S*.>"L?TW25!%N1JP[QBQ"Y<[K9>E"(
M]E1T^V97%/NN)\:<T6]LCT:^E_CI><)+X;,G8^:Y;6X],=H8SZAIEZ#83B*U
M5]ZT'=P!9U[J>[]C*\*/(X2M738]N>U?</4M?TROLRNZVB7<089]]:BQ<?^^
M,\)+=8^L;JF_"WG8V4T2IRD$G_%&'GF52>K/ZB[IE0+UG:$GS2B75SL8PIE(
M=CZ,HN"TL5 &A!G$ *!(F(I_36&2+G.,3E$3SA,O2/[NA3OZB7UD)THOG*]K
M'\,^\ 8AB*YF#\'6X&1<,W $XEFH>2P+^E%I(U+JTW,P1<<D]J3ICJ:R+V*<
ML6;8N+_VC? R*SS6E.]<J*G/6^2P_WD9$<WN0>2/O8PB2_D@^6AEZA@3S=9<
M7-26X%_R%^DE37<AVRIYAE3X4%2G\*7E*8S,RV._X;RHR4B$%5)<0"WE%)16
M ,P#= O094Z:KTQ*0\R:G$A<2COY%)2>YL'&O7JY,S-W]:5%[Z@B>EXT",36
M;>PP13:L6R%M'-Z0.Y_1$S0G$RB-+=&:D#8UUPNU\GQ]%&]XXA^WHM216$)P
MSY+>9^\8G*]&%\)PJ&YK  [&ST I7U60RL"(0H;1W)C6["T/<#M2C2GD<;8#
MCVK^B72QRV[C!"X(9V>Q$@&<1BXJ=%1>=#'@#^H_(>>)'T1>\B"D,7T"6DBN
M6)^=7I']I_L'A'JK6^QCM8_ES=-22Y#I)$^H+$A2EW\<X5*7X:&*B,WU7'9!
MQ[LL!;-[$-U8B-T,A*[);9W U4@R\2N;Z;_7L2U_]E4,(G&3'=\[U??M"N]4
MYV(AG@(P>XGPM[=9(%4?$'<N22-\1MT1>$5>37E5A6.9T,'6A)*_79D.7AUR
MG<_P'XQD:  XQ])DCMED%P)F MMPOI;R-I!2H[QY]<>A^&ZN=V/;*93(H/M;
M5)B9/..J9K3LQ5V:\IH2W7G7S<(9W2<<:IN#EEYVC786I2%OW=P89O>L<K;S
MT&45)JJKM;+EKMN:5[UT/U3N)S^FE*G$<4;)<^)=QW?T)]S&3GT\J^Y;+54F
MB?DL0N8OJ#A(L4\['3XXA@%#[!2"^I%'U]!$R.:\3C(#WJL/LSY2C+$0U+\C
MWB=,!_B%0K,@I@Z _^*&7M*-%T2\]4#$.USMH);"&LJ_5S<(QTSX.-!C*1YE
M(>@ZP&.LRD!_"&%;@;H0\>^7IN"47'MIL!*%PX-PES4BV=!WW&,*LWJK/AJ/
MQA1?2^)UD,'IN,A$I4QNWHZ+>T[X8'Z.0Y_)(W=D0JGT*.OTE7O,PE<C<,2Y
MJT9@K+N_O!R8Z)D$"CO?;+<"#FP^^!MX+KSH@;>RV^Z2;0S=EG*7S8XG*L"H
MSOX4>[F\(J'W.3FCW\C5+?U*P_0G7$/:!'+:*J8UDD5C[M41WSZ-5N$.SH-C
MX!J4Z.:Q00ZKT#T"[AB9#8^P#E=;5[YAL>_71Q3JR7:NEG/V@3?=@B&%-;_Y
M7'3L8QN(%HH..PQ'52A:KD]UM%#L/6$G&/KRY@84LK-A%51L>J*6\3LJ0'_>
MQM$)PZAJ\)6W'*3^H"YP4WS'L:M@ I2'BBY<$]>E17;'/D! '!HU_HMNF=27
MMI!S'DTYG0!5$94347XRGT29!'X9I%\_L5?8#<V[1^%FB/2CA6ZCZ,=1WVD%
MRO*PF63-GLAQ@M8M<:Q<:-(\S @T4=;3>ZC=ER[6C(N7=!LG/'F;)D'L8PNS
M&68S,$.;X*FRHNVN4_K[#EPG @RVKF(M&AK;M#%]++NQV"D@CZE.&);.-54/
M+CHW/#?9+(ZO\,)5^B_MR:Y@#JU6S!KRB(OTOQQVD3E4I%; 6_ D3AB%C&3!
M&KCC=CVV>(XO$%YHG "3&R8:PN=<^L9*0RFDHR@ZX@KFM?IIVGZ^+>X#AWV,
M-3A,'.49:F]3#2*J HUBABS>X(O'IOT#.3W2@+VM_L<])!C7U22)_=TJ@Y2:
M*YK<!2O'@J;Z_N3O=[V8*=!07KIB-+]JTWQ\1[K0K*PZAG8LI<IECZCL"2%C
M3J6H^N(CZ/QZR2D_K;I(>?^"><A&AS&MZIR-I8S*'(DCCU?,AG:B2AW?J8@,
M0,GI!6>.ET+ &("]$@*A' 3Q  9)"B#@!&)0NF*(E/0P6#Q:J1##:&9Q0>[2
MO1O/V_[6K5JWN$YY"(9&<-=>>LTIDT/A<ON,AEE:_(6_,[B &GS(@3CV8Z&N
M1UP4-RQFD"_%')1RM>:< YDR7+BE]:'TP[#MYP'P*WJS,6WLHYSL-C=8A89"
M(,IA3"_BXU =#GT,*-]ZVE6.N0EK!;M%;]GT-"KKF]0,N@NFXF<M?W4YX2BA
M?I"!S;<SP]G]^>@+0?$^//:J;,JXXW1*<22GK;8J+L@_PA13PR_O%K[9)O26
M1FEP!UV.XHW#)D,&N"#D1QN@I3+4U$?R6"5\A]T ABLE64L&JZ(D6;SZ6O2(
M.XH92)_?4G&TV(#68J1.] )Q'#'1AX_**P;3""WZ J[J$XG'9V(J'*:LJNJ)
MF)#!NC>&[_/Z)%YX1K,!LB*;YU;KE&"@NDKSD22BF40 W">-J6E>I8LI5C?R
MF?$Y"H8]+?@$Q_N^_FV51:.,=-JQ02D/-!<V;Y08<R6-.Z^'<DVC3/+O(/"^
MR-J"*-8B<^N$H0/>\Q@>JCMVT6SSH\+=*\ &-Q3%W@)1U8NV*#2_38(5K<*I
MA5P>QV'H);4H:^0TB!'"TU1H; EH%UI:[* +!G\7^;"1S$(UI!-=)T7+D.@]
MVYAZ2" (0G/(X1E,9'SH''>=Y5HG.E?M-9=Q%;U_$B<0*"(Z(G/:' =W3#^*
M?(S6Q*:8X42=#<;3[+2K'7%(8CF!D*A:N0ZAE*5J]@&:-ESD/1N,#K3F#.>E
M@!N?5S7Z:G2BP'QN2<E;GE/=M5A5RH(X<H_A<;X>%$0HF>:<FUT<-)6*8&"M
MP+CB2L*H2B2G?J/ZD&255LR&HLM0S:.JN3R@3(MRLMO'LPH-!>^E-;?K.B[V
MVZN/)Z4@:!<^KLY%?A=<>$&[I!J5U3I[U#CX?EQ0BE_WHJ52.1I1>I)::$C1
M[L8L;\>WFQ'"6EE6Y_N)K]1J0C@3RB$X821S#\!/U1Y)FE.-GI1A(0RFV:-R
MREC=JI=YL[*&1C; (*V;[]A^J4%%W<V%SVAW<,/W5ABPI18-KU^WK8^B;CL=
M9O*IVWJ0#-C]5AYNW$%U2$@)+#5=CXW[+:K+.E>).A]&,3FWL5 %CQ?]2_DM
M O+19TC&NEM4_&S%D,N6;5E@0#S?:ADUM7ZG1F>#'H+;9Y@6%WW/I$9*E5_-
MPGN&&[&FW>9(L_21KLXR@=#*4U"?BN3^;&)AXBPHTCSG<Z/(F2!S$[27:JLL
MB+.3@:1) ZJ1 "@GNST65&@871<M.>B_.9SG_O9PJ$H!UI%AHFSO$1>)(2CG
MVJ<97N;)XK.[:(;Q4)E1WG/U6)P\R>J6/8^7<16\,\ RK)GNJC5I#Q[*XT=,
M@&I#7CFE8_QP?\STL:-VT&B7;*>IBM/K GRDA=YK*@B2B:[C%61(Z*^?H;$O
M6!>/G".M2T>R<)NPW,+95#MJ!@B">K9K:5!BTM?7M7YW=*RA6"\4-3LZ35CE
M"[81A:*X&)<L(_8W9SA7(QJ?5_"Y&-,-!9'N>-?\EM*\Y'%W@?;NX(_!)LBH
M+[)*S1W!S6G.6=S%0>5_8P.)1T(Q-$\5QG7V2BG>=/-V5S;*WU]KLORSE[ZC
M-'I_OPV2=C'6'L>_&@H.^W4H::2A&PW %"ARS>:R,Y]/1KSHC3G6"0O0D\)*
M?/*KQ-),B?J2[.+0=]_7WH<H71-[*-Z^WR=Y]W'%X!U[/O@7W@/(3PY\2.:5
M'H1K=4^/CK8%^37,(EOO05W['^% ,&-1E7'5OWX[%7!+5^Q"*L(_?@UHZ%]Z
MF:DZJ)KM6CR4F"BU1#&>^/D$\@ S2,*FH%JI>QE2TQ5U2P9A^/._[.V1+[]\
M^OO+?WSY[]5V=_]K]/*M_\?KNYM?'Z+/Q[MO'UXG;U__[?"?GY</:?CZ;O7'
M?OC7[%EV1?_ZQ^OG7^\/5A^S_?\Y.3F\^MNSN_MW1[_NW_E7R:^7Q^FG%Z?O
MO5]>_=_EP^^7+^[^^<P_6M#3W:OG?V3_]<?!/P/O_>G)X5__V__KMU^>7Q[]
M'AY&N[^]?UC^DKQ<^']?_7(=_D]&O[T)/H7/OQT='OZZ^_;S:^_MY[-O/U^>
M?7S^X>3VQ=?5VX]A\G!Y^O?SC[NSF]7/'UX<O7Q[O!^>G9XLD^CVZ.'WD]OM
M\I?LY.[PVS)\F3SWEW]=I'_;7AZ<7CU\VJV__?/-I\-7M_=7MP>_[O]"_^O%
MP8>#Z//+W8?#@_VW)^G'\S]>K%Z?W/SE+_\@1U>7>WL66P=J]JX32D\C)IHT
MS8QWC72BZPTC0T(5"<*&[L%8$N2#\;>)COCE#E&N<<Q)^?<X]#)>0G'0$5F;
MAO!L;N/0=RK>E2,QKT@UR3N'8&MI8[1B16QLCT&L'L3AW@C6$[Q1ZL+--DBS
M"=[0DK]C )L@9&,99U[(8PA!E?+"1<2NT81)4A&4?Q2G61XG9OB8'@C2J9@,
MPTTA1!P(NP)**'F7+8##^SGP3(P50,J#!-E!HM:X78N7'<M+X;,@H7W+W144
MY%C&A< /J8&@G(W1<E>*B:;E+A\//KLRF4<(THS$J)<]C>ZZ:@+8J""=^N,#
M!$,U%ST40"\57=^_@4R@>_]5(J%;NY7*LKBY27B%]2%=N5MSG!\,S>^KCH-B
M%#2,$[Y\;.^]@MC5AI<L;$03;9ZXT2IE<!JE6;*#&TA=S^#"2[)@%6QY04#1
M-*Z:EO(R3\M;+]+U<W_4/#"WZT+J#N1TD7I/*'=T<V<H?J$R)*ENI[JYYXZ=
M+@@N(#LWKL2+Z]:)9^S"53AP<3QT_1Y<N0-W('/E;86@=DW* X^W7I(W\"@K
M0UYE[&+A8H;=Q<H"35>/W:D05L@K!Y3'M:?P"FS&G.(=JE/(D+K=E27])ML7
M597KO^Y\T3H.6C^\3[-@PSZ.OB&&X(>2XFZ%JF(/?!8M.FDQ@[!7&#1OWE;2
M ?^^+EL;IJ6 8&?&CY(H]?882E/[)T$5&5#_*B_]_K",CRD3ADT042CB&D=<
M(UD?>>DM0P;^!_K*G1?23B68Q]PFTZ&,U!9QL@6HR@FS4=R0NH(?:#4>>;=,
M+FNM#30M74=52=&A<A(GQ3NA<#N@7#<C<)SAQM%CK-&^5KG/012U@-JY96&+
M9M>T&>\>,Y$:L%T,J/F8^Z.*2Y_?OI#AAF,1&HZHJJ)+U=.R=.N671V1VS&,
M$)5A\JXBEYV9I:K$QG-]>1'\(*5^59F-73NMFDCBHJ+WV3L&^*N176:"SSCU
M&H_'UZ!LGR@CNRI@-RKYP5G?:H8YAXI^8X5$4@%P%($M;8MUN)\H)+V;61<E
M\QP7"NQB8%2C+25?-GST/U!#US2$KRR-BB5:9IA+4@G2(2Q73W=Z(*GQT!F8
MRQE$3"%?/G6D8 ;9(*E*%/2+'M$FZ%V<9?'F?,T;:,K$X3$K\DN^C?-0D6"B
M>H#PD7!#):([*O)I8L3)5GE\Q6+'O ^6\19'ACH?1M'LVU@HH^>V>LE!$1P5
M[YI2(UVBG=9QM;M.Z>\[=I2)#J@#;B'%5-<-H*18J/*/RL%$C);=/0BI1UHF
M5"E'ZJ6.\NT(Q[GCPZ+Q4:>MDNM?5D5J\"'S.19D'&H>"9U%C9*(THEXOB[[
M(XHO+"%ZQ9F0].$Q_06C%YT>?)3-YO)9<.&(%FW<34=S*>.=*%&Z' _F>%/H
M3,@Q0A]6@_\81/24_9L[QYD)+E._NFUEL<3(4A[9]R@) , ,5.D!0F JG$WZ
M6+72]$)ZON9-%X_CC1>8I>MW9TVN*\E$1OYME6Q4X\@7,1+K^M-3NM**I"NS
MN/Z*)NZEX/3==6LOO>8KRF?R ^89#;.T^ L7 BX "N NC@SYIWO/AB]+M&M)
MSPG@O&9-4W#>Y'X9Q?WFI>'@$%!CT"\(,)2<HMX'_1R22D7GI+=519I&?\=/
M)>G'W2H;,A1L;?PH:H2.@4V]0;E4ZS@Q;JEQ+32-CSI]7]>_K*I@('3.V;RO
M91QJ2D5G4:/>UQ=)[.]6W)UX19.[8.5</-08N#U8E'@H\P_%>.Z+3O,9$D'"
MZ730Q]96RP/MVFW>)9^O3J,@"[RP*(LMNG#&T9F7^M[OQS3S@C"5Z+6*%\L0
M>(X4F:%XJ<*FGUX])3D0DE>G+9N6QA$1@,B/.:B?,-5A6]:63Z2AY+)*?37[
MB$*S'B5_+65Z1A+8IV0/E\(9Z.)CN#U0)"7ZN^V5>Q9''F_9"YF"2E?7(]ZX
M2@0<'9S]F*C:A\317CF>4.$W\]8934A"MW'"_RRR!64:'<I-W,?MYD6L)8AE
MB$_;63?X[M4"<'G9ZA Q]K.J+U(4JZ(!<Y1NUVFN2P748?=C+Q"'!N8>5&PD
M17'9S41:U)>;$2T>80O[\8IGOGOU>K9U)FE+X.Q+V-,H O1+L^#+4]0M/%'=
MG_W)W[M&3!#!@^MN80(5$[+"7]>*OR;9;1+O;FX)4R7)Z<7Y4[0'BG)94H9H
M"."<(:5[L$S;.(TN:0J%#,_7'Z"O>03S/Y0]X65,6M[2HA!2TZL:%D#AET2
MA2$W)6!RPR$_18Q_'42"#D,M"(C%Y"!:I"G-%I%?XCJ8HQY X :HDK=/\?(@
MU M3\4E)@^G#:7K9<DS9PR^!% OQ (3ZH5%*T[,X^Y5FT/O<C#U^#H?]G#^?
M:0Z)1'%&'AC#M@S84TP]HG^M'8Z9D@=#F1#E%ID4U:HP<C?\=:TJ>H%P[1)>
M'%^Q27GIM>)&7MX:\EF4MX3-5Z]\F<)W]\K"\OQ4+00 [TJ<F$)=Z7@,#F"(
MTOM[<;P>!R#GE%$U/8^DZ>5F4D)S>$Q<2H!@3ULIDOOQ1,1\Y1WN#R7:Q$Y
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MW6*Q"&]([QD164_;)DD=GTR%*8/W9QAJYBFM.Z*MA=RTX[QX@'Q%'?)K5X[
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M#,6NVMO NT-CQ<I<Z3FBMPV<K'E[F[,88JOC\(YW1LJWH\J6*V9S]:683Q@
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M2A]8J9:?7( @'K?H,8E)G4\*C4Z@ZAF?T;_3<J8Y((@H7985Z9U#^"<,BT&
MV89NJ*]E.%^0@:]=:WAP=RW)BT*@4/EL6=X44P5F= 3#J4^1M[AO[!AE<T6K
MV9.&!&/O9#F2V;VVQC<U6S*@B/#ATA9Z_!5M-1B3+,1VF>T*>W) #GVO^JA;
ME# 0T:'.\B%VA$,%Y-#8$J?,H;UZO:&_T>/29V%V0[L54D1;UUL]'H7"HYM+
M2:B=\)Y+B +T?LY>!]_8#@K[ZC18HP2PCJBY0R+H>WRF) ?UTQG#XMX@B/V_
M_P=02P$"% ,4    " #S12E5,B(H(: *  #8/   &               @ $
M    96$Q-C4T.3 M-FM?<V%V97)O;F4N:'1M4$L! A0#%     @ \T4I5:$,
MN:+K*@  I20! !L              ( !U@H  &5A,38U-#DP97@Y.2TQ7W-A
M=F5R;VYE+FAT;5!+ 0(4 Q0    ( /-%*57C7@T<V5P  *VA!  ;
M      "  ?HU  !E83$V-30Y,&5X.3DM,E]S879E<F]N92YH=&U02P$"% ,4
M    " #S12E5E94TKND/  #IF0  $0              @ $,DP  <W9R92TR
M,#(R,#8S,"YX<V102P$"% ,4    " #S12E5;[!9F(4+  !/AP  %0
M        @ $DHP  <W9R92TR,#(R,#8S,%]C86PN>&UL4$L! A0#%     @
M\T4I57/];%/R'P  ,;T! !4              ( !W*X  '-V<F4M,C R,C V
M,S!?9&5F+GAM;%!+ 0(4 Q0    ( /-%*57\012-65,  ";X P 5
M      "  0'/  !S=G)E+3(P,C(P-C,P7VQA8BYX;6Q02P$"% ,4    " #S
M12E59L;4+/X?   QV@$ %0              @ &-(@$ <W9R92TR,#(R,#8S
?,%]P<F4N>&UL4$L%!@     (  @ (P(  +Y" 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
